CINXE.COM

<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-sticky-header-enabled vector-toc-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>Sanofi - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-sticky-header-enabled vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"b29a10af-e2a7-4081-9caa-f079a9152d8a","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Sanofi","wgTitle":"Sanofi","wgCurRevisionId":1281041578,"wgRevisionId":1281041578,"wgArticleId":566975,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["All articles with dead external links","Articles with dead external links from January 2022","Webarchive template wayback links","Articles with dead external links from November 2019","CS1 French-language sources (fr)","CS1 German-language sources (de)","Articles with short description","Short description is different from Wikidata","Use dmy dates from April 2022","Articles containing potentially dated statements from 2009","All articles containing potentially dated statements","Articles containing potentially dated statements from 2013","Commons category link is on Wikidata","CAC 40","Sanofi","Biotechnology companies of France","Companies in the Euro Stoxx 50","Companies in the Dow Jones Global Titans 50","Companies listed on Euronext Paris","French brands","French companies established in 1973","Healthcare companies of France","Health care companies established in 1973","Multinational companies headquartered in France","Pharmaceutical companies established in 1973","Pharmaceutical companies of France"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Sanofi","wgRelevantArticleId":566975,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":90000,"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q158205","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGELevelingUpEnabledForUser":false}; RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","mediawiki.page.media","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.quicksurveys.init","ext.growthExperiments.SuggestedEditSession"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&only=styles&skin=vector-2022"> <script async="" src="/w/load.php?lang=en&modules=startup&only=scripts&raw=1&skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&modules=site.styles&only=styles&skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.21"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="Sanofi - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/Sanofi"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Sanofi&action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/Sanofi"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&feed=atom"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Sanofi rootpage-Sanofi skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" title="Main menu" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Main menu </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events">Current events</a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x">Random article</a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works">About Wikipedia</a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact us</a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia">Learn to edit</a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors">Community portal</a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r">Recent changes</a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia">Upload file</a></li><li id="n-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages">Special pages</a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"> Search </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page's font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Appearance </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/?wmf_source=donate&wmf_medium=sidebar&wmf_campaign=en.wikipedia.org&uselang=en" class="">Donate</a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&returnto=Sanofi" title="You are encouraged to create an account and log in; however, it is not mandatory" class="">Create account</a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&returnto=Sanofi" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o" class="">Log in</a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Personal tools </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/?wmf_source=donate&wmf_medium=sidebar&wmf_campaign=en.wikipedia.org&uselang=en">Donate</a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&returnto=Sanofi" title="You are encouraged to create an account and log in; however, it is not mandatory"> Create account</a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&returnto=Sanofi" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o"> Log in</a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing">learn more</a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> <div class="vector-sticky-pinned-container"> <nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark"> <div id="vector-toc-pinned-container" class="vector-pinned-container"> <div id="vector-toc" class="vector-toc vector-pinnable-element"> <div class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned" data-feature-name="toc-pinned" data-pinnable-element-id="vector-toc" > <h2 class="vector-pinnable-header-label">Contents</h2> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button> </div> <ul class="vector-toc-contents" id="mw-panel-toc-list"> <li id="toc-mw-content-text" class="vector-toc-list-item vector-toc-level-1"> <a href="#" class="vector-toc-link"> <div class="vector-toc-text">(Top)</div> </a> </li> <li id="toc-History" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#History"> <div class="vector-toc-text"> 1 History </div> </a> <button aria-controls="toc-History-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> Toggle History subsection </button> <ul id="toc-History-sublist" class="vector-toc-list"> <li id="toc-Sanofi-Synthélabo" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Sanofi-Synthélabo"> <div class="vector-toc-text"> 1.1 Sanofi-Synthélabo </div> </a> <ul id="toc-Sanofi-Synthélabo-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Aventis" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Aventis"> <div class="vector-toc-text"> 1.2 Aventis </div> </a> <ul id="toc-Aventis-sublist" class="vector-toc-list"> <li id="toc-Sanofi-Aventis_merger" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Sanofi-Aventis_merger"> <div class="vector-toc-text"> 1.2.1 Sanofi-Aventis merger </div> </a> <ul id="toc-Sanofi-Aventis_merger-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Post-merger_activities" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Post-merger_activities"> <div class="vector-toc-text"> 1.3 Post-merger activities </div> </a> <ul id="toc-Post-merger_activities-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Name_change,_acquisitions_and_investments" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Name_change,_acquisitions_and_investments"> <div class="vector-toc-text"> 1.4 Name change, acquisitions and investments </div> </a> <ul id="toc-Name_change,_acquisitions_and_investments-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Company_financials" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Company_financials"> <div class="vector-toc-text"> 1.5 Company financials </div> </a> <ul id="toc-Company_financials-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Acquisition_history" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Acquisition_history"> <div class="vector-toc-text"> 1.6 Acquisition history </div> </a> <ul id="toc-Acquisition_history-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Products" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Products"> <div class="vector-toc-text"> 2 Products </div> </a> <button aria-controls="toc-Products-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> Toggle Products subsection </button> <ul id="toc-Products-sublist" class="vector-toc-list"> <li id="toc-Pipeline" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pipeline"> <div class="vector-toc-text"> 2.1 Pipeline </div> </a> <ul id="toc-Pipeline-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Management" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Management"> <div class="vector-toc-text"> 2.2 Management </div> </a> <ul id="toc-Management-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Stockholders" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Stockholders"> <div class="vector-toc-text"> 2.3 Stockholders </div> </a> <ul id="toc-Stockholders-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Head_office" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Head_office"> <div class="vector-toc-text"> 3 Head office </div> </a> <ul id="toc-Head_office-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Collaborative_research" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Collaborative_research"> <div class="vector-toc-text"> 4 Collaborative research </div> </a> <ul id="toc-Collaborative_research-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Sanofi_Pasteur" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Sanofi_Pasteur"> <div class="vector-toc-text"> 5 Sanofi Pasteur </div> </a> <button aria-controls="toc-Sanofi_Pasteur-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> Toggle Sanofi Pasteur subsection </button> <ul id="toc-Sanofi_Pasteur-sublist" class="vector-toc-list"> <li id="toc-BCG_supply_shortage_2012–2014" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#BCG_supply_shortage_2012–2014"> <div class="vector-toc-text"> 5.1 BCG supply shortage 2012–2014 </div> </a> <ul id="toc-BCG_supply_shortage_2012–2014-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-COVID-19_vaccine" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#COVID-19_vaccine"> <div class="vector-toc-text"> 5.2 COVID-19 vaccine </div> </a> <ul id="toc-COVID-19_vaccine-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Associations" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Associations"> <div class="vector-toc-text"> 6 Associations </div> </a> <ul id="toc-Associations-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Aventis_Foundation" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Aventis_Foundation"> <div class="vector-toc-text"> 7 Aventis Foundation </div> </a> <ul id="toc-Aventis_Foundation-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-See_also" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#See_also"> <div class="vector-toc-text"> 8 See also </div> </a> <ul id="toc-See_also-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Notes" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Notes"> <div class="vector-toc-text"> 9 Notes </div> </a> <ul id="toc-Notes-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-References" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#References"> <div class="vector-toc-text"> 10 References </div> </a> <ul id="toc-References-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-External_links" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#External_links"> <div class="vector-toc-text"> 11 External links </div> </a> <ul id="toc-External_links-sublist" class="vector-toc-list"> </ul> </li> </ul> </div> </div> </nav> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left" title="Table of Contents" > <input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Toggle the table of contents </label> <div class="vector-dropdown-content"> <div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <h1 id="firstHeading" class="firstHeading mw-first-heading">Sanofi</h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 50 languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-50" aria-hidden="true" > 50 languages </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="interlanguage-link interwiki-af mw-list-item"><a href="https://af.wikipedia.org/wiki/Sanofi" title="Sanofi – Afrikaans" lang="af" hreflang="af" data-title="Sanofi" data-language-autonym="Afrikaans" data-language-local-name="Afrikaans" class="interlanguage-link-target">Afrikaans</a></li><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%B3%D8%A7%D9%86%D9%88%D9%81%D9%8A" title="سانوفي – Arabic" lang="ar" hreflang="ar" data-title="سانوفي" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target">العربية</a></li><li class="interlanguage-link interwiki-azb mw-list-item"><a href="https://azb.wikipedia.org/wiki/%D8%B3%D8%A7%D9%86%D9%88%D9%81%DB%8C" title="سانوفی – South Azerbaijani" lang="azb" hreflang="azb" data-title="سانوفی" data-language-autonym="تۆرکجه" data-language-local-name="South Azerbaijani" class="interlanguage-link-target">تۆرکجه</a></li><li class="interlanguage-link interwiki-bn mw-list-item"><a href="https://bn.wikipedia.org/wiki/%E0%A6%B8%E0%A6%BE%E0%A6%A8%E0%A7%8B%E0%A6%AB%E0%A6%BF" title="সানোফি – Bangla" lang="bn" hreflang="bn" data-title="সানোফি" data-language-autonym="বাংলা" data-language-local-name="Bangla" class="interlanguage-link-target">বাংলা</a></li><li class="interlanguage-link interwiki-bg mw-list-item"><a href="https://bg.wikipedia.org/wiki/%D0%A1%D0%B0%D0%BD%D0%BE%D1%84%D0%B8" title="Санофи – Bulgarian" lang="bg" hreflang="bg" data-title="Санофи" data-language-autonym="Български" data-language-local-name="Bulgarian" class="interlanguage-link-target">Български</a></li><li class="interlanguage-link interwiki-bs mw-list-item"><a href="https://bs.wikipedia.org/wiki/Sanofi" title="Sanofi – Bosnian" lang="bs" hreflang="bs" data-title="Sanofi" data-language-autonym="Bosanski" data-language-local-name="Bosnian" class="interlanguage-link-target">Bosanski</a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Sanofi" title="Sanofi – Catalan" lang="ca" hreflang="ca" data-title="Sanofi" data-language-autonym="Català" data-language-local-name="Catalan" class="interlanguage-link-target">Català</a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Sanofi" title="Sanofi – Czech" lang="cs" hreflang="cs" data-title="Sanofi" data-language-autonym="Čeština" data-language-local-name="Czech" class="interlanguage-link-target">Čeština</a></li><li class="interlanguage-link interwiki-da mw-list-item"><a href="https://da.wikipedia.org/wiki/Sanofi" title="Sanofi – Danish" lang="da" hreflang="da" data-title="Sanofi" data-language-autonym="Dansk" data-language-local-name="Danish" class="interlanguage-link-target">Dansk</a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Sanofi" title="Sanofi – German" lang="de" hreflang="de" data-title="Sanofi" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target">Deutsch</a></li><li class="interlanguage-link interwiki-et mw-list-item"><a href="https://et.wikipedia.org/wiki/Sanofi" title="Sanofi – Estonian" lang="et" hreflang="et" data-title="Sanofi" data-language-autonym="Eesti" data-language-local-name="Estonian" class="interlanguage-link-target">Eesti</a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Sanofi" title="Sanofi – Spanish" lang="es" hreflang="es" data-title="Sanofi" data-language-autonym="Español" data-language-local-name="Spanish" class="interlanguage-link-target">Español</a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Sanofi" title="Sanofi – Esperanto" lang="eo" hreflang="eo" data-title="Sanofi" data-language-autonym="Esperanto" data-language-local-name="Esperanto" class="interlanguage-link-target">Esperanto</a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Sanofi" title="Sanofi – Basque" lang="eu" hreflang="eu" data-title="Sanofi" data-language-autonym="Euskara" data-language-local-name="Basque" class="interlanguage-link-target">Euskara</a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%B3%D8%A7%D9%86%D9%88%D9%81%DB%8C" title="سانوفی – Persian" lang="fa" hreflang="fa" data-title="سانوفی" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target">فارسی</a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Sanofi" title="Sanofi – French" lang="fr" hreflang="fr" data-title="Sanofi" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target">Français</a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EC%82%AC%EB%85%B8%ED%94%BC" title="사노피 – Korean" lang="ko" hreflang="ko" data-title="사노피" data-language-autonym="한국어" data-language-local-name="Korean" class="interlanguage-link-target">한국어</a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/Sanofi" title="Sanofi – Armenian" lang="hy" hreflang="hy" data-title="Sanofi" data-language-autonym="Հայերեն" data-language-local-name="Armenian" class="interlanguage-link-target">Հայերեն</a></li><li class="interlanguage-link interwiki-hr mw-list-item"><a href="https://hr.wikipedia.org/wiki/Sanofi" title="Sanofi – Croatian" lang="hr" hreflang="hr" data-title="Sanofi" data-language-autonym="Hrvatski" data-language-local-name="Croatian" class="interlanguage-link-target">Hrvatski</a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Sanofi" title="Sanofi – Indonesian" lang="id" hreflang="id" data-title="Sanofi" data-language-autonym="Bahasa Indonesia" data-language-local-name="Indonesian" class="interlanguage-link-target">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-is mw-list-item"><a href="https://is.wikipedia.org/wiki/Sanofi" title="Sanofi – Icelandic" lang="is" hreflang="is" data-title="Sanofi" data-language-autonym="Íslenska" data-language-local-name="Icelandic" class="interlanguage-link-target">Íslenska</a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Sanofi" title="Sanofi – Italian" lang="it" hreflang="it" data-title="Sanofi" data-language-autonym="Italiano" data-language-local-name="Italian" class="interlanguage-link-target">Italiano</a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%A1%D7%90%D7%A0%D7%95%D7%A4%D7%99" title="סאנופי – Hebrew" lang="he" hreflang="he" data-title="סאנופי" data-language-autonym="עברית" data-language-local-name="Hebrew" class="interlanguage-link-target">עברית</a></li><li class="interlanguage-link interwiki-kk mw-list-item"><a href="https://kk.wikipedia.org/wiki/Sanofi" title="Sanofi – Kazakh" lang="kk" hreflang="kk" data-title="Sanofi" data-language-autonym="Қазақша" data-language-local-name="Kazakh" class="interlanguage-link-target">Қазақша</a></li><li class="interlanguage-link interwiki-sw mw-list-item"><a href="https://sw.wikipedia.org/wiki/Sanofi" title="Sanofi – Swahili" lang="sw" hreflang="sw" data-title="Sanofi" data-language-autonym="Kiswahili" data-language-local-name="Swahili" class="interlanguage-link-target">Kiswahili</a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Sanofi" title="Sanofi – Latvian" lang="lv" hreflang="lv" data-title="Sanofi" data-language-autonym="Latviešu" data-language-local-name="Latvian" class="interlanguage-link-target">Latviešu</a></li><li class="interlanguage-link interwiki-hu mw-list-item"><a href="https://hu.wikipedia.org/wiki/Sanofi" title="Sanofi – Hungarian" lang="hu" hreflang="hu" data-title="Sanofi" data-language-autonym="Magyar" data-language-local-name="Hungarian" class="interlanguage-link-target">Magyar</a></li><li class="interlanguage-link interwiki-arz mw-list-item"><a href="https://arz.wikipedia.org/wiki/%D8%B3%D8%A7%D9%86%D9%88%D9%81%D9%89" title="سانوفى – Egyptian Arabic" lang="arz" hreflang="arz" data-title="سانوفى" data-language-autonym="مصرى" data-language-local-name="Egyptian Arabic" class="interlanguage-link-target">مصرى</a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Sanofi" title="Sanofi – Malay" lang="ms" hreflang="ms" data-title="Sanofi" data-language-autonym="Bahasa Melayu" data-language-local-name="Malay" class="interlanguage-link-target">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Sanofi" title="Sanofi – Dutch" lang="nl" hreflang="nl" data-title="Sanofi" data-language-autonym="Nederlands" data-language-local-name="Dutch" class="interlanguage-link-target">Nederlands</a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E3%82%B5%E3%83%8E%E3%83%95%E3%82%A3" title="サノフィ – Japanese" lang="ja" hreflang="ja" data-title="サノフィ" data-language-autonym="日本語" data-language-local-name="Japanese" class="interlanguage-link-target">日本語</a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Sanofi" title="Sanofi – Norwegian Bokmål" lang="nb" hreflang="nb" data-title="Sanofi" data-language-autonym="Norsk bokmål" data-language-local-name="Norwegian Bokmål" class="interlanguage-link-target">Norsk bokmål</a></li><li class="interlanguage-link interwiki-uz mw-list-item"><a href="https://uz.wikipedia.org/wiki/Sanofi" title="Sanofi – Uzbek" lang="uz" hreflang="uz" data-title="Sanofi" data-language-autonym="Oʻzbekcha / ўзбекча" data-language-local-name="Uzbek" class="interlanguage-link-target">Oʻzbekcha / ўзбекча</a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Sanofi" title="Sanofi – Polish" lang="pl" hreflang="pl" data-title="Sanofi" data-language-autonym="Polski" data-language-local-name="Polish" class="interlanguage-link-target">Polski</a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Sanofi" title="Sanofi – Portuguese" lang="pt" hreflang="pt" data-title="Sanofi" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target">Português</a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Sanofi" title="Sanofi – Romanian" lang="ro" hreflang="ro" data-title="Sanofi" data-language-autonym="Română" data-language-local-name="Romanian" class="interlanguage-link-target">Română</a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/Sanofi" title="Sanofi – Russian" lang="ru" hreflang="ru" data-title="Sanofi" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target">Русский</a></li><li class="interlanguage-link interwiki-sah mw-list-item"><a href="https://sah.wikipedia.org/wiki/Sanofi" title="Sanofi – Yakut" lang="sah" hreflang="sah" data-title="Sanofi" data-language-autonym="Саха тыла" data-language-local-name="Yakut" class="interlanguage-link-target">Саха тыла</a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Sanofi_(company)" title="Sanofi (company) – Simple English" lang="en-simple" hreflang="en-simple" data-title="Sanofi (company)" data-language-autonym="Simple English" data-language-local-name="Simple English" class="interlanguage-link-target">Simple English</a></li><li class="interlanguage-link interwiki-sk mw-list-item"><a href="https://sk.wikipedia.org/wiki/Sanofi" title="Sanofi – Slovak" lang="sk" hreflang="sk" data-title="Sanofi" data-language-autonym="Slovenčina" data-language-local-name="Slovak" class="interlanguage-link-target">Slovenčina</a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Sanofi" title="Sanofi – Slovenian" lang="sl" hreflang="sl" data-title="Sanofi" data-language-autonym="Slovenščina" data-language-local-name="Slovenian" class="interlanguage-link-target">Slovenščina</a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Sanofi" title="Sanofi – Serbian" lang="sr" hreflang="sr" data-title="Sanofi" data-language-autonym="Српски / srpski" data-language-local-name="Serbian" class="interlanguage-link-target">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Sanofi" title="Sanofi – Serbo-Croatian" lang="sh" hreflang="sh" data-title="Sanofi" data-language-autonym="Srpskohrvatski / српскохрватски" data-language-local-name="Serbo-Croatian" class="interlanguage-link-target">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/Sanofi" title="Sanofi – Finnish" lang="fi" hreflang="fi" data-title="Sanofi" data-language-autonym="Suomi" data-language-local-name="Finnish" class="interlanguage-link-target">Suomi</a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Sanofi" title="Sanofi – Swedish" lang="sv" hreflang="sv" data-title="Sanofi" data-language-autonym="Svenska" data-language-local-name="Swedish" class="interlanguage-link-target">Svenska</a></li><li class="interlanguage-link interwiki-th mw-list-item"><a href="https://th.wikipedia.org/wiki/%E0%B8%8B%E0%B8%B2%E0%B9%82%E0%B8%99%E0%B8%9F%E0%B8%B5%E0%B9%88" title="ซาโนฟี่ – Thai" lang="th" hreflang="th" data-title="ซาโนฟี่" data-language-autonym="ไทย" data-language-local-name="Thai" class="interlanguage-link-target">ไทย</a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Sanofi" title="Sanofi – Turkish" lang="tr" hreflang="tr" data-title="Sanofi" data-language-autonym="Türkçe" data-language-local-name="Turkish" class="interlanguage-link-target">Türkçe</a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/Sanofi" title="Sanofi – Ukrainian" lang="uk" hreflang="uk" data-title="Sanofi" data-language-autonym="Українська" data-language-local-name="Ukrainian" class="interlanguage-link-target">Українська</a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/Sanofi" title="Sanofi – Vietnamese" lang="vi" hreflang="vi" data-title="Sanofi" data-language-autonym="Tiếng Việt" data-language-local-name="Vietnamese" class="interlanguage-link-target">Tiếng Việt</a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E8%B5%9B%E8%AF%BA%E8%8F%B2" title="赛诺菲 – Chinese" lang="zh" hreflang="zh" data-title="赛诺菲" data-language-autonym="中文" data-language-local-name="Chinese" class="interlanguage-link-target">中文</a></li> </ul> <div class="after-portlet after-portlet-lang"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q158205#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Sanofi" title="View the content page [c]" accesskey="c">Article</a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:Sanofi" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t">Talk</a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" >English </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Sanofi">Read</a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Sanofi&action=edit" title="Edit this page [e]" accesskey="e">Edit</a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Sanofi&action=history" title="Past revisions of this page [h]" accesskey="h">View history</a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" >Tools </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Sanofi">Read</a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Sanofi&action=edit" title="Edit this page [e]" accesskey="e">Edit</a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Sanofi&action=history">View history</a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Sanofi" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Sanofi" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Sanofi&oldid=1281041578" title="Permanent link to this revision of this page">Permanent link</a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Sanofi&action=info" title="More information about this page">Page information</a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&page=Sanofi&id=1281041578&wpFormIdentifier=titleform" title="Information on how to cite this page">Cite this page</a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlShortener&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FSanofi">Get shortened URL</a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrCode&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FSanofi">Download QR code</a></li> </ul> </div> </div> <div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export" > <div class="vector-menu-heading"> Print/export </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&page=Sanofi&action=show-download-screen" title="Download this page as a PDF file">Download as PDF</a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Sanofi&printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Sanofi" hreflang="en">Wikimedia Commons</a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q158205" title="Structured data on this page hosted by Wikidata [g]" accesskey="g">Wikidata item</a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> <div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div> </div> <div id="contentSub"><div id="mw-content-subtitle"></div></div> <div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">French multinational pharmaceutical and healthcare company</div> <style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><style data-mw-deduplicate="TemplateStyles:r1242257876">.mw-parser-output .ib-company .infobox-label{padding-right:0.5em}.mw-parser-output .ib-company .infobox-data,.mw-parser-output .ib-company .infobox-below{line-height:1.35em}.mw-parser-output .ib-company-logo img{background-color:#f8f9fa}.mw-parser-output .ib-company-locality,.mw-parser-output .ib-company-country{display:inline}</style><table class="infobox ib-company vcard"><caption class="infobox-title fn org" style="font-size: 125%;">Sanofi S.A.</caption><tbody><tr><td colspan="2" class="infobox-image ib-company-logo logo"><a href="/wiki/File:Sanofi-2022.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Sanofi-2022.svg/220px-Sanofi-2022.svg.png" decoding="async" width="220" height="58" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Sanofi-2022.svg/330px-Sanofi-2022.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Sanofi-2022.svg/440px-Sanofi-2022.svg.png 2x" data-file-width="512" data-file-height="136" /></a></td></tr><tr><th scope="row" class="infobox-label">Formerly</th><td class="infobox-data nickname"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class="plainlist"> <ul><li>Sanofi-Synthélabo (1999–2004)</li> <li>Sanofi-Aventis (2004–2011)</li></ul> </div></td></tr><tr><th scope="row" class="infobox-label">Company type</th><td class="infobox-data category"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></div></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" /><div class="plainlist"><ul><li><a href="/wiki/Euronext_Paris" title="Euronext Paris">Euronext Paris</a>: <a rel="nofollow" class="external text" href="https://euronext.com/products/equities/FR0000120578-XPAR">SAN</a></li><li><a href="/wiki/Nasdaq" title="Nasdaq">Nasdaq</a>: <a rel="nofollow" class="external text" href="https://www.nasdaq.com/market-activity/stocks/sny">SNY</a></li><li><a href="/wiki/CAC_40" title="CAC 40">CAC 40</a> component</li></ul></div></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td class="infobox-data"><a class="external text" href="https://isin.toolforge.org/?language=en&isin=FR0000120578">FR0000120578</a></td></tr><tr><th scope="row" class="infobox-label">Industry</th><td class="infobox-data category"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" /><div class="plainlist"><ul><li><a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceuticals</a></li><li><a href="/wiki/Biotechnology" title="Biotechnology">Biotechnology</a></li><li><a href="/wiki/Healthcare_industry" title="Healthcare industry">Healthcare</a></li></ul></div></td></tr><tr><th scope="row" class="infobox-label">Founded</th><td class="infobox-data">15 February 1973; 52 years ago (1973-02-15)</td></tr><tr><th scope="row" class="infobox-label">Headquarters</th><td class="infobox-data label"><a href="/wiki/Paris" title="Paris">Paris</a>, France</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;">Area served</div></th><td class="infobox-data">Worldwide</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;">Key people</div></th><td class="infobox-data agent"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" /><div class="plainlist"><ul><li><a href="/wiki/Serge_Weinberg" title="Serge Weinberg">Serge Weinberg</a> (<a href="/wiki/Chairman" class="mw-redirect" title="Chairman">chairman</a>)</li><li><a href="/wiki/Paul_Hudson_(businessman)" title="Paul Hudson (businessman)">Paul Hudson</a> (<a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a>)</li></ul></div></td></tr><tr><th scope="row" class="infobox-label">Products</th><td class="infobox-data"><a href="/wiki/Medication" title="Medication">Medications</a>, <a href="/wiki/Generic_drug" title="Generic drug">generic drugs</a>, <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter drugs</a>, <a href="/wiki/Vaccine" title="Vaccine">vaccines</a>, <a href="/wiki/Medical_diagnosis" title="Medical diagnosis">diagnostics</a>, <a href="/wiki/Contact_lens" title="Contact lens">contact lenses</a>, <a href="/wiki/Veterinary_medicine" title="Veterinary medicine">animal health</a> (<a href="#Products">list...</a>)</td></tr><tr><th scope="row" class="infobox-label">Revenue</th><td class="infobox-data"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /> <a href="/wiki/Euro" title="Euro">€</a>41.08 billion (2024)</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td class="infobox-data"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /> €7.252 billion (2024)</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td class="infobox-data"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /> €5.618 billion (2024)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Asset" title="Asset">Total assets</a></th><td class="infobox-data"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /> €132.8 billion (2024)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></th><td class="infobox-data"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /> €77.86 billion (2024)</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;">Number of employees</div></th><td class="infobox-data">82,878 (2024)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Subsidiary" title="Subsidiary">Subsidiaries</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" /><div class="plainlist"> <ul><li><a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Sanofi Pasteur</a></li> <li><a href="/wiki/Genzyme" title="Genzyme">Genzyme</a></li> <li><a href="/wiki/Shantha_Biotechnics" title="Shantha Biotechnics">Shantha Biotechnics</a></li> <li><a href="/wiki/Chattem" title="Chattem">Chattem</a></li> <li><a href="/wiki/Ablynx" title="Ablynx">Ablynx</a></li> <li><a href="/wiki/Bioverativ" title="Bioverativ">Bioverativ</a></li> <li class="mw-empty-elt"></li></ul> </div></td></tr><tr><th scope="row" class="infobox-label">Website</th><td class="infobox-data"><a rel="nofollow" class="external text" href="http://sanofi.com">sanofi.com</a></td></tr><tr><td colspan="2" class="infobox-below">Footnotes / references <a href="#cite_note-FY-1">[1]</a></td></tr></tbody></table> Sanofi S.A. is a French <a href="/wiki/Multinational_corporation" title="Multinational corporation">multinational</a> pharmaceutical and healthcare company headquartered in <a href="/wiki/Paris" title="Paris">Paris</a>, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the <a href="/wiki/Euro_Stoxx_50" class="mw-redirect" title="Euro Stoxx 50">Euro Stoxx 50</a> <a href="/wiki/Stock_market_index" title="Stock market index">stock market index</a>.<a href="#cite_note-2">[2]</a> In 2023, the company’s seat in <a href="/wiki/Forbes_Global_2000" title="Forbes Global 2000">Forbes Global 2000</a> was 89.<a href="#cite_note-3">[3]</a> Sanofi engages in the <a href="/wiki/Research_and_development" title="Research and development">research and development</a>, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter medications</a>. The corporation covers seven major therapeutic areas: <a href="/wiki/Circulatory_system" title="Circulatory system">cardiovascular</a>, <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a>, <a href="/wiki/Diabetes" title="Diabetes">diabetes</a>, <a href="/wiki/Internal_medicine" title="Internal medicine">internal medicine</a>, <a href="/wiki/Oncology" title="Oncology">oncology</a>, <a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a>, and <a href="/wiki/Vaccine" title="Vaccine">vaccines</a>. It is the world's largest producer of vaccines through its subsidiary <a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Sanofi Pasteur</a>.<a href="#cite_note-4">[4]</a> <meta property="mw:PageProp/toc" /> <div class="mw-heading mw-heading2"><h2 id="History">History</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=1" title="Edit section: History">edit</a>]</div> <div class="mw-heading mw-heading3"><h3 id="Sanofi-Synthélabo">Sanofi-Synthélabo</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=2" title="Edit section: Sanofi-Synthélabo">edit</a>]</div> Sanofi was founded in 15 February 1973<a href="#cite_note-5">[5]</a> as a subsidiary of <a href="/wiki/Elf_Aquitaine" title="Elf Aquitaine">Elf Aquitaine</a> (a French oil company subsequently acquired by <a href="/wiki/TotalEnergies" title="TotalEnergies">Total</a>), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company formed in 1947 by Sociéte Belge de l'Azote et des Produits Chimiques du Marly;<a href="#cite_note-6">[6]</a> Labaz developed <a href="/wiki/Benziodarone" title="Benziodarone">benziodarone</a> in 1957.<a href="#cite_note-7">[7]</a>: 146  In 1993, Sanofi made a move into the Eastern Europe market by acquiring a controlling interest in Chinoin, a Hungarian drug company whose 1992, sales totaled about US$104 million.<a href="#cite_note-PL1993-8">[8]</a><a href="#cite_note-9">[9]</a> In the same year, Sanofi made its first significant venture into the US, and strengthened its presence in Eastern Europe, by first partnering with <a href="/wiki/Sterling_Drug" title="Sterling Drug">Sterling Winthrop</a> and then acquiring the prescription pharmaceuticals business in 1994.<a href="#cite_note-PL1993-8">[8]</a><a href="#cite_note-SterlingHist-10">[10]</a> Sanofi was incorporated under the laws of France in 1994, as a société anonyme, a form of limited <a href="/wiki/Liability_(financial_accounting)" title="Liability (financial accounting)">liability</a> company.<a href="#cite_note-20F-2002-11">[11]</a>: 18  Synthélabo was founded in 1970, through the merger of two French pharmaceutical laboratories, Laboratoires Dausse (founded in 1834)б and Laboratoires Robert & Carrière (founded in 1899). In 1973, the French cosmetics group <a href="/wiki/L%27Or%C3%A9al" title="L'Oréal">L'Oréal</a> acquired the majority of its share capital.<a href="#cite_note-20F-2002-11">[11]</a>: 19  In 1991, Synthelabo acquired Laboratories Delalande<a href="#cite_note-12">[12]</a> and Laboratoires Delagrange, and through this deal picked up the product <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a>.<a href="#cite_note-13">[13]</a><a href="#cite_note-14">[14]</a> <figure class="mw-halign-left" typeof="mw:File/Thumb"><a href="/wiki/File:Sanofi_Synthelabo_Logo.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Sanofi_Synthelabo_Logo.svg/200px-Sanofi_Synthelabo_Logo.svg.png" decoding="async" width="200" height="25" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Sanofi_Synthelabo_Logo.svg/300px-Sanofi_Synthelabo_Logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Sanofi_Synthelabo_Logo.svg/400px-Sanofi_Synthelabo_Logo.svg.png 2x" data-file-width="400" data-file-height="50" /></a><figcaption>Logo for Sanofi-Synthélabo (1999—2004)</figcaption></figure> Sanofi-Synthélabo was formed in 1999 when Sanofi merged with Synthélabo; at the time of the merger, Sanofi was the second largest pharmaceutical group in France in terms of sales and Synthélabo was the third largest. The merged company was based in Paris, France.<a href="#cite_note-20F-2002-11">[11]</a>: 18–19 <a href="#cite_note-15">[15]</a> The merged companies focused on pharmaceuticals, divesting several businesses soon after the merger, including beauty, diagnostics, animal health and nutrition, custom chemicals, and two medical equipment businesses.<a href="#cite_note-20F-2002-11">[11]</a>: 19  <div class="mw-heading mw-heading3"><h3 id="Aventis">Aventis</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=3" title="Edit section: Aventis">edit</a>]</div> Aventis was formed in 1999, when the French company <a href="/wiki/Rh%C3%B4ne-Poulenc" title="Rhône-Poulenc">Rhône-Poulenc</a> S.A. merged with the German corporation <a href="/wiki/Hoechst_Marion_Roussel" class="mw-redirect" title="Hoechst Marion Roussel">Hoechst Marion Roussel</a>, which itself was formed from the 1995 merger of <a href="/wiki/Hoechst_AG" title="Hoechst AG">Hoechst AG</a> with <a href="/wiki/Cassella" title="Cassella">Cassella</a>, <a href="/wiki/Roussel_Uclaf" title="Roussel Uclaf">Roussel Uclaf</a>, and <a href="/wiki/Marion_Merrell_Dow" title="Marion Merrell Dow">Marion Merrell Dow</a>. <a href="/wiki/Hoechst_AG" title="Hoechst AG">Hoechst AG</a>, the majority partner at the time in <a href="/wiki/Hoechst_Marion_Roussel" class="mw-redirect" title="Hoechst Marion Roussel">Hoechst Marion Roussel</a>, was itself a merger of two of the three <a href="/wiki/IG_Farben#Seizure_by_the_Allies" title="IG Farben">forcibly separated</a> subsidiaries of <a href="/wiki/IG_Farben" title="IG Farben">IG Farben</a>, exploiter of <a href="/wiki/Auschwitz" class="mw-redirect" title="Auschwitz">Auschwitz</a> slave labor and supplier of <a href="/wiki/Zyklon_B" title="Zyklon B">Zyklon B</a> during <a href="/wiki/The_Holocaust" title="The Holocaust">The Holocaust</a>.<a href="#cite_note-16">[16]</a> The merged company was based in <a href="/wiki/Schiltigheim" title="Schiltigheim">Schiltigheim</a>, near <a href="/wiki/Strasbourg" title="Strasbourg">Strasbourg</a>, France.<a href="#cite_note-Aventis-Form20F2002-17">[17]</a>: 13 <a href="#cite_note-Bris-18">[18]</a>: 9–11 <a href="#cite_note-Burns-19">[19]</a>: 40–41  At the time of the merger, Rhône-Poulenc's business included the pharmaceutical businesses Rorer, Centeon (blood products), and <a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Pasteur Merieux</a> (vaccines), the plant and animal health businesses Rhône-Poulenc Agro, Rhône-Poulenc Animal Nutrition, and <a href="/wiki/Merial" class="mw-redirect" title="Merial">Merial</a>, and a 67 percent share in <a href="/wiki/Rhodia_(company)" title="Rhodia (company)">Rhodia</a>, a speciality chemicals company.<a href="#cite_note-Bris-18">[18]</a>: 10  Hoechst, one of the companies that resulted from the post-WWII split of <a href="/wiki/IG_Farben" title="IG Farben">IG Farben</a>, had seven primary businesses: Hoechst Marion Roussel (pharmaceuticals), <a href="/wiki/AgrEvo" class="mw-redirect" title="AgrEvo">AgrEvo</a> (a joint venture with <a href="/wiki/Schering_AG" title="Schering AG">Schering</a> in crop protection agents and pest control products), HR Vet (veterinary products), <a href="/wiki/Dade_Behring" title="Dade Behring">Dade Behring</a> (diagnostics), Centeon, <a href="/wiki/Celanese" title="Celanese">Celanese</a> (chemicals), and Messer (chemicals).<a href="#cite_note-Bris-18">[18]</a>: 9  <a href="/wiki/Institut_M%C3%A9rieux" title="Institut Mérieux">Merieux</a> has been in the business of selling blood products, and in the 1980s, during the <a href="/wiki/History_of_HIV/AIDS#1981–1982:_From_GRID_to_AIDS" title="History of HIV/AIDS">AIDS epidemic</a>, Merieux and other companies were involved in scandals related to HIV-<a href="/wiki/Contaminated_haemophilia_blood_products" title="Contaminated haemophilia blood products">contaminated haemophilia blood products</a> that were sold to developing nations.<a href="#cite_note-NYTimes1996-20">[20]</a> In 2000, Aventis and <a href="/wiki/Millennium_Pharmaceuticals" class="mw-redirect" title="Millennium Pharmaceuticals">Millennium Pharmaceuticals</a>, a US biotechnology company formed to discover new drugs based on the then-new science of <a href="/wiki/Genomics" title="Genomics">genomics</a>, announced that Aventis would make a $250M investment in Millennium and would pay $200M to Millennium in research fees over five years, one of the largest such deals between a big pharmaceutical company and a biotech company at the time.<a href="#cite_note-21">[21]</a> In late 2000, in the midst of the <a href="/wiki/StarLink_corn_recall" title="StarLink corn recall">recall of Starlink</a>, its <a href="/wiki/Genetically_modified_maize" title="Genetically modified maize">genetically modified maize</a> product, Aventis announced that it had determined to sell off Aventis Cropscience, the seed and pesticide business unit it had created from the agriculture businesses of its predecessors.<a href="#cite_note-22">[22]</a> In October 2001, <a href="/wiki/Bayer" title="Bayer">Bayer</a> and Aventis announced that Bayer would acquire the unit for about $6.6 billion; the unit became <a href="/wiki/Bayer_CropScience" class="mw-redirect" title="Bayer CropScience">Bayer CropScience</a>, making Bayer the world's second-largest agrochemical company behind <a href="/wiki/Syngenta" title="Syngenta">Syngenta</a>.<a href="#cite_note-23">[23]</a> In 2003, Aventis entered into a collaboration with <a href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron Pharmaceuticals</a>, a New York biotechnology company, to develop Regeneron's <a href="/wiki/VEGF" class="mw-redirect" title="VEGF">VEGF</a>-inhibiting drug, <a href="/wiki/Aflibercept" title="Aflibercept">aflibercept</a>, which was then in <a href="/wiki/Phases_of_clinical_research" title="Phases of clinical research">Phase I</a> clinical trials. Aventis invested $45 million in Regeneron and made an upfront payment of $80 million in cash.<a href="#cite_note-24">[24]</a> Regeneron partnered the use of the drug with <a href="/wiki/Bayer_Healthcare" class="mw-redirect" title="Bayer Healthcare">Bayer Healthcare</a> in the field of proliferative eye diseases, and under the name Eylea it was approved by the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) in 2011;<a href="#cite_note-25">[25]</a> after several setbacks in clinical trials,<a href="#cite_note-26">[26]</a> Regeneron and Sanofi got the drug approved for metastatic colorectal cancer in combination with other agents, under the brand name Zaltrap in 2012.<a href="#cite_note-ZaltrapFDA-27">[27]</a> <div class="mw-heading mw-heading4"><h4 id="Sanofi-Aventis_merger">Sanofi-Aventis merger</h4>[<a href="/w/index.php?title=Sanofi&action=edit&section=4" title="Edit section: Sanofi-Aventis merger">edit</a>]</div> Sanofi-Aventis was formed in 2004, when Sanofi-Synthélabo acquired Aventis. In early 2004, Sanofi-Synthélabo made a <a href="/wiki/Takeover" title="Takeover">hostile takeover</a> bid for Aventis worth €47.8 billion. Initially, Aventis rejected the bid because it felt that the bid offered inferior value based on the company's share value, and the board of Aventis went so far as to enact <a href="/wiki/Shareholder_rights_plan" title="Shareholder rights plan">poison pill</a> provisions and to invite <a href="/wiki/Novartis" title="Novartis">Novartis</a> to enter merger negotiations.<a href="#cite_note-28">[28]</a> The three-month takeover battle concluded when Sanofi-Synthélabo launched a friendly bid of €54.5 billion in place of the previously rejected hostile bid. The French government played a strong role, desiring what it called a "local solution", by putting heavy pressure on Sanofi-Synthélabo to raise its bid for Aventis and for Aventis to accept the offer<a href="#cite_note-29">[29]</a> and by rejecting Aventis's poison pill proposal.<a href="#cite_note-30">[30]</a> One of the largest risks in the deal for both sides was the fate of the patents protecting <a href="/wiki/Clopidogrel" title="Clopidogrel">Clopidogrel</a> (Plavix), which was one of the top-selling drugs in the world at the time and the major source of Sanofi's revenue.<a href="#cite_note-31">[31]</a> <div class="mw-heading mw-heading3"><h3 id="Post-merger_activities">Post-merger activities</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=5" title="Edit section: Post-merger activities">edit</a>]</div> In 2006, Iraqis infected with HIV sued Sanofi and Baxter over HIV-<a href="/wiki/Contaminated_haemophilia_blood_products" title="Contaminated haemophilia blood products">contaminated haemophilia blood products</a> sold by Merieux in the 1980s.<a href="#cite_note-32">[32]</a> In 2006, the US patents on <a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a> (Plavix) were challenged when a Canadian generics company, <a href="/wiki/Apotex" title="Apotex">Apotex</a>, filed an <a href="/wiki/Abbreviated_New_Drug_Application" title="Abbreviated New Drug Application">Abbreviated New Drug Application</a> under the <a href="/wiki/Hatch-Waxman_Act" class="mw-redirect" title="Hatch-Waxman Act">Hatch-Waxman Act</a>, received FDA approval, and started marketing a generic formulation of clopidogrel. While Sanofi-Aventis and its partner in the drug, <a href="/wiki/Bristol_Myers_Squibb" title="Bristol Myers Squibb">Bristol Myers Squibb</a> (BMS), were able to get an injunction to stop Apotex from selling it,<a href="#cite_note-33">[33]</a> the case became complicated when settlement negotiations fell apart twice – the second time because of an <a href="/wiki/Oral_agreement" class="mw-redirect" title="Oral agreement">oral agreement</a> made by BMS CEO Peter Dolan that BMS failed to disclose to the <a href="/wiki/Federal_Trade_Commission" title="Federal Trade Commission">Federal Trade Commission</a> during the review of the settlement agreement to ensure that it did not violate <a href="/wiki/Antitrust" class="mw-redirect" title="Antitrust">antitrust</a> law. When Apotex disclosed the oral agreement to the FTC, the FTC launched an investigation that led to Dolan's dismissal by BMS.<a href="#cite_note-34">[34]</a> Apotex finally lost on the patent litigation issues after its third appeal was decided in favor of BMS/Sanofi in November 2011; Apotex had to pay ~$442 million in damages and ~$108 million in interest for infringing the patent,<a href="#cite_note-35">[35]</a> which it paid in full by February 2012.<a href="#cite_note-36">[36]</a> Apotex also sued BMS and Sanofi for $3.4 billion for allegedly breaching the settlement agreement; Apotex lost a jury trial in March 2013.<a href="#cite_note-37">[37]</a> In 2007, Sanofi-Aventis expanded on Aventis's prior relationship with <a href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron Pharmaceuticals</a>; in the new deal Sanofi-Aventis agreed to pay Regeneron $100 million per year for five years, under which Regeneron would use its <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a> <a href="/wiki/Drug_discovery" title="Drug discovery">discovery</a> platform to create new <a href="/wiki/Biopharmaceuticals" class="mw-redirect" title="Biopharmaceuticals">biopharmaceuticals</a>, to which Sanofi-Aventis gained the exclusive right to co-develop.<a href="#cite_note-RegenExpand-38">[38]</a> In 2009, the companies expanded the deal to $160 million per year and extended it to 2017.<a href="#cite_note-RegenExpand-38">[38]</a><a href="#cite_note-GEN2009-39">[39]</a> As of 2009<a class="external text" href="https://en.wikipedia.org/w/index.php?title=Sanofi&action=edit">[update]</a>, the collaboration had four antibodies in clinical development and had filed an IND for a fifth. Two were against undisclosed targets, one targeted the <a href="/wiki/Interleukin-6" class="mw-redirect" title="Interleukin-6">interleukin-6</a> <a href="/wiki/Cell_surface_receptor" title="Cell surface receptor">receptor</a> as a treatment for <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, another targeted <a href="/wiki/Nerve_growth_factor" title="Nerve growth factor">nerve growth factor</a> for the treatment of pain, and another targeted <a href="/wiki/DLL4" title="DLL4">delta-like ligand 4</a> as a cancer treatment.<a href="#cite_note-GEN2009-39">[39]</a> Between 2008, when <a href="/wiki/Chris_Viehbacher" title="Chris Viehbacher">Chris Viehbacher</a> was hired as CEO, and 2010, the company spent more than $17 billion in mergers and acquisitions to strengthen its consumer healthcare and generics platforms, especially in emerging markets, in the face of looming <a href="/wiki/Patent_cliff" title="Patent cliff">patent cliffs</a> and the growth of the consumer healthcare segment.<a href="#cite_note-40">[40]</a><a href="#cite_note-41">[41]</a><a href="#cite_note-Chattem-42">[42]</a> In September, <a href="/wiki/Zentiva" title="Zentiva">Zentiva</a> was acquired for €1.8 billion, expanding the group's presence in eastern European markets.<a href="#cite_note-43">[43]</a> In 2009, Medley Farma, the third largest pharmaceutical company in Brazil and a leading generics company there, was acquired for about $635 million.<a href="#cite_note-Law360Medley-44">[44]</a> Sanofi outbid <a href="/wiki/Teva_Pharmaceuticals" title="Teva Pharmaceuticals">Teva Pharmaceuticals</a>.<a href="#cite_note-45">[45]</a> The deal was approved by Brazil's antitrust authorities in May 2010.<a href="#cite_note-Law360Medley-44">[44]</a> Later that year, Indian vaccine manufacturer <a href="/wiki/Shantha_Biotechnics" title="Shantha Biotechnics">Shantha Biotechnics</a> was acquired for $784 million.<a href="#cite_note-46">[46]</a> In October Sanofi-Aventis announced that it would lay off about 1700 US employees (about 25% of its US workforce) because of restructuring triggered by growing generic competition and other factors, and that the company would focus its US operations on diabetes, atrial fibrillation, and oncology.<a href="#cite_note-47">[47]</a> In 2010, US consumer healthcare company <a href="/wiki/Chattem" title="Chattem">Chattem, Inc.</a> was acquired for around $1.9 billion.<a href="#cite_note-Chattem-42">[42]</a> In the same year, Nepentes Pharma was acquired for $130 million and BMP Sunstone Corporation for $520.6 million.<a href="#cite_note-48">[48]</a> <div class="mw-heading mw-heading3"><h3 id="Name_change,_acquisitions_and_investments">Name change, acquisitions and investments</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=6" title="Edit section: Name change, acquisitions and investments">edit</a>]</div> The company dropped the -Aventis suffix of its name on May 6, 2011, after receiving approval at its <a href="/wiki/Annual_general_meeting" title="Annual general meeting">annual general meeting</a>. The reason given by the company for the change was to make its name easier to pronounce in countries such as China.<a href="#cite_note-49">[49]</a> In 2011, <a href="/wiki/Genzyme_Corporation" class="mw-redirect" title="Genzyme Corporation">Genzyme Corporation</a> was acquired for around $20.1 billion. This biotechnology company, headquartered in Cambridge, Massachusetts, specializes in the treatment of <a href="/wiki/Orphan_diseases" class="mw-redirect" title="Orphan diseases">orphan diseases</a>, renal diseases, endocrinology, oncology, and biosurgery.<a href="#cite_note-50">[50]</a> In January 2012, Sanofi co-invested in the $125 million <a href="/wiki/Series_A_round" title="Series A round">Series A financing</a> of Warp Drive Bio. Sanofi sought support for its internal cancer research program and also took on an obligation to acquire Warp Drive if certain milestones were met.<a href="#cite_note-51">[51]</a> In January 2014, Genzyme and <a href="/wiki/Alnylam_Pharmaceuticals" title="Alnylam Pharmaceuticals">Alnylam Pharmaceuticals</a>, a US biotechnology company developing <a href="/wiki/RNAi" class="mw-redirect" title="RNAi">RNAi</a> therapeutics, announced that Genyzme would invest $700 million in Alnylam. Under the deal, Genzyme obtained further rights to patisiran, an RNAi treatment for <a href="/wiki/Transthyretin" title="Transthyretin">transthyretin</a>-mediated <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a> – a condition that can result in <a href="/wiki/Familial_amyloidotic_polyneuropathy" class="mw-redirect" title="Familial amyloidotic polyneuropathy">familial amyloidotic polyneuropathy</a> and familial amyloidotic cardiomyopathy<a href="#cite_note-52">[52]</a> and obtained rights to other compounds in Alnylam's pipeline.<a href="#cite_note-53">[53]</a> In March 2014, Sanofi joined the bidding for Merck & Co.'s over-the-counter health-products unit, the maker of <a href="/wiki/Coppertone_(sunscreen)" title="Coppertone (sunscreen)">Coppertone</a> sunblock and the antihistamine <a href="/wiki/Pseudoephedrine/loratadine" title="Pseudoephedrine/loratadine">Claritin</a>; bids were expected to range between $10 billion and $12 billion.<a href="#cite_note-54">[54]</a> In October 2014, Sanofi's directors fired US-resident chief executive <a href="/wiki/Chris_Viehbacher" title="Chris Viehbacher">Chris Viehbacher</a>, blaming his alleged lack of communication with the board and poor execution of his strategy.<a href="#cite_note-55">[55]</a> Board chairperson Serge Weinberg took over as interim CEO until 2 April 2015 when <a href="/wiki/Bayer" title="Bayer">Bayer Healthcare</a> board chairman <a href="/wiki/Olivier_Brandicourt" title="Olivier Brandicourt">Olivier Brandicourt</a> (appointed by Sanofi on 19 February 2015<a href="#cite_note-56">[56]</a>) took over. Before Brandicourt even started his new job, French government ministers <a href="/wiki/St%C3%A9phane_Le_Foll" title="Stéphane Le Foll">Stéphane Le Foll</a> and <a href="/wiki/S%C3%A9gol%C3%A8ne_Royal" title="Ségolène Royal">Ségolène Royal</a> attacked the $4.5 million <a href="/wiki/Golden_handshake" title="Golden handshake">golden handshake</a> he was getting from Sanofi – and his pay of about $4.7 million a year.<a href="#cite_note-57">[57]</a> Furthermore, in 2014, the business took a 66% stake in Globalpharma, a Dubai-based generics manufacturer.<a href="#cite_note-58">[58]</a> In July 2015, <a href="/wiki/Genzyme" title="Genzyme">Genzyme</a> announced that it would acquire the cancer drug Caprelsa (<a href="/wiki/Vandetanib" title="Vandetanib">vandetanib</a>) from <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a> for up to $300 million.<a href="#cite_note-59">[59]</a> In the same month, the company announced a new global collaboration with <a href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron Pharmaceuticals</a> to discover, develop, and commercialize new immuno-oncology drugs, which could generate more than $2 billion for Regeneron,<a href="#cite_note-60">[60]</a> with $640 million upfront, $750 million for proof of concept data, and $650 million from the development of <a href="/wiki/REGN2810" class="mw-redirect" title="REGN2810">REGN2810</a>.<a href="#cite_note-61">[61]</a> In June 2016, the company announced that it had struck an asset-swap deal with <a href="/wiki/Boehringer_Ingelheim" title="Boehringer Ingelheim">Boehringer Ingelheim</a>. Sanofi would sell its <a href="/wiki/Merial" class="mw-redirect" title="Merial">Merial</a> animal health division (valuing it at €11.4 billion), while acquiring Boehringer's consumer health division (valuing it at €6.7 billion) and €4.7 billion in cash. The deal meant that Sanofi was now one of the global consumer healthcare leaders by market share.<a href="#cite_note-62">[62]</a> In July 2017, the company announced its intention to acquire Protein Sciences, a privately held Connecticut-based vaccines biotechnology company, for $650 million and with up to $100 million in milestone achievements.<a href="#cite_note-63">[63]</a> In January 2018, Sanofi announced that it would acquire <a href="/wiki/Bioverativ" title="Bioverativ">Bioverativ</a> for $11.6 billion<a href="#cite_note-64">[64]</a> and days later announced that it would acquire <a href="/wiki/Ablynx" title="Ablynx">Ablynx</a> for €3.9 billion ($4.8 billion).<a href="#cite_note-65">[65]</a> In December 2019, the company announced that it would acquire Synthorx for $2.5 billion ($68 per share), adding the lead product candidate THOR-707 (SAR444245), a form of <a href="/wiki/Interleukin-2" class="mw-redirect" title="Interleukin-2">interleukin-2</a> (IL-2) being developed for use against multiple solid tumors.<a href="#cite_note-66">[66]</a><a href="#cite_note-67">[67]</a> In October 2022, Sanofi announced that it had stopped Phase 2 studies of THOR-707 (SAR444245) because the drug's efficacy “was lower than projected”.<a href="#cite_note-68">[68]</a> Sanofi would take a roughly $1.6 billion impairment charge because of delays to the program.<a href="#cite_note-69">[69]</a><a href="#cite_note-70">[70]</a> In May 2020, <a href="/wiki/Regeneron" class="mw-redirect" title="Regeneron">Regeneron</a> announced that it would repurchase around $5 billion of its shares held directly by Sanofi. Before the transaction, Sanofi had held 23.2 million Regeneron shares.<a href="#cite_note-71">[71]</a> In June, the company announced that it had agreed a potential $2 billion deal with Translate Bio, expanding an already existing collaboration for COVID-19 treatments.<a href="#cite_note-72">[72]</a> The company agreed to produce 60 million doses of a coronavirus vaccine for the United Kingdom government in July 2020. It used recombinant protein-based technology for Sanofi's flu vaccine along with <a href="/wiki/GlaxoSmithKline" class="mw-redirect" title="GlaxoSmithKline">GSK</a>'s pandemic technology and was seeking regulatory approval by the first half of 2021.<a href="#cite_note-73">[73]</a> Sanofi also agreed to a $2.1 billion deal with the United States for 100 million doses.<a href="#cite_note-74">[74]</a> In August, Sanofi announced that it would acquire Principia Biopharma for $3.7 billion, acquiring its <a href="/wiki/BTK_inhibitor" class="mw-redirect" title="BTK inhibitor">BTK inhibitor</a> program.<a href="#cite_note-75">[75]</a><a href="#cite_note-76">[76]</a><a href="#cite_note-77">[77]</a> The acquisition was completed in September 2020.<a href="#cite_note-78">[78]</a> In November, Sanofi announced that it would acquire Kiadis Pharma for €308 million (around $359 million, or €5.45 per share), expanding its immuno-oncology pipeline with the acquisition of Kiadis's three clinical compounds: K-NK002 in Phase II trials for <a href="/wiki/Hematopoietic_stem_cell" title="Hematopoietic stem cell">hematopoietic stem cell</a> transplants in blood cancer, K-NK003 for relapsed or refractory <a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">acute myeloid leukemia</a>, and K-NK-ID101 for <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a>.<a href="#cite_note-79">[79]</a> In January 2021, Sanofi announced that it would buy the British biotech Kymab Ltd and its potential first-in-class drug candidate – KY1005 –- for $1.45 billion.<a href="#cite_note-80">[80]</a><a href="#cite_note-81">[81]</a><a href="#cite_note-82">[82]</a> In April, the business announced that it would acquire Tidal Therapeutics for up to $470m.<a href="#cite_note-83">[83]</a> in August the company announced that it would acquire Translate Bio and its mRNA vaccine technology for $3.2 billion.<a href="#cite_note-84">[84]</a> On 8 September 2021, Sanofi announced that it would acquire US biotech company <a href="/wiki/Kadmon_Corporation" title="Kadmon Corporation">Kadmon Corporation</a> for $1.9 billion<a href="#cite_note-85">[85]</a> On 18 November 2021, it was reported that Sanofi would be investing $180 million in French startup <a href="/wiki/Owkin" title="Owkin">Owkin</a>, whose predictive algorithms aim to improve the research and development of new cures against cancer.<a href="#cite_note-86">[86]</a> In December, the company announced that it would acquire Origimm Biotechnology GmbH and its acne vaccine candidate (ORI-001),<a href="#cite_note-87">[87]</a><a href="#cite_note-88">[88]</a> as well as Amunix Pharmaceuticals, for an initial $1 billion plus potentially $200 million in additional milestones.<a href="#cite_note-89">[89]</a> In April 2022, Sanofi broke ground on its biggest industrial investment, a $638m vaccine and enzymes production facility in <a href="/wiki/Tuas" title="Tuas">Tuas</a>, <a href="/wiki/Singapore" title="Singapore">Singapore</a>, targeted for completion in 2025.<a href="#cite_note-90">[90]</a> In March 2023, the company announced it would acquire Provention Bio and its type 1 diabetes therapy pipeline.<a href="#cite_note-91">[91]</a> In the fall of 2023, Sanofi announced plans to separate the OTC and focus on its key prescription production, increasing investment and reducing costs. The most likely way to separate a non-prescription division (about 11,000 employees, 2023 revenue — over $4 billion) is to create a public company headquartered in France. The division is planned for the fourth quarter of 2024.<a href="#cite_note-92">[92]</a> In December 2023, the company has signed a 140 million dollars partnership with Aqemia, a company that solves a mathematical equation that eliminates the need for heavy computing facilities with large computing power.<a href="#cite_note-93">[93]</a> In January 2024, Sanofi announced that it had agreed to buy a U.S. biotech firm Inhibrx for up to $2.2 billion, with a focus on obtaining Inhibrx's INBRX-101, an experimental treatment for <a href="/wiki/Alpha-1_antitrypsin_deficiency" title="Alpha-1 antitrypsin deficiency">Alpha-1 Antitrypsin Deficiency</a> (AATD), an inherited rare disease that causes progressive deterioration of the lung tissue.<a href="#cite_note-94">[94]</a> The post-acquisition company now employs more than 90,000 employees in 90 countries.<a href="#cite_note-95">[95]</a> In October 2024, Sanofi and CD&R entered exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder.<a href="#cite_note-96">[96]</a> <div class="mw-heading mw-heading3"><h3 id="Company_financials">Company financials</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=7" title="Edit section: Company financials">edit</a>]</div> <table class="wikitable"> <caption>Historical financial data (in billions of <a href="/wiki/Euro" title="Euro">euro</a>)<a href="#cite_note-97">[97]</a><a href="#cite_note-98">[98]</a><a href="#cite_note-99">[99]</a><a href="#cite_note-100">[100]</a><a href="#cite_note-101">[101]</a><a href="#cite_note-Form_20-F_2018-102">[102]</a><a href="#cite_note-103">[103]</a> </caption> <tbody><tr> <th>Year</th> <th>2001</th> <th>2002</th> <th>2003</th> <th>2004</th> <th>2005</th> <th>2006</th> <th>2007</th> <th>2008</th> <th>2009</th> <th>2010</th> <th>2011</th> <th>2012</th> <th>2013</th> <th>2014</th> <th>2015</th> <th>2016 </th> <th>2017 </th> <th>2018 </th> <th>2019 </th> <th>2023 </th></tr> <tr> <td>Revenue</td> <td>6.069</td> <td>7.448</td> <td>8.048</td> <td>14.87</td> <td>27.31</td> <td>28.37</td> <td>28.05</td> <td>27.57</td> <td>29.31</td> <td>30.38</td> <td>33.39</td> <td>34.95</td> <td>30.97</td> <td>31.69</td> <td>34.54</td> <td>33.82 </td> <td>35.07 </td> <td>34.46 </td> <td>36.13 </td> <td>43.07 </td></tr> <tr> <td>Net Income</td> <td>1.098</td> <td>1.640</td> <td>1.865</td> <td>-3.665</td> <td>2.202</td> <td>4.006</td> <td>5.263</td> <td>3.851</td> <td>5.265</td> <td>5.467</td> <td>5.646</td> <td>4.888</td> <td>3.716</td> <td>4.390</td> <td>4.287</td> <td>4.800 </td> <td>8.42 </td> <td>4.31 </td> <td>2.81 </td> <td>5.43 </td></tr> <tr> <td>Assets</td> <td>18.23</td> <td>17.36</td> <td>17.42</td> <td>82.85</td> <td>86.24</td> <td>77.76</td> <td>71.91</td> <td>71.99</td> <td>80.25</td> <td>85.26</td> <td>100.7</td> <td>100.4</td> <td>96.06</td> <td>97.39</td> <td>102.3</td> <td>104.7 </td> <td>99.81 </td> <td>111.41 </td> <td>112.74 </td> <td>126.4 </td></tr> <tr> <td>Equity</td> <td>12.75</td> <td>12.60</td> <td>12.74</td> <td>41.63</td> <td>46.40</td> <td>45.60</td> <td>44.54</td> <td>44.87</td> <td>48.32</td> <td>53.10</td> <td>56.19</td> <td>57.35</td> <td>56.9</td> <td>56.12</td> <td>58.05</td> <td>57.72 </td> <td>58.07 </td> <td>58.88 </td> <td>58.93 </td> <td>74.35 </td></tr></tbody></table> Note. In 2001–2004: Sanofi-Synthélabo; in 2004–2011: Sanofi-Aventis. <div class="mw-heading mw-heading3"><h3 id="Acquisition_history">Acquisition history</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=8" title="Edit section: Acquisition history">edit</a>]</div> <style data-mw-deduplicate="TemplateStyles:r1214851843">.mw-parser-output .hidden-begin{box-sizing:border-box;width:100%;padding:5px;border:none;font-size:95%}.mw-parser-output .hidden-title{font-weight:bold;line-height:1.6;text-align:left}.mw-parser-output .hidden-content{text-align:left}@media all and (max-width:500px){.mw-parser-output .hidden-begin{width:auto!important;clear:none!important;float:none!important}}</style><div class="hidden-begin mw-collapsible mw-collapsed" style="border:1px #aaa solid;"><div class="hidden-title skin-nightmode-reset-color" style="text-align:center;">Sanofi Acquisitions</div><div class="hidden-content mw-collapsible-content" style=""> <style data-mw-deduplicate="TemplateStyles:r1116488514">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("https://upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview"> <ul><li>Sanofi <ul><li>Sanofi–Aventis <ul><li><a href="/wiki/Aventis" class="mw-redirect" title="Aventis">Aventis</a> (Merged 2004) <ul><li><a href="/wiki/Rh%C3%B4ne-Poulenc" title="Rhône-Poulenc">Rhône-Poulenc</a> (Merged 1999) <ul><li>Rorer</li> <li>Centeon</li> <li>Pasteur Merieux</li> <li>Rhône-Poulenc Agro</li> <li>Rhône-Poulenc Animal Nutrition</li> <li>Merial (Sold to <a href="/wiki/Boehringer_Ingelheim" title="Boehringer Ingelheim">Boehringer Ingelheim</a> 2016)</li> <li><a href="/wiki/Rhodia_(company)" title="Rhodia (company)">Rhodia</a></li></ul></li> <li><a href="/wiki/Hoechst_Marion_Roussel" class="mw-redirect" title="Hoechst Marion Roussel">Hoechst Marion Roussel</a> (Merged 1999) <ul><li><a href="/wiki/AgrEvo" class="mw-redirect" title="AgrEvo">AgrEvo</a></li> <li>HR Vet</li> <li><a href="/wiki/Dade_Behring" title="Dade Behring">Dade Behring</a></li> <li>Centeon</li> <li><a href="/wiki/Celanese" title="Celanese">Celanese</a></li> <li>Messer</li></ul></li></ul></li> <li><a href="/wiki/Sanofi-Synth%C3%A9labo" class="mw-redirect" title="Sanofi-Synthélabo">Sanofi-Synthélabo</a> (Merged 2004) <ul><li>Sanofi (Est 1973 as subsidiary of <a href="/wiki/Elf_Aquitaine" title="Elf Aquitaine">Elf Aquitaine</a>) <ul><li>Midy</li> <li><a href="/wiki/Sterling_Winthrop" class="mw-redirect" title="Sterling Winthrop">Sterling Winthrop</a> (Acq 1994)</li></ul></li> <li><a href="/wiki/Synth%C3%A9labo" class="mw-redirect" title="Synthélabo">Synthélabo</a> <ul><li>Laboratoires Dausse (Founded 1834, merged 1970)</li> <li>Robert & Carrière (Founded 1899, merged 1970)</li></ul></li></ul></li> <li><a href="/wiki/Zentiva" title="Zentiva">Zentiva</a> (Acq 2008) <ul><li>Leciva Slovakofarma (Acq 2003)</li> <li>Sicomed SA Bucharest (Acq 2005)</li></ul></li> <li>Medley Farma (Acq 2009)</li> <li>Shantha Biotechnics (Acq 2009)</li> <li>Chattem (Acq 2010)</li> <li>Nepentes Pharma (Acq 2010)</li> <li>BMP Sunstone Corporation (Acq 2010)</li></ul></li> <li><a href="/wiki/Genzyme_Corporation" class="mw-redirect" title="Genzyme Corporation">Genzyme Corporation</a> (Acq 2011) <ul><li>Whatman Biochemicals Ltd (Acq 1981)</li> <li>Koch-Light Laboratories (Acq 1982)</li> <li>Integrated Genetics (Acq 1989, spun off 1991)</li> <li>Genecore International (Diagnostic enzyme div, acq 1991)</li> <li>Medix Biotech, Inc. (Acq 1992)</li> <li>Enzymatix Ltd (Acq 1992)</li> <li>Vivigen (Acq 1992)</li> <li>Virotech (Acq 1993)</li> <li>Omni Res srl (Acq 1993)</li> <li>Sygena Ltd (Acq 1994)</li> <li>BioSurface Technology Inc. (Acq 1994)</li> <li>TSI Inc. (Acq 1994)</li> <li>PharmaGenics, Inc. (Acq 1997)</li> <li>Biomatrix (Acq 2000)</li> <li>SangStat Medical Corp. (Acq 2003)</li> <li>Ilex Oncology Inc. (Acq 2004)</li> <li>Bone Care International Inc. (Acq 2005)</li> <li>AnorMED Inc. (Acq 2006)</li> <li>Bioenvision (Acq 2007)</li></ul></li> <li>Protein Sciences (Acq 2017)</li> <li><a href="/wiki/Bioverativ" title="Bioverativ">Bioverativ</a> (Acq 2018) <ul><li>True North Therapeutics (Acq 2017)</li></ul></li> <li><a href="/wiki/Ablynx" title="Ablynx">Ablynx</a> (Acq 2018)</li> <li>Synthorx (Acq 2019)</li> <li>Principia Biopharma (Acq 2020)</li> <li>Kiadis Pharma (Acq 2020)</li> <li>Kymab Ltd (Acq 2021)</li> <li>Tidal Therapeutics (Acq 2021)</li> <li>Translate Bio (Acq 2021)</li> <li><a href="/wiki/Kadmon_Corporation" title="Kadmon Corporation">Kadmon Corporation</a> (Acq 2021)</li> <li>Origimm Biotechnology GmbH (Acq 2021)</li> <li>Amunix Pharmaceuticals (Acq 2021)</li> <li>Provention Bio (Acq 2023)</li> <li>Inhibrx (Acq 2024)<a href="#cite_note-104">[104]</a></li></ul></li></ul> </div> </div></div> <div class="mw-heading mw-heading2"><h2 id="Products">Products</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=9" title="Edit section: Products">edit</a>]</div> The following products are listed on the Sanofi Genzyme website. <a href="/wiki/Generic_drug" title="Generic drug">Generic drug</a> names are given in parentheses following the brand name. – <a href="/wiki/Autoimmune" class="mw-redirect" title="Autoimmune">Autoimmune</a> <style data-mw-deduplicate="TemplateStyles:r1184024115">.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}</style><div class="div-col"> <ul><li><a href="/wiki/Aubagio" class="mw-redirect" title="Aubagio">Aubagio</a> (<a href="/wiki/Teriflunomide" title="Teriflunomide">Teriflunomide</a>), small molecule for <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>. Approved by the FDA in September 2012.<a href="#cite_note-105">[105]</a></li> <li><a href="/wiki/Auvi-Q" class="mw-redirect" title="Auvi-Q">Auvi-Q</a> (<a href="/wiki/Epinephrine_autoinjector" title="Epinephrine autoinjector">Epinephrine autoinjector</a>), licensed from Intelliject<a href="#cite_note-106">[106]</a> and approved by the FDA in 2012, for emergency treatment of life-threatening <a href="/wiki/Allergic_reactions" class="mw-redirect" title="Allergic reactions">allergic reactions</a>.<a href="#cite_note-107">[107]</a></li></ul> </div> Product recall and effects: The epinephrine (adrenaline) auto-injection devices made by Sanofi SA currently on the market in the US and Canada were voluntarily recalled on 28 October 2015.<a href="#cite_note-108">[108]</a><a href="#cite_note-109">[109]</a> The reason given by Sanofi was that the products had been found to potentially have inaccurate dosage delivery systems, which might include failure to deliver the drugs.<a href="#cite_note-auvi-q.com-110">[110]</a><a href="#cite_note-fda.gov-111">[111]</a> Sanofi US also added the following warning: If a patient experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death, because anaphylaxis is a potentially life‑threatening condition.<a href="#cite_note-auvi-q.com-110">[110]</a> In its news release on 28 October 2015, Sanofi Canada stated that it was "actively working with suppliers of alternative epinephrine auto-injectors to have a full stock available in Canada as soon as possible. Canadian customers were asked to immediately return the Allerject product to their local pharmacy to obtain an alternate epinephrine auto-injector."<a href="#cite_note-112">[112]</a> The US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) also filed a news release,<a href="#cite_note-fda.gov-111">[111]</a> confirming that the recall involved all Auvi-Q currently on the market in the United States. The FDA release went on to provide information for consumers re: exchanging the device for another brand of product, also provided on the Auvi-Q web site. Sanofi US would provide reimbursement for out of pocket costs incurred for the purchase of new, alternate epinephrine auto-injectors with proof of purchase.<a href="#cite_note-113">[113]</a> The alternate products expected to most commonly replace the recalled Sanofi devices were the EpiPens made by <a href="/wiki/Mylan" title="Mylan">Mylan</a> in the US and by Pfizer—under license from Mylan—in Canada.<a href="#cite_note-114">[114]</a> Mylan already had an 85% market share of the auto-injectors in the USA<a href="#cite_note-115">[115]</a> in the first half of 2015. Maylan was expected to benefit from the recall by its competitor Sanofi, according to a report published in the Fierce Pharma newsletter of 2 November 2015. As Bernstein analyst Ronny Gal wrote in a note to clients,"....it is very hard to see Auvi-Q returning to the market, as it will need to be redesigned and face uphill battle to recapture patient trust after the recall."<a href="#cite_note-116">[116]</a> Gal also believed that the company would eventually have 95% of the epinephrine auto-injector market, according to another Fierce Pharma report on 3 November 2015.<a href="#cite_note-117">[117]</a> – <a href="/wiki/Cardiovascular" class="mw-redirect" title="Cardiovascular">Cardiovascular</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Adenoscan" class="mw-redirect" title="Adenoscan">Adenoscan</a> (<a href="/wiki/Adenosine" title="Adenosine">Adenosine</a>), for arrhythmias, marketed by Astellas.</li> <li><a href="/wiki/Altace" class="mw-redirect" title="Altace">Altace</a> (<a href="/wiki/Ramipril" title="Ramipril">Ramipril</a>), for <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, marketed by Pfizer.</li> <li><a href="/wiki/Arixtra" class="mw-redirect" title="Arixtra">Arixtra</a> (<a href="/wiki/Fondaparinux" title="Fondaparinux">Fondaparinux</a>), for thrombosis, marketed by GlaxoSmithKline and now owned by Mylan.</li> <li><a href="/wiki/Avalide" class="mw-redirect" title="Avalide">Avalide</a> (<a href="/wiki/Irbesartan" title="Irbesartan">Irbesartan</a>), for <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, marketed by Bristol-Myers Squibb.</li> <li><a href="/wiki/Avapro" class="mw-redirect" title="Avapro">Avapro</a> (<a href="/wiki/Irbesartan" title="Irbesartan">Irbesartan</a>), for <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, marketed by Bristol-Myers Squibb.</li> <li><a href="/wiki/Cardizem" class="mw-redirect" title="Cardizem">Cardizem</a> (<a href="/wiki/Diltiazem" title="Diltiazem">Diltiazem</a>), for <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, Now owned by Bausch Health.</li> <li><a href="/wiki/Cholestagel" class="mw-redirect" title="Cholestagel">Cholestagel</a> (<a href="/wiki/Colesevelam" title="Colesevelam">Colesevelam</a>), for low-calorie diet and exercise.</li> <li><a href="/wiki/Cordarone" class="mw-redirect" title="Cordarone">Cordarone</a> (<a href="/wiki/Amiodarone" title="Amiodarone">Amiodarone</a>), for heart rhythm problems.</li> <li>Iprivask (<a href="/wiki/Desirudin" class="mw-redirect" title="Desirudin">Desirudin</a>), for atherothrombosis, Now owned by Bausch Health.</li> <li><a href="/wiki/Kynamro" class="mw-redirect" title="Kynamro">Kynamro</a> (<a href="/wiki/Mipomersen" title="Mipomersen">Mipomersen</a>), an <a href="/wiki/Antisense_drug" class="mw-redirect" title="Antisense drug">antisense drug</a> invented by <a href="/wiki/Isis_Pharmaceuticals" class="mw-redirect" title="Isis Pharmaceuticals">Isis Pharmaceuticals</a> and acquired by Genzyme in 2008, (pre-Sanofi)<a href="#cite_note-118">[118]</a> and approved by the FDA in 2013, for the <a href="/wiki/Orphan_disease" class="mw-redirect" title="Orphan disease">orphan disease</a> <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">homozygous familial hypercholesterolemia</a>.<a href="#cite_note-119">[119]</a></li> <li><a href="/wiki/Lasix" class="mw-redirect" title="Lasix">Lasix</a> (<a href="/wiki/Furosemide" title="Furosemide">Furosemide</a>), for edema.</li> <li><a href="/wiki/Lovenox" class="mw-redirect" title="Lovenox">Lovenox</a> (<a href="/wiki/Enoxaparin" class="mw-redirect" title="Enoxaparin">Enoxaparin</a>), for thrombosis, (its biggest seller in 2008).<a href="#cite_note-120">[120]</a></li> <li><a href="/wiki/Multaq" class="mw-redirect" title="Multaq">Multaq</a> (<a href="/wiki/Dronedarone" title="Dronedarone">Dronedarone</a>), for cardiac arrhythmias.</li> <li><a href="/wiki/Nitrolingual" class="mw-redirect" title="Nitrolingual">Nitrolingual</a> (<a href="/wiki/Nitroglycerin" title="Nitroglycerin">Nitroglycerin</a>), for chest pain and angina, marketed by G. Pohl-Boskamp GmbH & Co.</li> <li><a href="/wiki/Plavix" class="mw-redirect" title="Plavix">Plavix</a> (<a href="/wiki/Clopidogrel" title="Clopidogrel">Clopidogrel</a>), for atherothrombosis, marketed by Bristol-Myers Squibb.</li> <li><a href="/wiki/Praluent" class="mw-redirect" title="Praluent">Praluent</a> (<a href="/wiki/Alirocumab" title="Alirocumab">Alirocumab</a>), for heterozygous familial hypercholesterolemia and clinical atherosclerotic cardiovascular disease, marketed by Regeneron.</li> <li><a href="/wiki/Ranexa" class="mw-redirect" title="Ranexa">Ranexa</a> (<a href="/wiki/Ranolazine" title="Ranolazine">Ranolazine</a>), for stable angina, marketed by Gilead Sciences.</li></ul> </div> – <a href="/wiki/Dermatology" title="Dermatology">Dermatology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Dupixent" class="mw-redirect" title="Dupixent">Dupixent</a> (<a href="/wiki/Dupilumab" title="Dupilumab">Dupilumab</a>), for eczema, marketed by Regeneron.</li> <li><a href="/wiki/Dynabac" class="mw-redirect" title="Dynabac">Dynabac</a> (<a href="/wiki/Dirithromycin" title="Dirithromycin">Dirithromycin</a>), for acute bacteria exacerbations.</li> <li>Sklice (<a href="/wiki/Ivermectin" title="Ivermectin">Ivermectin</a>), for head lice, now owned by Arbor Pharmaceuticals.</li></ul> </div> – <a href="/wiki/Diabetes" title="Diabetes">Diabetes</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li>Adlyxin (<a href="/wiki/Lixisenatide" title="Lixisenatide">Lixisenatide</a>), for type 2 diabetes mellitus.</li> <li>Admelog (insulin lispro), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Afrezza" class="mw-redirect" title="Afrezza">Afrezza</a> (<a href="/wiki/Inhalable_insulin" title="Inhalable insulin">Inhalable insulin</a>), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Amaryl" class="mw-redirect" title="Amaryl">Amaryl</a> (<a href="/wiki/Glimepiride" title="Glimepiride">Glimepiride</a>), for type 2 diabetes mellitus.</li> <li><a href="/wiki/Apidra" class="mw-redirect" title="Apidra">Apidra</a> (insulin glulisine), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Diabeta" class="mw-redirect" title="Diabeta">Diabeta</a> (<a href="/wiki/Glyburide" class="mw-redirect" title="Glyburide">Glyburide</a>), for type 2 diabetes mellitus.</li> <li><a href="/wiki/Glucophage" class="mw-redirect" title="Glucophage">Glucophage</a> (<a href="/wiki/Metformin" title="Metformin">Metformin</a>), for type 2 diabetes mellitus, marketed by EMD Serono.</li> <li>Insuman (<a href="/wiki/Insulin" title="Insulin">Human insulin</a>), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Lantus" class="mw-redirect" title="Lantus">Lantus</a> (insulin glargine), for type 1 and type 2 diabetes mellitus.</li> <li>Soliqua (insulin glargine/lixisenatide), for type 2 diabetes mellitus.</li> <li><a href="/wiki/Toujeo" class="mw-redirect" title="Toujeo">Toujeo</a> (insulin glargine), for <a href="/wiki/Diabetes_mellitus#Type_1_diabetes" class="mw-redirect" title="Diabetes mellitus">type 1</a> and <a href="/wiki/Diabetes_mellitus#Type_2_diabetes" class="mw-redirect" title="Diabetes mellitus">type 2</a> <a href="/wiki/Diabetes_mellitus" class="mw-redirect" title="Diabetes mellitus">diabetes mellitus</a>.</li></ul> </div> – <a href="/wiki/Endocrinology" title="Endocrinology">Endocrinology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li>Adlyxin (<a href="/wiki/Lixisenatide" title="Lixisenatide">Lixisenatide</a>), for type 2 diabetes mellitus.</li> <li>Admelog (insulin lispro), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Afrezza" class="mw-redirect" title="Afrezza">Afrezza</a> (<a href="/wiki/Inhalable_insulin" title="Inhalable insulin">Inhalable insulin</a>), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Amaryl" class="mw-redirect" title="Amaryl">Amaryl</a> (<a href="/wiki/Glimepiride" title="Glimepiride">Glimepiride</a>), for type 2 diabetes mellitus.</li> <li><a href="/wiki/Apidra" class="mw-redirect" title="Apidra">Apidra</a> (insulin glulisine), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Cholestagel" class="mw-redirect" title="Cholestagel">Cholestagel</a> (<a href="/wiki/Colesevelam" title="Colesevelam">Colesevelam</a>), for low-calorie diet and exercise.</li> <li><a href="/wiki/Diabeta" class="mw-redirect" title="Diabeta">Diabeta</a> (<a href="/wiki/Glyburide" class="mw-redirect" title="Glyburide">Glyburide</a>), for type 2 diabetes mellitus.</li> <li><a href="/wiki/Glucophage" class="mw-redirect" title="Glucophage">Glucophage</a> (<a href="/wiki/Metformin" title="Metformin">Metformin</a>), for type 2 diabetes mellitus, marketed by EMD Serono.</li> <li><a href="/wiki/Hectorol" class="mw-redirect" title="Hectorol">Hectorol</a> (<a href="/wiki/Doxercalciferol" title="Doxercalciferol">Doxercalciferol</a>), for parathyroid hormone.</li> <li>Insuman (<a href="/wiki/Insulin" title="Insulin">Human insulin</a>), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Lantus" class="mw-redirect" title="Lantus">Lantus</a> (insulin glargine), for type 1 and type 2 diabetes mellitus.</li> <li><a href="/wiki/Skelid" class="mw-redirect" title="Skelid">Skelid</a> (<a href="/wiki/Tiludronic_acid" title="Tiludronic acid">Tiludronic acid</a>), for <a href="/wiki/Paget%27s_disease_of_bone" title="Paget's disease of bone">Paget's disease of bone</a>.</li> <li>Soliqua (insulin glargine/lixisenatide), for type 2 diabetes mellitus.</li> <li><a href="/wiki/Toujeo" class="mw-redirect" title="Toujeo">Toujeo</a> (insulin glargine), for <a href="/wiki/Diabetes_mellitus#Type_1_diabetes" class="mw-redirect" title="Diabetes mellitus">type 1</a> and <a href="/wiki/Diabetes_mellitus#Type_2_diabetes" class="mw-redirect" title="Diabetes mellitus">type 2</a> <a href="/wiki/Diabetes_mellitus" class="mw-redirect" title="Diabetes mellitus">diabetes mellitus</a>.</li></ul> </div> – <a href="/wiki/Gastroenterology" title="Gastroenterology">Gastroenterology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Dupixent" class="mw-redirect" title="Dupixent">Dupixent</a> (<a href="/wiki/Dupilumab" title="Dupilumab">Dupilumab</a>), for eosinophilic esophagitis, marketed by Regeneron.</li> <li><a href="/wiki/Lanzor" class="mw-redirect" title="Lanzor">Lanzor</a> (<a href="/wiki/Lansoprazole" title="Lansoprazole">Lansoprazole</a>), for acid reflux disease.</li> <li>Seprafilm (<a href="/wiki/Adhesion_barrier" title="Adhesion barrier">Adhesion barrier</a>), for internal adhesions.</li> <li><a href="/wiki/Zaltrap" class="mw-redirect" title="Zaltrap">Zaltrap</a> (<a href="/wiki/Aflibercept" title="Aflibercept">Aflibercept</a>), <a href="/wiki/Recombinant_DNA" title="Recombinant DNA">recombinant</a> <a href="/wiki/Fusion_protein" title="Fusion protein">fusion protein</a>, approved in metastatic colorectal cancer in combination with other agents in 2012, marketed by Regeneron.<a href="#cite_note-ZaltrapFDA-27">[27]</a></li></ul> </div> – <a href="/wiki/Hematology" title="Hematology">Hematology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Alprolix" class="mw-redirect" title="Alprolix">Alprolix</a> (<a href="/wiki/Factor_IX" title="Factor IX">Factor IX</a>), for hemophilia B.</li> <li><a href="/wiki/Arixtra" class="mw-redirect" title="Arixtra">Arixtra</a> (<a href="/wiki/Fondaparinux" title="Fondaparinux">Fondaparinux</a>), for thrombosis, marketed by GlaxoSmithKline and now owned by Mylan.</li> <li><a href="/wiki/Cablivi" class="mw-redirect" title="Cablivi">Cablivi</a> (<a href="/wiki/Caplacizumab" title="Caplacizumab">Caplacizumab</a>), for thrombosis.</li> <li><a href="/wiki/Campath" class="mw-redirect" title="Campath">Campath</a> (<a href="/wiki/Alemtuzumab" title="Alemtuzumab">Alemtuzumab</a>), for <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.</li> <li><a href="/wiki/Clolar" class="mw-redirect" title="Clolar">Clolar</a> (<a href="/wiki/Clofarabine" title="Clofarabine">Clofarabine</a>), for leukemia.</li> <li>Eloctate (<a href="/wiki/Factor_VIII" title="Factor VIII">Factor VIII</a>), for hemophilia A.</li> <li><a href="/wiki/Ferrlecit" class="mw-redirect" title="Ferrlecit">Ferrlecit</a> (<a href="/wiki/Sodium_ferric_gluconate_complex" title="Sodium ferric gluconate complex">Sodium ferric gluconate complex</a>), for <a href="/wiki/Iron_deficiency_anemia" class="mw-redirect" title="Iron deficiency anemia">iron deficiency anemia</a>.</li> <li><a href="/wiki/Fludara" class="mw-redirect" title="Fludara">Fludara</a> (<a href="/wiki/Fludarabine" title="Fludarabine">Fludarabine</a>), for leukemia.</li> <li><a href="/wiki/Mozobil" class="mw-redirect" title="Mozobil">Mozobil</a> (<a href="/wiki/Plerixafor" title="Plerixafor">Plerixafor</a>), for <a href="/wiki/Macrocycle" title="Macrocycle">macrocycle</a>, approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> for peripheral blood stem cell mobilizer for non-Hodgkin's lymphoma and multiple myeloma in December 2008.<a href="#cite_note-121">[121]</a></li> <li>Oforta (<a href="/wiki/Fludarabine" title="Fludarabine">Fludarabine</a>), for leukemia.</li> <li><a href="/wiki/Thymoglobulin" title="Thymoglobulin">Thymoglobulin</a>, for hemophilia A.</li> <li><a href="/wiki/Zemaira" class="mw-redirect" title="Zemaira">Zemaira</a> (<a href="/wiki/Alpha-1_antitrypsin" title="Alpha-1 antitrypsin">Alpha-1 antitrypsin</a>), for chronic augmentation, Now owned by <a href="/wiki/CSL_Behring" title="CSL Behring">CSL Behring</a>.</li></ul> </div> – Infectious diseases <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li>Antibiotics:</li> <li>Amoklavin (<a href="/wiki/Amoxicillin/clavulanic_acid" title="Amoxicillin/clavulanic acid">Amoxicillin/clavulanic acid</a>)</li> <li><a href="/wiki/Claforan" class="mw-redirect" title="Claforan">Claforan</a> (<a href="/wiki/Cefotaxime" title="Cefotaxime">Cefotaxime</a>)</li> <li><a href="/wiki/Priftin" class="mw-redirect" title="Priftin">Priftin</a> (<a href="/wiki/Rifapentine" title="Rifapentine">Rifapentine</a>)</li> <li><a href="/wiki/Suprax" class="mw-redirect" title="Suprax">Suprax</a> (<a href="/wiki/Cefixime" title="Cefixime">Cefixime</a>)</li> <li><a href="/wiki/Tavanic" class="mw-redirect" title="Tavanic">Tavanic</a> (<a href="/wiki/Levofloxacin" title="Levofloxacin">Levofloxacin</a>)</li> <li>Vaccines: <ul><li>Bacterial diseases:</li></ul></li> <li><a href="/wiki/ActHIB" class="mw-redirect" title="ActHIB">ActHIB</a> (<a href="/wiki/Hib_vaccine" title="Hib vaccine">Hib vaccine</a>)</li> <li><a href="/wiki/Adacel_(vaccine)" class="mw-redirect" title="Adacel (vaccine)">Adacel</a> (<a href="/wiki/DPT_vaccine" title="DPT vaccine">DPT vaccine</a>)</li> <li><a href="/wiki/Daptacel" class="mw-redirect" title="Daptacel">Daptacel</a> (<a href="/wiki/DPT_vaccine" title="DPT vaccine">DPT vaccine</a>)</li> <li><a href="/wiki/Dengvaxia" class="mw-redirect" title="Dengvaxia">Dengvaxia</a> (<a href="/wiki/Dengue_vaccine" title="Dengue vaccine">Dengue vaccine</a>)</li> <li><a href="/wiki/Menactra" class="mw-redirect" title="Menactra">Menactra</a> (<a href="/wiki/Meningococcal_vaccine" title="Meningococcal vaccine">Meningococcal infections</a>)</li> <li>Mycobax (<a href="/wiki/Tuberculosis_vaccine" class="mw-redirect" title="Tuberculosis vaccine">Tuberculosis vaccine</a>)</li> <li><a href="/wiki/Pentacel" class="mw-redirect" title="Pentacel">Pentacel</a> (<a href="/wiki/DTaP-IPV/Hib_vaccine" title="DTaP-IPV/Hib vaccine">DTaP-IPV/Hib vaccine</a>)</li> <li>Pneumo 23 (<a href="/wiki/Pneumococcal_vaccine" title="Pneumococcal vaccine">Pneumococcal infections</a>)</li> <li><a href="/wiki/Quadracel" class="mw-redirect" title="Quadracel">Quadracel</a> (<a href="/wiki/DTaP-IPV/Hib_vaccine" title="DTaP-IPV/Hib vaccine">DTaP-IPV/Hib vaccine</a>)</li> <li><a href="/wiki/Shanchol" class="mw-redirect" title="Shanchol">Shanchol</a> (<a href="/wiki/Cholera_vaccine" title="Cholera vaccine">Cholera vaccine</a>)</li> <li><a href="/wiki/Synercid" class="mw-redirect" title="Synercid">Synercid</a> (<a href="/wiki/Quinupristin/dalfopristin" title="Quinupristin/dalfopristin">Quinupristin/dalfopristin</a>), marketed by Pfizer.</li> <li>Tenivac (<a href="/wiki/Tetanus_vaccine" title="Tetanus vaccine">Tetanus vaccine</a>)</li> <li><a href="/wiki/Tripedia" class="mw-redirect" title="Tripedia">Tripedia</a> (<a href="/wiki/DPT_vaccine" title="DPT vaccine">DPT vaccine</a>), discontinued in 2012.</li> <li>Tubersol (<a href="/wiki/Tuberculosis_vaccine" class="mw-redirect" title="Tuberculosis vaccine">Tuberculosis vaccine</a>)</li> <li><a href="/wiki/Typhim_Vi" class="mw-redirect" title="Typhim Vi">Typhim Vi</a> (<a href="/wiki/Typhoid_fever" title="Typhoid fever">Typhoid fever</a>)</li> <li>Vaccin Tetanique Pasteur (<a href="/wiki/Tetanus_vaccine" title="Tetanus vaccine">Tetanus vaccine</a>) <ul><li>Viral diseases:</li></ul></li> <li>ACAM 2000 (<a href="/wiki/Smallpox_vaccine" title="Smallpox vaccine">Smallpox vaccine</a>), eradicated in 1980 (vaccine produced as a measure in response to the threat of bioterrorism).</li> <li>Avaxim (<a href="/wiki/Hepatitis_A_vaccine" title="Hepatitis A vaccine">Hepatitis A vaccine</a>)</li> <li><a href="/wiki/Flublok" class="mw-redirect" title="Flublok">Flublok</a> (<a href="/wiki/Influenza_vaccine" title="Influenza vaccine">Influenza vaccine</a>)</li> <li><a href="/wiki/Fluzone" class="mw-redirect" title="Fluzone">Fluzone</a> (<a href="/wiki/Influenza_vaccine" title="Influenza vaccine">Influenza vaccine</a>)</li> <li>Hbvaxpro (<a href="/wiki/Hepatitis_B_vaccine" title="Hepatitis B vaccine">Hepatitis B vaccine</a>)</li> <li>Imovax Polio (<a href="/wiki/Polio_vaccine" title="Polio vaccine">Polio vaccine</a>)</li> <li>Imovax Rabies (<a href="/wiki/Rabies_vaccine" title="Rabies vaccine">Rabies vaccine</a>)</li> <li><a href="/wiki/Ipol" class="mw-redirect" title="Ipol">Ipol</a> (<a href="/wiki/Polio_vaccine" title="Polio vaccine">Polio vaccine</a>)</li> <li>Ixiaro (<a href="/wiki/Japanese_encephalitis" title="Japanese encephalitis">Japanese encephalitis</a>)</li> <li>M-M-RVaxPro (<a href="/wiki/MMR_vaccine" title="MMR vaccine">MMR vaccine</a>)</li> <li>Rouvax (<a href="/wiki/Measles_vaccine" title="Measles vaccine">Measles vaccine</a>)</li> <li>Rudivax (<a href="/wiki/Rubella_vaccine" title="Rubella vaccine">Rubella vaccine</a>)</li> <li>Stamaril (<a href="/wiki/Yellow_fever_vaccine" title="Yellow fever vaccine">Yellow fever vaccine</a>)</li> <li><a href="/wiki/Vaxigrip" class="mw-redirect" title="Vaxigrip">Vaxigrip</a> (<a href="/wiki/Influenza_vaccine" title="Influenza vaccine">Influenza vaccine</a>)</li> <li>YF-VAX (<a href="/wiki/Yellow_fever_vaccine" title="Yellow fever vaccine">Yellow fever vaccine</a>)</li></ul> </div> – <a href="/wiki/Metabolic" class="mw-redirect" title="Metabolic">Metabolic</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Actonel" class="mw-redirect" title="Actonel">Actonel</a> (<a href="/wiki/Risedronic_acid" title="Risedronic acid">Risedronic acid</a>), for <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> and <a href="/wiki/Paget%27s_disease_of_bone" title="Paget's disease of bone">Paget's disease</a>, now owned by Allergan.</li> <li><a href="/wiki/Renagel" class="mw-redirect" title="Renagel">Renagel</a> (<a href="/wiki/Sevelamer" title="Sevelamer">Sevelamer</a>) hydrochloride, for <a href="/wiki/Chronic_kidney_disease" title="Chronic kidney disease">end stage renal disease</a>.</li> <li><a href="/wiki/Renvela" class="mw-redirect" title="Renvela">Renvela</a> (<a href="/wiki/Sevelamer" title="Sevelamer">Sevelamer</a>) hydrochloride, for <a href="/wiki/Chronic_kidney_disease" title="Chronic kidney disease">end stage renal disease</a>.</li></ul> </div> – <a href="/wiki/Neurology" title="Neurology">Neurology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Ambien" class="mw-redirect" title="Ambien">Ambien</a> (<a href="/wiki/Zolpidem" title="Zolpidem">Zolpidem</a>), for <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>.</li> <li><a href="/wiki/Ambien_CR" class="mw-redirect" title="Ambien CR">Ambien CR</a> (<a href="/wiki/Zolpidem" title="Zolpidem">Zolpidem</a>), for <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>.</li> <li><a href="/wiki/Aubagio" class="mw-redirect" title="Aubagio">Aubagio</a> (<a href="/wiki/Teriflunomide" title="Teriflunomide">Teriflunomide</a>), for <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.</li> <li><a href="/wiki/Depakine" class="mw-redirect" title="Depakine">Depakine</a> (<a href="/wiki/Valproic_acid" class="mw-redirect" title="Valproic acid">Valproic acid</a>), for <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>, now owned by AbbVie.</li> <li><a href="/wiki/Depakote" class="mw-redirect" title="Depakote">Depakote</a> (<a href="/wiki/Valproate_semisodium" class="mw-redirect" title="Valproate semisodium">Valproate semisodium</a>), for <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>, now owned by AbbVie.</li> <li><a href="/wiki/Hyalgan" class="mw-redirect" title="Hyalgan">Hyalgan</a> (<a href="/wiki/Sodium_hyaluronate" title="Sodium hyaluronate">Sodium hyaluronate</a>), for <a href="/wiki/Blood_tests" class="mw-redirect" title="Blood tests">blood tests</a>.</li> <li><a href="/wiki/Lemtrada" class="mw-redirect" title="Lemtrada">Lemtrada</a> (<a href="/wiki/Alemtuzumab" title="Alemtuzumab">Alemtuzumab</a>), for <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.</li> <li><a href="/wiki/Pediapred" class="mw-redirect" title="Pediapred">Pediapred</a> (<a href="/wiki/Prednisolone" title="Prednisolone">Prednisolone</a>), for <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.</li> <li><a href="/wiki/Rilutek" class="mw-redirect" title="Rilutek">Rilutek</a> (<a href="/wiki/Riluzole" title="Riluzole">Riluzole</a>), for ALS.</li> <li><a href="/wiki/Sabril" class="mw-redirect" title="Sabril">Sabril</a> (<a href="/wiki/Vigabatrin" title="Vigabatrin">Vigabatrin</a>), for <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>, marketed by Lundbeck.</li></ul> </div> – <a href="/wiki/Oncology" title="Oncology">Oncology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Anzemet" class="mw-redirect" title="Anzemet">Anzemet</a> (<a href="/wiki/Dolasetron" title="Dolasetron">Dolasetron</a>), for nausea and vomiting.</li> <li><a href="/wiki/Campath" class="mw-redirect" title="Campath">Campath</a> (<a href="/wiki/Alemtuzumab" title="Alemtuzumab">Alemtuzumab</a>), for <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.</li> <li><a href="/wiki/Caprelsa" class="mw-redirect" title="Caprelsa">Caprelsa</a> (<a href="/wiki/Vandetanib" title="Vandetanib">Vandetanib</a>), for breast, colorectal cancer and female infertility.</li> <li><a href="/wiki/Clolar" class="mw-redirect" title="Clolar">Clolar</a> (<a href="/wiki/Clofarabine" title="Clofarabine">Clofarabine</a>), for leukemia.</li> <li><a href="/wiki/Clomid" class="mw-redirect" title="Clomid">Clomid</a> (<a href="/wiki/Clomifene" title="Clomifene">Clomifene</a>), for <a href="/wiki/Female_infertility" title="Female infertility">female infertility</a>.</li> <li><a href="/wiki/Dupixent" class="mw-redirect" title="Dupixent">Dupixent</a> (<a href="/wiki/Dupilumab" title="Dupilumab">Dupilumab</a>), for eczema, marketed by Regeneron.</li> <li><a href="/wiki/Eligard" class="mw-redirect" title="Eligard">Eligard</a> (<a href="/wiki/Leuprorelin" title="Leuprorelin">Leuprorelin</a>), for prostate cancer, marketed by Astellas.</li> <li><a href="/wiki/Elitek" class="mw-redirect" title="Elitek">Elitek</a> (<a href="/wiki/Rasburicase" title="Rasburicase">Rasburicase</a>), for the treatment to help stop uric acid.</li> <li><a href="/wiki/Eloxatin" class="mw-redirect" title="Eloxatin">Eloxatin</a> (<a href="/wiki/Oxaliplatin" title="Oxaliplatin">Oxaliplatin</a>), for <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>.</li> <li><a href="/wiki/Fludara" class="mw-redirect" title="Fludara">Fludara</a> (<a href="/wiki/Fludarabine" title="Fludarabine">Fludarabine</a>), for leukemia.</li> <li><a href="/wiki/Gliadel_Wafer" class="mw-redirect" title="Gliadel Wafer">Gliadel Wafer</a> (<a href="/wiki/Carmustine" title="Carmustine">Carmustine</a>), for cancer, now owned by Arbor Pharmaceuticals.</li> <li><a href="/wiki/Jevtana" class="mw-redirect" title="Jevtana">Jevtana</a> (<a href="/wiki/Cabazitaxel" title="Cabazitaxel">Cabazitaxel</a>), for prostate cancer.</li> <li><a href="/wiki/Kevzara" class="mw-redirect" title="Kevzara">Kevzara</a> (<a href="/wiki/Sarilumab" title="Sarilumab">Sarilumab</a>), for blood tests, <a href="/wiki/Lung_cancer" title="Lung cancer">lung</a> and <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>, marketed by Regeneron.</li> <li><a href="/wiki/Libtayo" class="mw-redirect" title="Libtayo">Libtayo</a> (<a href="/wiki/Cemiplimab" title="Cemiplimab">Cemiplimab</a>), for squamous cell skin cancer, marketed by Regeneron.</li> <li><a href="/wiki/Mozobil" class="mw-redirect" title="Mozobil">Mozobil</a> (<a href="/wiki/Plerixafor" title="Plerixafor">Plerixafor</a>), <a href="/wiki/Macrocycle" title="Macrocycle">macrocycle</a>, approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> for peripheral blood stem cell mobilizer for non-Hodgkin's lymphoma and multiple myeloma in December 2008.<a href="#cite_note-122">[122]</a></li> <li>Oforta (<a href="/wiki/Fludarabine" title="Fludarabine">Fludarabine</a>), for leukemia.</li> <li><a href="/wiki/Taxotere" class="mw-redirect" title="Taxotere">Taxotere</a> (<a href="/wiki/Docetaxel" title="Docetaxel">Docetaxel</a>), for <a href="/wiki/Breast_cancer" title="Breast cancer">breast</a>, <a href="/wiki/Lung_cancer" title="Lung cancer">lung</a> and <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>.</li> <li><a href="/wiki/Uroxatral" class="mw-redirect" title="Uroxatral">Uroxatral</a> (<a href="/wiki/Alfuzosin" title="Alfuzosin">Alfuzosin</a>), for <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a>.</li> <li><a href="/wiki/Zaltrap" class="mw-redirect" title="Zaltrap">Zaltrap</a> (<a href="/wiki/Aflibercept" title="Aflibercept">Aflibercept</a>), <a href="/wiki/Recombinant_DNA" title="Recombinant DNA">recombinant</a> <a href="/wiki/Fusion_protein" title="Fusion protein">fusion protein</a>, approved in metastatic colorectal cancer in combination with other agents in 2012, marketed by Regeneron.<a href="#cite_note-ZaltrapFDA-27">[27]</a></li></ul> </div> – Other <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Aldurazyme" class="mw-redirect" title="Aldurazyme">Aldurazyme</a> (<a href="/wiki/Laronidase" class="mw-redirect" title="Laronidase">Laronidase</a>), for hurler syndrome.</li> <li><a href="/wiki/Aplenzin" class="mw-redirect" title="Aplenzin">Aplenzin</a> (<a href="/wiki/Bupropion" title="Bupropion">Bupropion</a>), for depression and quit smoking.</li> <li>Captique (<a href="/wiki/Dermal_filler" class="mw-redirect" title="Dermal filler">Dermal filler</a>), for facial wrinkles.</li> <li>Carticel (<a href="/wiki/Knee_cartilage_replacement_therapy" title="Knee cartilage replacement therapy">Knee cartilage replacement therapy</a>), for knee pain.</li> <li><a href="/wiki/Cerdelga" class="mw-redirect" title="Cerdelga">Cerdelga</a> (<a href="/wiki/Eliglustat" title="Eliglustat">Eliglustat</a>), for type 1 gaucher disease.</li> <li><a href="/wiki/Ceredase" class="mw-redirect" title="Ceredase">Ceredase</a> (<a href="/wiki/Alglucerase" title="Alglucerase">Alglucerase</a>), for <a href="/wiki/Gaucher%27s_disease" title="Gaucher's disease">Gaucher's disease</a>.</li> <li><a href="/wiki/Cerezyme" class="mw-redirect" title="Cerezyme">Cerezyme</a> (<a href="/wiki/Imiglucerase" title="Imiglucerase">Imiglucerase</a>), for <a href="/wiki/Gaucher%27s_disease" title="Gaucher's disease">Gaucher's disease</a>.</li> <li><a href="/wiki/Elaprase" class="mw-redirect" title="Elaprase">Elaprase</a> (<a href="/wiki/Idursulfase" title="Idursulfase">Idursulfase</a>), marketed by Shire.</li> <li>Epicel (cultured epidermal autografts), for thickness burns.</li> <li><a href="/wiki/Fabrazyme" class="mw-redirect" title="Fabrazyme">Fabrazyme</a> (<a href="/wiki/Agalsidase" class="mw-redirect" title="Agalsidase">Agalsidase</a>), for Fabry disease.</li> <li><a href="/wiki/Flagyl" class="mw-redirect" title="Flagyl">Flagyl</a> (<a href="/wiki/Metronidazole" title="Metronidazole">Metronidazole</a>), for vaginal infections, marketed by Pfizer.</li> <li>Hylaform Plus (<a href="/wiki/Injectable_filler" title="Injectable filler">Injectable filler</a>), for facial wrinkles.</li> <li><a href="/wiki/Lumizyme" class="mw-redirect" title="Lumizyme">Lumizyme</a> (<a href="/wiki/Alglucosidase_alfa" title="Alglucosidase alfa">Alglucosidase alfa</a>), for Pompe disease.</li> <li><a href="/wiki/Myozyme" class="mw-redirect" title="Myozyme">Myozyme</a> (<a href="/wiki/Alglucosidase_alfa" title="Alglucosidase alfa">Alglucosidase alfa</a>), for Pompe disease.</li> <li><a href="/wiki/Sculptra" title="Sculptra">Sculptra</a> (<a href="/wiki/Polylactic_acid" title="Polylactic acid">Polylactic acid</a>), for facial fat loss.</li> <li><a href="/wiki/Thyrogen" class="mw-redirect" title="Thyrogen">Thyrogen</a> (<a href="/wiki/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">Thyroid-stimulating hormone</a>), for thyroid cancer.</li></ul> </div> – <a href="/wiki/Over_the_counter" class="mw-redirect" title="Over the counter">Over the counter</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li>Allegra (<a href="/wiki/Fexofenadine" title="Fexofenadine">Fexofenadine</a>), for <a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">allergic rhinitis</a>.</li> <li><a href="/wiki/Buscopan" class="mw-redirect" title="Buscopan">Buscopan</a> (<a href="/wiki/Hyoscine_butylbromide" title="Hyoscine butylbromide">Hyoscine butylbromide</a>), for abdominal pain.</li> <li><a href="/wiki/Maalox" title="Maalox">Maalox</a> (<a href="/wiki/Calcium_carbonate#Health_and_dietary_applications" title="Calcium carbonate">Calcium carbonate</a>), an <a href="/wiki/Antacid" title="Antacid">antacid</a>.</li> <li><a href="/wiki/Nasacort" class="mw-redirect" title="Nasacort">Nasacort</a> (<a href="/wiki/Triamcinolone" title="Triamcinolone">Triamcinolone</a>), for <a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">allergic rhinitis</a>.</li> <li>Novaldol (<a href="/wiki/Paracetamol" title="Paracetamol">Paracetamol</a>), for pain and fever.</li> <li><a href="/wiki/Unisom" class="mw-redirect" title="Unisom">Unisom</a> (<a href="/wiki/Doxylamine" title="Doxylamine">Doxylamine</a>), for night-time allergy and cold relief.</li> <li><a href="/wiki/Xyzal" class="mw-redirect" title="Xyzal">Xyzal</a> (<a href="/wiki/Levocetirizine" title="Levocetirizine">Levocetirizine</a>), for <a href="/wiki/Allergic_rhinitis" title="Allergic rhinitis">allergic rhinitis</a>, marketed by UCB.</li> <li><a href="/wiki/Telfast" class="mw-redirect" title="Telfast">Telfast</a> for Seasonal <a href="/wiki/Allergy" title="Allergy">Allergy</a> Relief<a href="#cite_note-123">[123]</a></li> <li>Enterogermina Medicine for <a href="/wiki/Diarrhea" title="Diarrhea">Diarrhea</a><a href="#cite_note-124">[124]</a></li></ul> </div> – <a href="/wiki/Pain" title="Pain">Pain</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li>Bi-profined (<a href="/wiki/Ketoprofen" title="Ketoprofen">Ketoprofen</a>), for pain.</li> <li><a href="/wiki/Solpadol" class="mw-redirect" title="Solpadol">Solpadol</a> (<a href="/wiki/Codeine" title="Codeine">Codeine</a>), for <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a>.</li></ul> </div> – <a href="/wiki/Respiratory" class="mw-redirect" title="Respiratory">Respiratory</a> and inflammatory diseases <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Atrovent" class="mw-redirect" title="Atrovent">Atrovent</a> (<a href="/wiki/Ipratropium_bromide" title="Ipratropium bromide">Ipratropium bromide</a>), for asthma, marketed by Boehringer Ingelheim.</li> <li><a href="/wiki/Azmacort" class="mw-redirect" title="Azmacort">Azmacort</a> (<a href="/wiki/Triamcinolone" title="Triamcinolone">Triamcinolone</a>), for asthma.</li> <li><a href="/wiki/Dupixent" class="mw-redirect" title="Dupixent">Dupixent</a> (<a href="/wiki/Dupilumab" title="Dupilumab">Dupilumab</a>), for eosinophilic asthma and chronic rhinosinusitis with nasal polyposis, marketed by Regeneron.</li> <li><a href="/wiki/Dynabac" class="mw-redirect" title="Dynabac">Dynabac</a> (<a href="/wiki/Dirithromycin" title="Dirithromycin">Dirithromycin</a>), for acute bacterial exacerbations.</li> <li><a href="/wiki/Ketek" class="mw-redirect" title="Ketek">Ketek</a> (<a href="/wiki/Telithromycin" title="Telithromycin">Telithromycin</a>), for <a href="/wiki/Community_acquired_pneumonia" class="mw-redirect" title="Community acquired pneumonia">community acquired pneumonia</a>.</li> <li><a href="/wiki/Priftin" class="mw-redirect" title="Priftin">Priftin</a> (<a href="/wiki/Rifapentine" title="Rifapentine">Rifapentine</a>), for tuberculosis.</li> <li><a href="/wiki/Rifadin" class="mw-redirect" title="Rifadin">Rifadin</a> (<a href="/wiki/Rifampin" class="mw-redirect" title="Rifampin">Rifampin</a>), for tuberculosis.</li> <li><a href="/wiki/Rifamate" class="mw-redirect" title="Rifamate">Rifamate</a> (<a href="/wiki/Isoniazid/rifampicin" title="Isoniazid/rifampicin">Isoniazid/rifampicin</a>), for tuberculosis.</li> <li><a href="/wiki/Rifater" class="mw-redirect" title="Rifater">Rifater</a> (<a href="/wiki/Rifampicin/isoniazid/pyrazinamide" title="Rifampicin/isoniazid/pyrazinamide">Rifampicin/isoniazid/pyrazinamide</a>), for tuberculosis.</li> <li><a href="/wiki/Tilade" class="mw-redirect" title="Tilade">Tilade</a> (<a href="/wiki/Nedocromil" title="Nedocromil">Nedocromil</a>), for asthma.</li> <li>Zagam (<a href="/wiki/Sparfloxacin" title="Sparfloxacin">Sparfloxacin</a>), for chronic bronchitis.</li> <li><a href="/wiki/Zemaira" class="mw-redirect" title="Zemaira">Zemaira</a> (<a href="/wiki/Alpha-1_antitrypsin" title="Alpha-1 antitrypsin">Alpha-1 antitrypsin</a>), for chronic augmentation, now owned by CSL Behring.</li> <li>Mucosolvan Medicine for <a href="/wiki/Cough" title="Cough">Cough</a><a href="#cite_note-125">[125]</a></li></ul> </div> – <a href="/wiki/Rheumatology" title="Rheumatology">Rheumatology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li>Arava (<a href="/wiki/Leflunomide" title="Leflunomide">Leflunomide</a>), for <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid</a> and <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a>.</li> <li><a href="/wiki/Kevzara" class="mw-redirect" title="Kevzara">Kevzara</a> (<a href="/wiki/Sarilumab" title="Sarilumab">Sarilumab</a>), for blood tests, <a href="/wiki/Lung_cancer" title="Lung cancer">lung</a> and <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>, marketed by Regeneron.</li> <li><a href="/wiki/Primaquine" title="Primaquine">Primaquine</a> (<a href="/wiki/Primaquine" title="Primaquine">Primaquine</a>), for malaria.</li> <li><a href="/wiki/Synvisc" class="mw-redirect" title="Synvisc">Synvisc</a> (<a href="/wiki/Hyaluronic_acid" title="Hyaluronic acid">Hyaluronic acid</a>), for knee pain.</li></ul> </div> – <a href="/wiki/Urology" title="Urology">Urology</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1184024115" /><div class="div-col"> <ul><li><a href="/wiki/Ditropan_XL" class="mw-redirect" title="Ditropan XL">Ditropan XL</a> (<a href="/wiki/Oxybutynin_chloride" class="mw-redirect" title="Oxybutynin chloride">Oxybutynin chloride</a>), for bladder relief, marketed by Janssen.</li> <li><a href="/wiki/Eligard" class="mw-redirect" title="Eligard">Eligard</a> (<a href="/wiki/Leuprorelin" title="Leuprorelin">Leuprorelin</a>), for prostate cancer, marketed by Astellas.</li> <li><a href="/wiki/Flomax" class="mw-redirect" title="Flomax">Flomax</a> (<a href="/wiki/Tamsulosin" title="Tamsulosin">Tamsulosin</a>), for bladder relief, marketed by Astellas.</li></ul> </div> The company also produces a broad range of over-the-counter products, among them <a href="/wiki/Fexofenadine" title="Fexofenadine">Allegra</a>, <a href="/wiki/IcyHot" class="mw-redirect" title="IcyHot">IcyHot</a> for muscle pain, <a href="/wiki/Gold_Bond_medicated_powder" class="mw-redirect" title="Gold Bond medicated powder">Gold Bond</a> for skin irritation, and <a href="/wiki/Selsun_Blue" title="Selsun Blue">Selsun Blue</a> dandruff shampoo. These brands were acquired in 2010, when Sanofi-Aventis purchased <a href="/wiki/Chattem" title="Chattem">Chattem</a>. <div class="mw-heading mw-heading3"><h3 id="Pipeline">Pipeline</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=10" title="Edit section: Pipeline">edit</a>]</div> As of 2013<a class="external text" href="https://en.wikipedia.org/w/index.php?title=Sanofi&action=edit">[update]</a>, Sanofi was in a race with <a href="/wiki/Amgen" title="Amgen">Amgen</a> and <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> to win approval for a <a href="/wiki/PCSK9_inhibitor" class="mw-redirect" title="PCSK9 inhibitor">drug that inhibits PCSK9</a>, a protein that slows the clearance of <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoprotein</a> (LDL) cholesterol – the form of cholesterol that leads to heart attacks.<a href="#cite_note-126">[126]</a> Sanofi's drug, a <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a>, was discovered by <a href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron Pharmaceuticals</a> and is called <a href="/wiki/Alirocumab" title="Alirocumab">alirocumab</a>.<a href="#cite_note-127">[127]</a> An FDA warning in March 2014, about possible cognitive adverse effects of PCSK9 inhibition threw the competition into disarray, as the FDA asked companies to include neurocognitive testing into their <a href="/wiki/Phase_III_clinical_trials" class="mw-redirect" title="Phase III clinical trials">Phase III clinical trials</a>.<a href="#cite_note-128">[128]</a> In 2013, Sanofi announced that another candidate from its collaboration with Regeneron, a monoclonal antibody against the interleukin 6 receptor, <a href="/wiki/Sarilumab" title="Sarilumab">sarilumab</a>, had better efficacy than placebo in its first Phase III trial in rheumatoid arthritis.<a href="#cite_note-129">[129]</a> <div class="mw-heading mw-heading3"><h3 id="Management">Management</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=11" title="Edit section: Management">edit</a>]</div> <ul><li><a href="/wiki/Serge_Weinberg" title="Serge Weinberg">Serge Weinberg</a>, <a href="/wiki/Chairman_of_the_board" class="mw-redirect" title="Chairman of the board">chairman</a><a href="#cite_note-130">[130]</a></li> <li><a href="/wiki/Paul_Hudson_(businessman)" title="Paul Hudson (businessman)">Paul Hudson</a>, <a href="/wiki/CEO" class="mw-redirect" title="CEO">chief executive officer</a><a href="#cite_note-131">[131]</a><a href="#cite_note-132">[132]</a></li> <li>Jean-François Dehecq was the <a href="/wiki/General_manager" title="General manager">general manager</a> of Sanofi from its creation in 1973 until 2007.</li> <li>François-Xavier Roger, <a href="/wiki/Chief_financial_officer" title="Chief financial officer">CFO</a><a href="#cite_note-133">[133]</a></li></ul> <div class="mw-heading mw-heading3"><h3 id="Stockholders">Stockholders</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=12" title="Edit section: Stockholders">edit</a>]</div> As of 31 December 2013:<a href="#cite_note-AR2013-134">[134]</a>: 185  <ul><li>Breakdown of share ownership: 8.93% by <a href="/wiki/L%27Or%C3%A9al" title="L'Oréal">L'Oréal</a>, 0.27% <a href="/wiki/Treasury_shares" class="mw-redirect" title="Treasury shares">treasury shares</a> and 1.31% <a href="/wiki/Stock_option" class="mw-redirect" title="Stock option">employees</a>. The remaining 89.49% were <a href="/wiki/Publicly_traded" class="mw-redirect" title="Publicly traded">publicly traded</a>.<a href="#cite_note-Total-136">[A]</a></li></ul> <div class="mw-heading mw-heading2"><h2 id="Head_office">Head office</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=13" title="Edit section: Head office">edit</a>]</div> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Sanofi_HQ.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/en/thumb/3/3d/Sanofi_HQ.jpg/220px-Sanofi_HQ.jpg" decoding="async" width="220" height="165" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/3/3d/Sanofi_HQ.jpg/330px-Sanofi_HQ.jpg 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/3/3d/Sanofi_HQ.jpg/440px-Sanofi_HQ.jpg 2x" data-file-width="640" data-file-height="480" /></a><figcaption>Former head office 174 avenue de France, Paris 13th arrondissement</figcaption></figure> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Rue_de_la_Bo%C3%A9tie,_54-56.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Rue_de_la_Bo%C3%A9tie%2C_54-56.jpg/170px-Rue_de_la_Bo%C3%A9tie%2C_54-56.jpg" decoding="async" width="170" height="227" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/Rue_de_la_Bo%C3%A9tie%2C_54-56.jpg/255px-Rue_de_la_Bo%C3%A9tie%2C_54-56.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/18/Rue_de_la_Bo%C3%A9tie%2C_54-56.jpg/340px-Rue_de_la_Bo%C3%A9tie%2C_54-56.jpg 2x" data-file-width="2112" data-file-height="2816" /></a><figcaption>Head office 54 rue de la Boétie, Paris 8th arrondissement</figcaption></figure> In January 2012, Sanofi moved its head office location to 54, <a href="/wiki/Rue_La_Bo%C3%A9tie" title="Rue La Boétie">Rue La Boétie</a> in the <a href="/wiki/8th_arrondissement_of_Paris" title="8th arrondissement of Paris">8th arrondissement of Paris</a>. This former mansion designed by architect René-Patouillard had previously been the head office of Alcatel-Lucent. Sanofi's previous head office was located in the <a href="/wiki/13th_arrondissement_of_Paris" title="13th arrondissement of Paris">13th arrondissement of Paris</a>, at 174 Avenue de France. The architecture of the head office is of the predominant style of the area surrounding the <a href="/wiki/Fran%C3%A7ois_Mitterrand_Library" class="mw-redirect" title="François Mitterrand Library">François Mitterrand Library</a>. After Sanofi and Aventis merged, the employees at the former Aventis head office in <a href="/wiki/Schiltigheim" title="Schiltigheim">Schiltigheim</a>, <a href="/wiki/Alsace" title="Alsace">Alsace</a>, moved to Paris.<a href="#cite_note-137">[136]</a> In November 2022, Sanofi moved into its new global headquarters in the 17th arrondissement of Paris, at 46-48 Avenue de la Grande Armée.<a href="#cite_note-138">[137]</a><a href="#cite_note-139">[138]</a> <div class="mw-heading mw-heading2"><h2 id="Collaborative_research">Collaborative research</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=14" title="Edit section: Collaborative research">edit</a>]</div> In addition to internal research and development activities, Sanofi is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of <a href="/wiki/Pre-clinical_development" class="mw-redirect" title="Pre-clinical development">non-clinical</a> safety assessment is the <a href="/wiki/Innovative_Medicines_Initiative" title="Innovative Medicines Initiative">InnoMed PredTox project</a><a href="#cite_note-140">[139]</a><a href="#cite_note-InnoMed_PredTox_official_project_website-141">[140]</a> The company is expanding its activities in joint research projects within the framework of the <a href="/wiki/Innovative_Medicines_Initiative" title="Innovative Medicines Initiative">Innovative Medicines Initiative</a> of <a href="/wiki/EFPIA" class="mw-redirect" title="EFPIA">EFPIA</a> and the <a href="/wiki/European_Commission" title="European Commission">European Commission</a>.<a href="#cite_note-IMI_Call_Topics_2008-142">[141]</a> In June 2010, Sanofi and the <a href="/wiki/Charit%C3%A9" title="Charité">Charité University of Berlin</a> signed a cooperation agreement for the research and development of medicines and therapies.<a href="#cite_note-143">[142]</a> On 25 October 2012, Sanofi said its earnings for the third quarter slumped, as generic competitors ate into profits from its <a href="/wiki/Eloxatin" class="mw-redirect" title="Eloxatin">Eloxatin</a> <a href="/wiki/Cancer" title="Cancer">cancer</a> treatment.<a href="#cite_note-144">[143]</a> <div class="mw-heading mw-heading2"><h2 id="Sanofi_Pasteur">Sanofi Pasteur</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=15" title="Edit section: Sanofi Pasteur">edit</a>]</div> <style data-mw-deduplicate="TemplateStyles:r1236090951">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Sanofi Pasteur</a></div> In 2005, Sanofi Pasteur, the vaccines division of Sanofi Group, was awarded a $97 Million <a href="/wiki/United_States_Department_of_Health_and_Human_Services" title="United States Department of Health and Human Services">United States Department of Health and Human Services</a> (HHS) contract.<a href="#cite_note-145">[144]</a> <div class="mw-heading mw-heading3"><h3 id="BCG_supply_shortage_2012–2014">BCG supply shortage 2012–2014</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=16" title="Edit section: BCG supply shortage 2012–2014">edit</a>]</div> In 2011, a Sanofi Pasteur plant flooded, causing it problems with mold.<a href="#cite_note-FDA_2012-146">[145]</a> The facility, located in Toronto, Ontario, Canada, produced <a href="/wiki/BCG_vaccine" title="BCG vaccine">BCG vaccine</a> products, made with the Glaxo 1077 strain,<a href="#cite_note-WHO_2004-147">[146]</a> such as a tuberculosis vaccine ImmuCYST, a BCG Immunotherapeutic, a bladder cancer drug. By April 2012, the FDA had found dozens of documented problems with sterility at the plant, including mold, nesting birds, and rusted electrical conduits.<a href="#cite_note-FDA_2012-146">[145]</a> The plant was closed for over two years, resulting in shortages of bladder cancer and tuberculosis vaccines.<a href="#cite_note-Sanofi_2014_BCG_vaccine-148">[147]</a> On 29 October 2014 <a href="/wiki/Health_Canada" title="Health Canada">Health Canada</a> gave Sanofi permission to resume production of BCG.<a href="#cite_note-FiercePharma_mar_2015-149">[148]</a> <div class="mw-heading mw-heading3"><h3 id="COVID-19_vaccine">COVID-19 vaccine</h3>[<a href="/w/index.php?title=Sanofi&action=edit&section=17" title="Edit section: COVID-19 vaccine">edit</a>]</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main articles: <a href="/wiki/Sanofi%E2%80%93GSK_COVID-19_vaccine" title="Sanofi–GSK COVID-19 vaccine">Sanofi–GSK COVID-19 vaccine</a> and <a href="/wiki/Sanofi%E2%80%93Translate_Bio_COVID-19_vaccine" title="Sanofi–Translate Bio COVID-19 vaccine">Sanofi–Translate Bio COVID-19 vaccine</a></div> In 2020, Sanofi, together with <a href="/wiki/GlaxoSmithKline" class="mw-redirect" title="GlaxoSmithKline">GSK</a>, signed a deal with the US government's Operation Warp Speed to provide 100 million doses of COVID-19 vaccine for up to US$2.1 billion, if the vaccine was approved.<a href="#cite_note-150">[149]</a> As of August 2020, COVID-19 vaccine development in Sanofi underscored its fundamental competitiveness weakness, with which management has been struggling and failed to deal with for many years, beyond cutting more costs. Unfortunately, even though the approach of Sanofi-GSK is based on pre-existing, approved platforms and technology (as with Flublok flu), without reinventing the wheel of the necessary infrastructure,<a href="#cite_note-151">[150]</a> the company lagged behind many other rivals in delivering a working vaccine. Sanofi planned to start Phase 1 clinical testing only in September and expected emergency use approval in the first half of 2021.<a href="#cite_note-152">[151]</a> Competitors such as Novavax had already completed Phase 1 studies, with promising results,<a href="#cite_note-153">[152]</a> and Moderna-NIH had already initiated its Phase 3 trial.<a href="#cite_note-154">[153]</a> According to CNBC reports,<a href="#cite_note-155">[154]</a> as part of the $2.1 billion US government deal, more than 750 million went to supporting Sanofi-GSK in vaccine development and clinical trials. Sanofi turn-outs "accelerate" the development via a smaller biotech firm, Translate Bio, with a $425M partnership.<a href="#cite_note-156">[155]</a> At the end of September 2021, Sanofi announced that it would stop developing its mRNA COVID-19 vaccine. Despite promising results, the drug would not continue to Phase 3 trials, and the company stated that it would be 'too late to reach the market.'<a href="#cite_note-157">[156]</a><a href="#cite_note-158">[157]</a> <div class="mw-heading mw-heading2"><h2 id="Associations">Associations</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=18" title="Edit section: Associations">edit</a>]</div> Sanofi is a full member of the <a href="/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations" title="European Federation of Pharmaceutical Industries and Associations">European Federation of Pharmaceutical Industries and Associations</a> (EFPIA),<a href="#cite_note-159">[158]</a> the <a href="/wiki/Biotechnology_Industry_Organization" class="mw-redirect" title="Biotechnology Industry Organization">Biotechnology Industry Organization</a> (BIO),<a href="#cite_note-160">[159]</a> and the <a href="/wiki/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a> (PhRMA).<a href="#cite_note-161">[160]</a> Sanofi's vaccine subsidiary, <a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Sanofi Pasteur</a>, is a member of <a href="/wiki/EuropaBio" title="EuropaBio">EuropaBio</a>.<a href="#cite_note-162">[161]</a> In June 2021, Sanofi partnered with <a href="/wiki/Capgemini" title="Capgemini">Capgemini</a>, <a href="/wiki/Orange_S.A." class="mw-redirect" title="Orange S.A.">Orange</a> & <a href="/wiki/Generali_Italia" title="Generali Italia">Generali</a> to launch Future4care, an all-European start-up accelerator centered on digital health.<a href="#cite_note-163">[162]</a><a href="#cite_note-164">[163]</a> <div class="mw-heading mw-heading2"><h2 id="Aventis_Foundation">Aventis Foundation</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=19" title="Edit section: Aventis Foundation">edit</a>]</div> The Aventis Foundation, a <a href="/wiki/Germany" title="Germany">German</a> charitable trust, was established in 1996, as the Hoechst Foundation, with an <a href="/wiki/Financial_endowment" title="Financial endowment">endowment</a> of €50 million. In 2000, the foundation was renamed the Aventis Foundation. The foundation promotes cultural and scientific projects, specifically focused on the Frankfurt Rhine-Main area.<a href="#cite_note-165">[164]</a> <div class="mw-heading mw-heading2"><h2 id="See_also">See also</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=20" title="Edit section: See also">edit</a>]</div> <ul><li><a href="/wiki/Amgen_Inc_v._Sanofi" title="Amgen Inc v. Sanofi">Amgen Inc v. Sanofi</a>, a United States Supreme Court case on patent enablement</li> <li><a href="/wiki/Sanofi_Biogenius_Canada" title="Sanofi Biogenius Canada">Sanofi Biogenius Canada</a></li></ul> <style data-mw-deduplicate="TemplateStyles:r1130092004">.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-related{font-size:100%;justify-content:flex-start}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;flex:0 0 auto;min-height:24px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;flex:0 1 auto;padding:0.15em 0;column-gap:1em;align-items:baseline;margin:0;list-style:none}.mw-parser-output .portal-bar-content-related{margin:0;list-style:none}.mw-parser-output .portal-bar-item{display:inline-block;margin:0.15em 0.2em;min-height:24px;line-height:24px}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap;align-items:baseline}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-related{font-size:100%;align-items:flex-start}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:center;flex:0;column-gap:1em;border-top:1px solid #a2a9b1;margin:0 auto;list-style:none}.mw-parser-output .portal-bar-content-related{border-top:none;margin:0;list-style:none}}.mw-parser-output .navbox+link+.portal-bar,.mw-parser-output .navbox+style+.portal-bar,.mw-parser-output .navbox+link+.portal-bar-bordered,.mw-parser-output .navbox+style+.portal-bar-bordered,.mw-parser-output .sister-bar+link+.portal-bar,.mw-parser-output .sister-bar+style+.portal-bar,.mw-parser-output .portal-bar+.navbox-styles+.navbox,.mw-parser-output .portal-bar+.navbox-styles+.sister-bar{margin-top:-1px}</style><div class="portal-bar noprint metadata noviewer portal-bar-bordered" role="navigation" aria-label="Portals"><a href="/wiki/Wikipedia:Contents/Portals" title="Wikipedia:Contents/Portals">Portals</a>:<ul class="portal-bar-content"><li class="portal-bar-item"><img alt="flag" src="//upload.wikimedia.org/wikipedia/en/thumb/c/c3/Flag_of_France.svg/40px-Flag_of_France.svg.png" decoding="async" width="21" height="14" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/c/c3/Flag_of_France.svg/60px-Flag_of_France.svg.png 2x" data-file-width="900" data-file-height="600" /> <a href="/wiki/Portal:France" title="Portal:France">France</a></li><li class="portal-bar-item"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/19px-Industry5.svg.png" decoding="async" width="19" height="19" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/29px-Industry5.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/38px-Industry5.svg.png 2x" data-file-width="512" data-file-height="512" /> <a href="/wiki/Portal:Companies" title="Portal:Companies">Companies</a></li></ul></div> <div class="mw-heading mw-heading2"><h2 id="Notes">Notes</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=21" title="Edit section: Notes">edit</a>]</div> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-upper-alpha"> <div class="mw-references-wrap"><ol class="references"> <li id="cite_note-Total-136"><a href="#cite_ref-Total_136-0">^</a> <a href="/wiki/Total_S.A." class="mw-redirect" title="Total S.A.">Total</a> reduced its stake to less than 5% in 2011.<a href="#cite_note-135">[135]</a> </li> </ol></div></div> <div class="mw-heading mw-heading2"><h2 id="References">References</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=22" title="Edit section: References">edit</a>]</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239543626" /><div class="reflist"> <div class="mw-references-wrap mw-references-columns"><ol class="references"> <li id="cite_note-FY-1"><a href="#cite_ref-FY_1-0">^</a> <style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1121404/000112140425000010/sny-20241231.htm">"Annual Report 2024 (Form 20-F)"</a>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a>. 13 February 2025.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Annual+Report+2024+%28Form+20-F%29&rft.pub=U.S.+Securities+and+Exchange+Commission&rft.date=2025-02-13&rft_id=https%3A%2F%2Fwww.sec.gov%2Fix%3Fdoc%3D%2FArchives%2Fedgar%2Fdata%2F1121404%2F000112140425000010%2Fsny-20241231.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-2"><a href="#cite_ref-2">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20190208093448/http://www.boerse-frankfurt.de/en/equities/indices/euro%20stoxx%2050%20EU0009658145/constituents">"Börse Frankfurt (Frankfurt Stock Exchange): Stock market quotes, charts and news"</a>. boerse-frankfurt.de. Archived from <a rel="nofollow" class="external text" href="http://www.boerse-frankfurt.de/en/equities/indices/euro+stoxx+50+EU0009658145/constituents">the original</a> on 8 February 2019. Retrieved 23 May 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=boerse-frankfurt.de&rft.atitle=B%C3%B6rse+Frankfurt+%28Frankfurt+Stock+Exchange%29%3A+Stock+market+quotes%2C+charts+and+news&rft_id=http%3A%2F%2Fwww.boerse-frankfurt.de%2Fen%2Fequities%2Findices%2Feuro%2Bstoxx%2B50%2BEU0009658145%2Fconstituents&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-3"><a href="#cite_ref-3">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20240129031905/https://www.forbes.com/lists/global2000/?sh=4f5ab07e5ac0">"The Global 2000 2023"</a>. Forbes. Archived from <a rel="nofollow" class="external text" href="https://www.forbes.com/lists/global2000/?sh=51d599675ac0">the original</a> on 29 January 2024. Retrieved 7 February 2024.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Forbes&rft.atitle=The+Global+2000+2023&rft_id=https%3A%2F%2Fwww.forbes.com%2Flists%2Fglobal2000%2F%3Fsh%3D51d599675ac0&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-4"><a href="#cite_ref-4">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.forbes.com/feeds/afx/2007/11/23/afx4368351.html">"Sanofi-Aventis to sign deal to build flu vaccine plant in China – source"</a>. <a href="/wiki/Forbes" title="Forbes">Forbes</a>. 23 November 2007. Retrieved 19 April 2009.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Forbes&rft.atitle=Sanofi-Aventis+to+sign+deal+to+build+flu+vaccine+plant+in+China+%E2%80%93+source&rft.date=2007-11-23&rft_id=https%3A%2F%2Fwww.forbes.com%2Ffeeds%2Fafx%2F2007%2F11%2F23%2Fafx4368351.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988">[<a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot">dead link</a>‍] </li> <li id="cite_note-5"><a href="#cite_ref-5">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://lexpansion.lexpress.fr/entreprises/le-fondateur-de-sanofi-est-mort_1366122.html">"Le fondateur de Sanofi est mort"</a>. lexpress.fr. 28 December 2012. Retrieved 4 June 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=lexpress.fr&rft.atitle=Le+fondateur+de+Sanofi+est+mort&rft.date=2012-12-28&rft_id=http%3A%2F%2Flexpansion.lexpress.fr%2Fentreprises%2Fle-fondateur-de-sanofi-est-mort_1366122.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-6"><a href="#cite_ref-6">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=4Ar0AAAAMAAJ">CPE. Chemical & Process Engineering</a>. L. Hill. 1964. p. 83.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=CPE.+Chemical+%26+Process+Engineering&rft.pages=83&rft.pub=L.+Hill&rft.date=1964&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D4Ar0AAAAMAAJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-7"><a href="#cite_ref-7">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSneader1985" class="citation book cs1">Sneader, Walter (13 September 1985). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Ev1sAAAAMAAJ">Drug discovery: the evolution of modern medicines</a>. Wiley. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/9780471904717" title="Special:BookSources/9780471904717"><bdi>9780471904717</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Drug+discovery%3A+the+evolution+of+modern+medicines&rft.pub=Wiley&rft.date=1985-09-13&rft.isbn=9780471904717&rft.aulast=Sneader&rft.aufirst=Walter&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DEv1sAAAAMAAJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-PL1993-8">^ <a href="#cite_ref-PL1993_8-0">a</a> <a href="#cite_ref-PL1993_8-1">b</a> Staff, The Pharma Letter. Sept 20, 1993 <a rel="nofollow" class="external text" href="http://www.thepharmaletter.com/article/sanofi-extends-holding-in-chinoin">Sanofi Extends Holding in Chinoin</a> </li> <li id="cite_note-9"><a href="#cite_ref-9">^</a> <a rel="nofollow" class="external text" href="http://www.securities.com/php/company-profile/HU/Chinoin_Zrt_en_1441051.html">Chinoin listing in at securities.com</a> Page accessed 5 February 2016 </li> <li id="cite_note-SterlingHist-10"><a href="#cite_ref-SterlingHist_10-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCollinsGwilt2000" class="citation journal cs1">Collins, Joseph C.; Gwilt, John R. (2000). <a rel="nofollow" class="external text" href="http://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p22-27.pdf">"The Life Cycle of Sterling Drug, Inc"</a> (PDF). <a href="/wiki/Bull._Hist._Chem." class="mw-redirect" title="Bull. Hist. Chem.">Bull. Hist. Chem.</a> 25 (1): 22–27.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Bull.+Hist.+Chem.&rft.atitle=The+Life+Cycle+of+Sterling+Drug%2C+Inc.&rft.volume=25&rft.issue=1&rft.pages=%3Cspan+class%3D%22nowrap%22%3E22-%3C%2Fspan%3E27&rft.date=2000&rft.aulast=Collins&rft.aufirst=Joseph+C.&rft.au=Gwilt%2C+John+R.&rft_id=http%3A%2F%2Fwww.scs.illinois.edu%2F~mainzv%2FHIST%2Fbulletin_open_access%2Fv25-1%2Fv25-1%2520p22-27.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-20F-2002-11">^ <a href="#cite_ref-20F-2002_11-0">a</a> <a href="#cite_ref-20F-2002_11-1">b</a> <a href="#cite_ref-20F-2002_11-2">c</a> <a href="#cite_ref-20F-2002_11-3">d</a> Sanofi-Synthélabo <a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000095010903003612/d20f.htm#tx363_10">Form 20F for the Fiscal Year ended 31 December 2002</a> </li> <li id="cite_note-12"><a href="#cite_ref-12">^</a> Denis Cosnard for Les Echos. 11 December 1991. <a rel="nofollow" class="external text" href="http://www.lesechos.fr/11/12/1991/LesEchos/16033-043-ECH_synthelabo-s-offre-delalande.htm#rdL6MOWh8K053a95.99">Synthélabo s'offre Delalande</a> </li> <li id="cite_note-13"><a href="#cite_ref-13">^</a> Denis Conard for Les Echos. 17 October 1991 <a rel="nofollow" class="external text" href="http://www.lesechos.fr/17/10/1991/LesEchos/15996-035-ECH_synthelabo-rachete-les-laboratoires-delagrange.htm">Synthélabo rachète les laboratoires Delagrange</a> </li> <li id="cite_note-14"><a href="#cite_ref-14">^</a> Bibliothèque nationale de France <a rel="nofollow" class="external text" href="http://data.bnf.fr/12198004/laboratoires_delagrange/">Laboratoires Delagrange</a> Page accessed 24 August 2016 </li> <li id="cite_note-15"><a href="#cite_ref-15">^</a> Tom Meek for PMLiVE 24 May 2013 <a rel="nofollow" class="external text" href="http://www.pmlive.com/pharma_news/a_look_back_at_sanofis_merger_with_synthelabo_477146">A look back at Sanofi's merger with Synthélabo</a> </li> <li id="cite_note-16"><a href="#cite_ref-16">^</a> Joseph Borkin: The Crime and Punishment of I.G. Farben (New York: The Free Press, 1990), p. 163. </li> <li id="cite_note-Aventis-Form20F2002-17"><a href="#cite_ref-Aventis-Form20F2002_17-0">^</a> Aventis <a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/807198/000104746903008314/a2103938z20-f.htm">Form 20-F for the fiscal year ended 31 December 2002</a> </li> <li id="cite_note-Bris-18">^ <a href="#cite_ref-Bris_18-0">a</a> <a href="#cite_ref-Bris_18-1">b</a> <a href="#cite_ref-Bris_18-2">c</a> Arturo Bris and Christos Cabolis, <a rel="nofollow" class="external text" href="http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.365.5937&rep=rep1&type=pdf">Corporate Governance Convergence Through Cross-Border Mergers The Case of Aventis</a>, Chapter 4 in <a rel="nofollow" class="external text" href="https://books.google.com/books/about/Corporate_Governance_and_Regulatory_Impa.html?id=Cfc22UYifJQC">Corporate Governance and Regulatory Impact on Mergers and Acquisitions: Research and Analysis on Activity Worldwide Since 1990</a>. Eds Greg N. Gregoriou, Luc Renneboog. Academic Press, 26 July 2007 </li> <li id="cite_note-Burns-19"><a href="#cite_ref-Burns_19-0">^</a> Lawton Robert Burns <a rel="nofollow" class="external text" href="https://books.google.com/books?id=JPEgAwAAQBAJ&dq">The Business of Healthcare Innovation</a> Cambridge University Press, 26 July 2012 </li> <li id="cite_note-NYTimes1996-20"><a href="#cite_ref-NYTimes1996_20-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMeier1996" class="citation news cs1">Meier, Barry (11 June 1996). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1996/06/11/business/blood-money-aids-hemophiliacs-are-split-liability-cases-bogged-down-disputes.html">"Blood, Money and AIDS: Haemophiliacs Are Split; Liability Cases Bogged Down in Disputes"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Blood%2C+Money+and+AIDS%3A+Haemophiliacs+Are+Split%3B+Liability+Cases+Bogged+Down+in+Disputes&rft.date=1996-06-11&rft.aulast=Meier&rft.aufirst=Barry&rft_id=https%3A%2F%2Fwww.nytimes.com%2F1996%2F06%2F11%2Fbusiness%2Fblood-money-aids-hemophiliacs-are-split-liability-cases-bogged-down-disputes.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-21"><a href="#cite_ref-21">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPollack2000" class="citation news cs1">Pollack, Andrew (24 June 2000). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2000/06/24/business/international-business-aventis-unit-sets-big-investment-biotechnology-start-up.html">"Aventis Unit Sets Big Investment in Biotechnology Start-Up"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Aventis+Unit+Sets+Big+Investment+in+Biotechnology+Start-Up&rft.date=2000-06-24&rft.aulast=Pollack&rft.aufirst=Andrew&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2000%2F06%2F24%2Fbusiness%2Finternational-business-aventis-unit-sets-big-investment-biotechnology-start-up.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-22"><a href="#cite_ref-22">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2000/11/16/business/aventis-to-sell-agriculture-unit.html">"Aventis to Sell Agriculture Unit"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Bloomberg News. 16 November 2000. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Aventis+to+Sell+Agriculture+Unit&rft.date=2000-11-16&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2000%2F11%2F16%2Fbusiness%2Faventis-to-sell-agriculture-unit.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-23"><a href="#cite_ref-23">^</a> CNN Money. 2 October 2001 <a rel="nofollow" class="external text" href="http://cnnfn.cnn.com/2001/10/02/europe/bayer/">Bayer buys CropScience</a> </li> <li id="cite_note-24"><a href="#cite_ref-24">^</a> Candace Hoffmann for First Word Pharma. 8 September 2003 <a rel="nofollow" class="external text" href="https://www.firstwordpharma.com/node/215613#axzz2yoOgZJHQ">Aventis inks deal with Regeneron for collaboration on cancer therapy</a> </li> <li id="cite_note-25"><a href="#cite_ref-25">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGever2011" class="citation web cs1">Gever, John (19 November 2011). <a rel="nofollow" class="external text" href="http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/29811">"FDA Approves Eylea for Macular Degeneration"</a>. MedpageToday.com. Retrieved 16 October 2013.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=FDA+Approves+Eylea+for+Macular+Degeneration&rft.pub=MedpageToday.com&rft.date=2011-11-19&rft.aulast=Gever&rft.aufirst=John&rft_id=http%3A%2F%2Fwww.medpagetoday.com%2FOphthalmology%2FGeneralOphthalmology%2F29811&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-26"><a href="#cite_ref-26">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCiombor_KK2013" class="citation journal cs1">Ciombor KK; et al. (2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710732">"Aflibercept"</a>. Clin Cancer Res. 19 (8): 1920–1925. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-12-2911">10.1158/1078-0432.CCR-12-2911</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710732">3710732</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23444216">23444216</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clin+Cancer+Res&rft.atitle=Aflibercept&rft.volume=19&rft.issue=8&rft.pages=%3Cspan+class%3D%22nowrap%22%3E1920-%3C%2Fspan%3E1925&rft.date=2013&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3710732%23id-name%3DPMC&rft_id=info%3Apmid%2F23444216&rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-12-2911&rft.au=Ciombor+KK&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3710732&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-ZaltrapFDA-27">^ <a href="#cite_ref-ZaltrapFDA_27-0">a</a> <a href="#cite_ref-ZaltrapFDA_27-1">b</a> <a href="#cite_ref-ZaltrapFDA_27-2">c</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/drugs/resources-information-approved-drugs/2012-notifications">"2012 Notifications"</a>. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). 13 February 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191226010037/https://www.fda.gov/drugs/resources-information-approved-drugs/2012-notifications">Archived</a> from the original on 26 December 2019. Retrieved 25 December 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&rft.atitle=2012+Notifications&rft.date=2018-02-13&rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2F2012-notifications&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-28"><a href="#cite_ref-28">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTimmons2004" class="citation news cs1">Timmons, Heather (3 April 2004). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2004/04/03/business/international-business-aventis-invites-novartis-to-counter-sanofi-s-bid.html">"Aventis Invites Novartis To Counter Sanofi's Bid"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Aventis+Invites+Novartis+To+Counter+Sanofi%27s+Bid&rft.date=2004-04-03&rft.aulast=Timmons&rft.aufirst=Heather&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2004%2F04%2F03%2Fbusiness%2Finternational-business-aventis-invites-novartis-to-counter-sanofi-s-bid.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-29"><a href="#cite_ref-29">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTimmons2004" class="citation news cs1">Timmons, Heather (27 April 2004). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2004/04/27/business/france-helped-broker-the-aventis-sanofi-deal.html">"France Helped Broker the Aventis-Sanofi Deal"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=France+Helped+Broker+the+Aventis-Sanofi+Deal&rft.date=2004-04-27&rft.aulast=Timmons&rft.aufirst=Heather&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2004%2F04%2F27%2Fbusiness%2Ffrance-helped-broker-the-aventis-sanofi-deal.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-30"><a href="#cite_ref-30">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2004/04/24/business/aventis-plan-is-rejected.html">"Aventis Plan Is Rejected"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Bloomberg News. 24 April 2004. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Aventis+Plan+Is+Rejected&rft.date=2004-04-24&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2004%2F04%2F24%2Fbusiness%2Faventis-plan-is-rejected.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-31"><a href="#cite_ref-31">^</a> Kimberly S Cleaves and Ann M Thayer <a rel="nofollow" class="external text" href="http://pubs.acs.org/subscribe/archive/mdd/v07/i08/pdf/804business2.pdf">Warning, merge with care: Sanofi-Aventis</a> Modern Drug Discovery, August 2004:21-26 </li> <li id="cite_note-32"><a href="#cite_ref-32">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFZielbauer2006" class="citation news cs1">Zielbauer, Paul von (4 September 2006). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2006/09/04/world/middleeast/04aids.html">"Iraqis Infected by H.I.V.-Tainted Blood Try New Tool: A Lawsuit"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Iraqis+Infected+by+H.I.V.-Tainted+Blood+Try+New+Tool%3A+A+Lawsuit&rft.date=2006-09-04&rft.aulast=Zielbauer&rft.aufirst=Paul+von&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F09%2F04%2Fworld%2Fmiddleeast%2F04aids.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-33"><a href="#cite_ref-33">^</a> BMS Press Release. 8 December 2006 <a rel="nofollow" class="external text" href="http://www.prnewswire.com/news-releases/preliminary-injunction-against-apotex-upheld-on-appeal-56053592.html">Preliminary Injunction Against Apotex Upheld on Appeal</a> </li> <li id="cite_note-34"><a href="#cite_ref-34">^</a> Aaron Smith for CNNMoney.com 26 October 2006 <a rel="nofollow" class="external text" href="https://money.cnn.com/2006/09/12/news/companies/bristol/index.htm?postversion=2006091217">Bristol CEO Dolan gets fired: Company says it heeded request of a federal monitor</a> </li> <li id="cite_note-35"><a href="#cite_ref-35">^</a> Donald Zuhn for Patent Docs. 9 November 2011 <a rel="nofollow" class="external text" href="http://www.patentdocs.org/2011/11/sanofi-aventis-v-apotex-inc-fed-cir-2011.html">Sanofi-Aventis v. Apotex Inc. (Fed. Cir. 2011)</a> </li> <li id="cite_note-36"><a href="#cite_ref-36">^</a> Linda a. Johnson for Associated Press 8 February 2012 <a rel="nofollow" class="external text" href="https://finance.yahoo.com/news/Apotex-pays-Bristol-Sanofi-apf-2142059502.html">Apotex pays Bristol, Sanofi damages over Plavix</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160305060611/http://finance.yahoo.com/news/Apotex-pays-Bristol-Sanofi-apf-2142059502.html">Archived</a> 5 March 2016 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a> </li> <li id="cite_note-37"><a href="#cite_ref-37">^</a> Carolina Bolado for Law360 14 March 2013. <a rel="nofollow" class="external text" href="http://www.law360.com/articles/423792/bristol-myers-escapes-3-4b-apotex-suit-over-plavix-deal">Bristol-Myers Escapes $3.4B Apotex Suit Over Plavix Deal</a> </li> <li id="cite_note-RegenExpand-38">^ <a href="#cite_ref-RegenExpand_38-0">a</a> <a href="#cite_ref-RegenExpand_38-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWinslow2009" class="citation news cs1">Winslow, Ron (10 November 2009). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB10001424052748703808904574528224003357650">"Sanofi Expands Regeneron Deal"</a>. <a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Wall+Street+Journal&rft.atitle=Sanofi+Expands+Regeneron+Deal&rft.date=2009-11-10&rft.aulast=Winslow&rft.aufirst=Ron&rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424052748703808904574528224003357650&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-GEN2009-39">^ <a href="#cite_ref-GEN2009_39-0">a</a> <a href="#cite_ref-GEN2009_39-1">b</a> Genetic Engineering and Biotechnology News. 11 November 2009 <a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/sanofi-aventis-commits-over-2-8b-to-regeneron-in-mab-discovery-alliance/68174500/">Sanofi-Aventis Commits Over $2.8B to Regeneron in mAb Discovery Alliance</a> </li> <li id="cite_note-40"><a href="#cite_ref-40">^</a> FierceBiotech. <a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/special-reports/sanofi-aventis-timeline-biopharma-deals">Sanofi-Aventis: A timeline of biopharma deals</a> </li> <li id="cite_note-41"><a href="#cite_ref-41">^</a> Andy Tisman for IMS Health 2010 <a rel="nofollow" class="external text" href="http://www.imshealth.com/deployedfiles/ims/Global/Content/Solutions/Healthcare%20Measurement/Consumer%20Health%20Insights/The_Rising_Tide_Of_OTC_Europe.pdf">The Rising Tide of OTC in Europe</a> </li> <li id="cite_note-Chattem-42">^ <a href="#cite_ref-Chattem_42-0">a</a> <a href="#cite_ref-Chattem_42-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/12/22/business/global/22drug.html">"Drug Maker Sanofi-Aventis Buys Chattem for $1.9 Billion"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Reuters. 21 December 2009. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Drug+Maker+Sanofi-Aventis+Buys+Chattem+for+%241.9+Billion&rft.date=2009-12-21&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F12%2F22%2Fbusiness%2Fglobal%2F22drug.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-43"><a href="#cite_ref-43">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/09/22/business/worldbusiness/22iht-drug.4.16376740.html">"Sanofi-Aventis to buy Czech generic drug maker"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. 22 September 2008. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Sanofi-Aventis+to+buy+Czech+generic+drug+maker&rft.date=2008-09-22&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F09%2F22%2Fbusiness%2Fworldbusiness%2F22iht-drug.4.16376740.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-Law360Medley-44">^ <a href="#cite_ref-Law360Medley_44-0">a</a> <a href="#cite_ref-Law360Medley_44-1">b</a> Leigh Kamping-Carder for Law360. 20 May 2010 <a rel="nofollow" class="external text" href="http://www.law360.com/articles/169962/brazil-clears-sanofi-s-635m-medley-pharma-buy">Brazil Clears Sanofi's $635M Medley Pharma Buy</a> </li> <li id="cite_note-45"><a href="#cite_ref-45">^</a> Gareth Macdonald for PharmaTechnologist, 15 April 2009 <a rel="nofollow" class="external text" href="http://www.in-pharmatechnologist.com/Regulatory-Safety/Sanofi-beats-Teva-in-Medley-melee">Sanofi beats Teva in Medley melee</a> </li> <li id="cite_note-46"><a href="#cite_ref-46">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/story/sanofi-snaps-indias-shantha-784m/2009-07-27">"Sanofi snaps up India's Shantha for $784M"</a>. FierceBiotech. 27 July 2009.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=FierceBiotech&rft.atitle=Sanofi+snaps+up+India%27s+Shantha+for+%24784M&rft.date=2009-07-27&rft_id=http%3A%2F%2Fwww.fiercebiotech.com%2Fstory%2Fsanofi-snaps-indias-shantha-784m%2F2009-07-27&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-47"><a href="#cite_ref-47">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGrytaSpencer2010" class="citation news cs1">Gryta, Thomas; Spencer, Mimosa (9 October 2010). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB10001424052748704657304575540024140661094">"Sanofi Cuts Jobs, Counters Genzyme"</a>. <a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Wall+Street+Journal&rft.atitle=Sanofi+Cuts+Jobs%2C+Counters+Genzyme&rft.date=2010-10-09&rft.aulast=Gryta&rft.aufirst=Thomas&rft.au=Spencer%2C+Mimosa&rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424052748704657304575540024140661094&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-48"><a href="#cite_ref-48">^</a> Phil Serafino for Bloomberg News. 28 October 2010 <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2010-10-28/sanofi-aventis-to-buy-bmp-sunstone-for-520-6-million.html">Sanofi-Aventis to Buy BMP Sunstone to Expand in China</a> </li> <li id="cite_note-49"><a href="#cite_ref-49">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMennella2011" class="citation news cs1">Mennella, Noelle (6 May 2011). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/sanofi-idUSLDE74521Z20110506">"Sanofi changes name, pace of acquisitions to slow"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. Retrieved 7 May 2011.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+changes+name%2C+pace+of+acquisitions+to+slow&rft.date=2011-05-06&rft.aulast=Mennella&rft.aufirst=Noelle&rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fsanofi-idUSLDE74521Z20110506&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-50"><a href="#cite_ref-50">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFNicholson2011" class="citation news cs1">Nicholson, Chris V. (16 February 2011). <a rel="nofollow" class="external text" href="https://dealbook.nytimes.com/2011/02/16/sanofi-agrees-to-buy-genzyme-for-at-least-20-1-billion/">"Sanofi Agrees to Buy Genzyme for $20.1 Billion"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Sanofi+Agrees+to+Buy+Genzyme+for+%2420.1+Billion&rft.date=2011-02-16&rft.aulast=Nicholson&rft.aufirst=Chris+V.&rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2011%2F02%2F16%2Fsanofi-agrees-to-buy-genzyme-for-at-least-20-1-billion%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-51"><a href="#cite_ref-51">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWeintraub2012" class="citation news cs1">Weintraub, Arlene (10 January 2012). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140407111220/http://www.xconomy.com/boston/2012/01/10/warp-drive-bio-launches-with-125m-from-third-rock-greylock-sanofi/?single_page=true">"Warp Drive Bio Launches With $125M from Third Rock, Greylock, Sanofi"</a>. Xconomy. Archived from <a rel="nofollow" class="external text" href="http://www.xconomy.com/boston/2012/01/10/warp-drive-bio-launches-with-125m-from-third-rock-greylock-sanofi/?single_page=true">the original</a> on 7 April 2014. Retrieved 6 April 2014.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Xconomy&rft.atitle=Warp+Drive+Bio+Launches+With+%24125M+from+Third+Rock%2C+Greylock%2C+Sanofi&rft.date=2012-01-10&rft.aulast=Weintraub&rft.aufirst=Arlene&rft_id=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2012%2F01%2F10%2Fwarp-drive-bio-launches-with-125m-from-third-rock-greylock-sanofi%2F%3Fsingle_page%3Dtrue&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-52"><a href="#cite_ref-52">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140414172941/http://www.alnylam.com/product-pipeline/ttr-amyloidosis-fap/">"TTR Amyloidosis (FAP)"</a>. Alnylam Pharmaceuticals. Archived from <a rel="nofollow" class="external text" href="http://www.alnylam.com/product-pipeline/ttr-amyloidosis-fap/">the original</a> on 14 April 2014. Retrieved 13 April 2014.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=TTR+Amyloidosis+%28FAP%29&rft.pub=Alnylam+Pharmaceuticals&rft_id=http%3A%2F%2Fwww.alnylam.com%2Fproduct-pipeline%2Fttr-amyloidosis-fap%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-53"><a href="#cite_ref-53">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBray2014" class="citation news cs1">Bray, Chad (13 January 2014). <a rel="nofollow" class="external text" href="https://dealbook.nytimes.com/2014/01/13/sanofi-unit-to-buy-700-million-stake-in-rare-disease-company/">"Sanofi Unit to Buy $700 Million Stake in Rare Disease Company"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Sanofi+Unit+to+Buy+%24700+Million+Stake+in+Rare+Disease+Company&rft.date=2014-01-13&rft.aulast=Bray&rft.aufirst=Chad&rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2014%2F01%2F13%2Fsanofi-unit-to-buy-700-million-stake-in-rare-disease-company%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-54"><a href="#cite_ref-54">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBaigorriTorsoliWelch2014" class="citation news cs1">Baigorri, Manuel; Torsoli, Albertina; Welch, David (25 March 2014). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2014-03-24/sanofi-said-to-join-bidders-for-merck-s-consumer-health-business.html">"Sanofi Said to Join Bidders for Merck's Consumer-Health Unit"</a>. Bloomberg News.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Bloomberg+News&rft.atitle=Sanofi+Said+to+Join+Bidders+for+Merck%27s+Consumer-Health+Unit&rft.date=2014-03-25&rft.aulast=Baigorri&rft.aufirst=Manuel&rft.au=Torsoli%2C+Albertina&rft.au=Welch%2C+David&rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-03-24%2Fsanofi-said-to-join-bidders-for-merck-s-consumer-health-business.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-55"><a href="#cite_ref-55">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHuetMennella2014" class="citation news cs1">Huet, Natalie; Mennella, Noëlle (29 October 2014). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-sanofi-sa-management-idUSKBN0II0BH20141029">"French drugmaker Sanofi sacks CEO, shares drop"</a>. Reuters. Retrieved 6 July 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=French+drugmaker+Sanofi+sacks+CEO%2C+shares+drop&rft.date=2014-10-29&rft.aulast=Huet&rft.aufirst=Natalie&rft.au=Mennella%2C+No%C3%ABlle&rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-sanofi-sa-management-idUSKBN0II0BH20141029&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-56"><a href="#cite_ref-56">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20150425041931/http://en.sanofi.com/NasdaQ_OMX/LOCAL/press_releases/sanofi___sanofi_appoints_olivi_1896027_19-02-2015!22_45_00.aspx">"Sanofi Appoints Olivier Brandicourt as Chief Executive Officer"</a> (Press release). Sanofi. 19 February 2015. Archived from <a rel="nofollow" class="external text" href="http://en.sanofi.com/NasdaQ_OMX/LOCAL/press_releases/sanofi___sanofi_appoints_olivi_1896027_19-02-2015!22_45_00.aspx">the original</a> on 25 April 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+Appoints+Olivier+Brandicourt+as+Chief+Executive+Officer&rft.pub=Sanofi&rft.date=2015-02-19&rft_id=http%3A%2F%2Fen.sanofi.com%2FNasdaQ_OMX%2FLOCAL%2Fpress_releases%2Fsanofi___sanofi_appoints_olivi_1896027_19-02-2015%2122_45_00.aspx&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-57"><a href="#cite_ref-57">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSilverman2015" class="citation news cs1">Silverman, Ed (24 February 2015). <a rel="nofollow" class="external text" href="https://blogs.wsj.com/pharmalot/2015/02/24/french-government-slams-sanofi-over-brandicourt-pay-package/">"French Government Slams Sanofi Over Brandicourt Pay Package"</a>. <a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a>. Retrieved 6 July 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Wall+Street+Journal&rft.atitle=French+Government+Slams+Sanofi+Over+Brandicourt+Pay+Package&rft.date=2015-02-24&rft.aulast=Silverman&rft.aufirst=Ed&rft_id=https%3A%2F%2Fblogs.wsj.com%2Fpharmalot%2F2015%2F02%2F24%2Ffrench-government-slams-sanofi-over-brandicourt-pay-package%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-58"><a href="#cite_ref-58">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFEric_Palmer2014" class="citation web cs1">Eric Palmer (26 June 2014). <a rel="nofollow" class="external text" href="http://www.fiercepharma.com/supply-chain/sanofi-buys-dubai-s-globalpharma-to-produce-generics-middle-east">"Sanofi buys Dubai's Globalpharma to produce generics in the Middle East"</a>. Questex LLC. Retrieved 24 February 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+buys+Dubai%27s+Globalpharma+to+produce+generics+in+the+Middle+East&rft.pub=Questex+LLC.&rft.date=2014-06-26&rft.au=Eric+Palmer&rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fsupply-chain%2Fsanofi-buys-dubai-s-globalpharma-to-produce-generics-middle-east&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-59"><a href="#cite_ref-59">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/genzyme-to-buy-caprelsa-from-astrazeneca-for-up-to-300m/81251554/">"Genzyme to Buy Caprelsa from AstraZeneca for Up to $300M - GEN News Highlights - GEN"</a>. Genengnews.com. 27 July 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Genengnews.com&rft.atitle=Genzyme+to+Buy+Caprelsa+from+AstraZeneca+for+Up+to+%24300M+-+GEN+News+Highlights+-+GEN&rft.date=2015-07-27&rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fgenzyme-to-buy-caprelsa-from-astrazeneca-for-up-to-300m%2F81251554%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-60"><a href="#cite_ref-60">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/regeneron-sanofi-launch-2b-immuno-oncology-collaboration/81251558/">"Regeneron, Sanofi Launch $2B+ Immuno-Oncology Collaboration - GEN News Highlights - GEN"</a>. Genengnews.com. 28 July 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Genengnews.com&rft.atitle=Regeneron%2C+Sanofi+Launch+%242B%2B+Immuno-Oncology+Collaboration+-+GEN+News+Highlights+-+GEN&rft.date=2015-07-28&rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fregeneron-sanofi-launch-2b-immuno-oncology-collaboration%2F81251558%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-61"><a href="#cite_ref-61">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/story/struggling-sanofi-paying-18b-partner-regeneron-immuno-oncology/2015-07-28">"UPDATED: Struggling Sanofi paying $1.8B to partner with Regeneron on immuno-oncology"</a>. FierceBiotech.com. 28 July 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=FierceBiotech.com&rft.atitle=UPDATED%3A+Struggling+Sanofi+paying+%241.8B+to+partner+with+Regeneron+on+immuno-oncology&rft.date=2015-07-28&rft_id=http%3A%2F%2Fwww.fiercebiotech.com%2Fstory%2Fstruggling-sanofi-paying-18b-partner-regeneron-immuno-oncology%2F2015-07-28&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-62"><a href="#cite_ref-62">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/pharma/aiming-for-top-dog-status-sanofi-and-boehringer-swap-animal-and-consumer-health-units">"Aiming for top dog status, Sanofi and Boehringer swap animal and consumer health units"</a>. FiercePharma.com. 27 June 2016.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=FiercePharma.com&rft.atitle=Aiming+for+top+dog+status%2C+Sanofi+and+Boehringer+swap+animal+and+consumer+health+units&rft.date=2016-06-27&rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Faiming-for-top-dog-status-sanofi-and-boehringer-swap-animal-and-consumer-health-units&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-63"><a href="#cite_ref-63">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20170715092729/http://mediaroom.sanofi.com/sanofi-to-acquire-protein-sciences/">"Sanofi – Sanofi to acquire Protein Sciences – Sanofi"</a>. mediaroom.sanofi.com. Archived from <a rel="nofollow" class="external text" href="http://mediaroom.sanofi.com/sanofi-to-acquire-protein-sciences/">the original</a> on 15 July 2017. Retrieved 12 July 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=mediaroom.sanofi.com&rft.atitle=Sanofi+%E2%80%93+Sanofi+to+acquire+Protein+Sciences+%E2%80%93+Sanofi&rft_id=http%3A%2F%2Fmediaroom.sanofi.com%2Fsanofi-to-acquire-protein-sciences%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-64"><a href="#cite_ref-64">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHirschler2018" class="citation news cs1">Hirschler, Ben (22 January 2018). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-biotech-m-a/biotech-ma-takes-off-as-sanofi-and-celgene-spend-20-billion-idUSKBN1FB20V">"Biotech M&A takes off as Sanofi and Celgene spend $20 billion"</a>. Reuters.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Biotech+M%26A+takes+off+as+Sanofi+and+Celgene+spend+%2420+billion&rft.date=2018-01-22&rft.aulast=Hirschler&rft.aufirst=Ben&rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-biotech-m-a%2Fbiotech-ma-takes-off-as-sanofi-and-celgene-spend-20-billion-idUSKBN1FB20V&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-65"><a href="#cite_ref-65">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBlamont2018" class="citation news cs1">Blamont, Matthias (30 January 2018). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180130091338/https://uk.reuters.com/article/uk-ablynx-m-a-sanofi/sanofi-beats-novo-to-buy-ablynx-for-3-9-billion-euros-in-biotech-ma-boom-idUKKBN1FI0PJ">"Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom"</a>. Reuters. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/uk-ablynx-m-a-sanofi/sanofi-beats-novo-to-buy-ablynx-for-3-9-billion-euros-in-biotech-ma-boom-idUKKBN1FI0PJ">the original</a> on 30 January 2018.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+beats+Novo+to+buy+Ablynx+for+%244.8+billion+in+biotech+M%26A+boom&rft.date=2018-01-30&rft.aulast=Blamont&rft.aufirst=Matthias&rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fuk-ablynx-m-a-sanofi%2Fsanofi-beats-novo-to-buy-ablynx-for-3-9-billion-euros-in-biotech-ma-boom-idUKKBN1FI0PJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-66"><a href="#cite_ref-66">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20210203235720/https://www.sanofi.com/media-room/press-releases/2019/2019-12-09%2007-00-00%201957603">"Sanofi: Press Releases, Monday, December 9, 2019"</a>. sanofi.com/en. Archived from <a rel="nofollow" class="external text" href="https://www.sanofi.com/media-room/press-releases/2019/2019-12-09%2007-00-00%201957603">the original</a> on 3 February 2021. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=sanofi.com%2Fen&rft.atitle=Sanofi%3A+Press+Releases%2C+Monday%2C+December+9%2C+2019&rft_id=https%3A%2F%2Fwww.sanofi.com%2Fmedia-room%2Fpress-releases%2F2019%2F2019-12-09%252007-00-00%25201957603&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-67"><a href="#cite_ref-67">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-to-buy-synthorx-for-2-5-billion/">"Sanofi Pushes Further into Immuno-Oncology with $2.5 Billion Synthorx Takeover"</a>. BioSpace. 9 December 2019. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+Pushes+Further+into+Immuno-Oncology+with+%242.5+Billion+Synthorx+Takeover&rft.date=2019-12-09&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-to-buy-synthorx-for-2-5-billion%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-68"><a href="#cite_ref-68">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylor2022" class="citation web cs1">Taylor, Nick Paul (28 October 2022). <a rel="nofollow" class="external text" href="https://www.fiercebiotech.com/biotech/wake-bempeg-blowup-sanofi-rethinks-25b-bet-il-2-after-midphase-efficacy-falls-short">"In wake of bempeg blowup, Sanofi rethinks $2.5B bet on IL-2 after midphase efficacy falls short"</a>. Fierce Biotech. Retrieved 31 October 2022.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Fierce+Biotech&rft.atitle=In+wake+of+bempeg+blowup%2C+Sanofi+rethinks+%242.5B+bet+on+IL-2+after+midphase+efficacy+falls+short&rft.date=2022-10-28&rft.aulast=Taylor&rft.aufirst=Nick+Paul&rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fwake-bempeg-blowup-sanofi-rethinks-25b-bet-il-2-after-midphase-efficacy-falls-short&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-69"><a href="#cite_ref-69">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biopharmadive.com/news/sanofi-synthorx-il2-cancer-drug-delay/635206/">"Sanofi reveals setback for cancer drug acquired in Synthorx buyout"</a>. BioPharma Dive. Retrieved 31 October 2022.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioPharma+Dive&rft.atitle=Sanofi+reveals+setback+for+cancer+drug+acquired+in+Synthorx+buyout&rft_id=https%3A%2F%2Fwww.biopharmadive.com%2Fnews%2Fsanofi-synthorx-il2-cancer-drug-delay%2F635206%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-70"><a href="#cite_ref-70">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clinicaltrials.gov/ct2/show/NCT04913220">"A Phase 1/2 Non-randomized, Open-label, Multi-cohort, Multi-center Study Assessing the Clinical Benefit of SAR444245 (THOR- 707) Combined With Cemiplimab for the Treatment of Participants With Advanced Unresectable or Metastatic Skin Cancers"</a>. Sanofi. 19 December 2024. NCT04913220.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=A+Phase+1%2F2+Non-randomized%2C+Open-label%2C+Multi-cohort%2C+Multi-center+Study+Assessing+the+Clinical+Benefit+of+SAR444245+%28THOR-+707%29+Combined+With+Cemiplimab+for+the+Treatment+of+Participants+With+Advanced+Unresectable+or+Metastatic+Skin+Cancers&rft.pub=Sanofi&rft.date=2024-12-19&rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04913220&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-71"><a href="#cite_ref-71">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200527014812/https://uk.reuters.com/article/us-sanofi-regeneron-idUKKBN2311TC">"U.S.' Regeneron to buy back $5 billion stake held by Sanofi"</a>. Reuters. 25 May 2020. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-sanofi-regeneron-idUKKBN2311TC">the original</a> on 27 May 2020. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=U.S.%27+Regeneron+to+buy+back+%245+billion+stake+held+by+Sanofi&rft.date=2020-05-25&rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-sanofi-regeneron-idUKKBN2311TC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-72"><a href="#cite_ref-72">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKar-GuptaMishra2020" class="citation news cs1">Kar-Gupta, Sudip; Mishra, Manas (23 June 2020). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200624190925/https://uk.reuters.com/article/uk-sanofi-translate-bio-idUKKBN23U0LF">"Sanofi clinches $2 billion vaccines deal with Translate Bio"</a>. Reuters. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/uk-sanofi-translate-bio-idUKKBN23U0LF">the original</a> on 24 June 2020. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sanofi+clinches+%242+billion+vaccines+deal+with+Translate+Bio&rft.date=2020-06-23&rft.aulast=Kar-Gupta&rft.aufirst=Sudip&rft.au=Mishra%2C+Manas&rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fuk-sanofi-translate-bio-idUKKBN23U0LF&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-73"><a href="#cite_ref-73">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.bbc.com/news/business-53577637">"Coronavirus vaccine: UK signs deal with GSK and Sanofi"</a>. BBC News. 29 July 2020. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronavirus+vaccine%3A+UK+signs+deal+with+GSK+and+Sanofi&rft.date=2020-07-29&rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fbusiness-53577637&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-74"><a href="#cite_ref-74">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cnbc.com/2020/07/31/us-agrees-to-pay-sanofi-and-gsk-2point1-billion-for-100-million-doses-of-coronavirus-vaccine.html">"U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine"</a>. CNBC. 31 July 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=U.S.+agrees+to+pay+Sanofi+and+GSK+%242.1+billion+for+100+million+doses+of+coronavirus+vaccine&rft.pub=CNBC&rft.date=2020-07-31&rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F07%2F31%2Fus-agrees-to-pay-sanofi-and-gsk-2point1-billion-for-100-million-doses-of-coronavirus-vaccine.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-75"><a href="#cite_ref-75">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-snaps-up-principa-biopharma-and-its-btk-program-for-100-per-share/">"Sanofi Acquires Principia Biopharma in $3.6 Billion Deal"</a>. BioSpace. 17 August 2020. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+Acquires+Principia+Biopharma+in+%243.6+Billion+Deal&rft.date=2020-08-17&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-snaps-up-principa-biopharma-and-its-btk-program-for-100-per-share%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-76"><a href="#cite_ref-76">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-to-acquire-principia-biopharma/">"Sanofi to acquire Principia Biopharma"</a>. BioSpace. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+to+acquire+Principia+Biopharma&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-to-acquire-principia-biopharma%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-77"><a href="#cite_ref-77">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKar-Gupta2020" class="citation news cs1">Kar-Gupta, Sudip (17 August 2020). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200817141118/https://uk.reuters.com/article/us-principia-m-a-sanofi-idUKKCN25D0DV">"Sanofi in hunt for specialty drugs with $3.7 billion deal for U.S.-based Principia"</a>. Reuters. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-principia-m-a-sanofi-idUKKCN25D0DV">the original</a> on 17 August 2020. Retrieved 11 December 2020 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+in+hunt+for+specialty+drugs+with+%243.7+billion+deal+for+U.S.-based+Principia&rft.date=2020-08-17&rft.aulast=Kar-Gupta&rft.aufirst=Sudip&rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-principia-m-a-sanofi-idUKKCN25D0DV&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-78"><a href="#cite_ref-78">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.expresspharma.in/latest-updates/sanofi-concludes-acquisition-of-principia-biopharma/">"Sanofi concludes acquisition of Principia Biopharma"</a>. Express Pharma. 29 September 2020. Retrieved 29 September 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Express+Pharma&rft.atitle=Sanofi+concludes+acquisition+of+Principia+Biopharma&rft.date=2020-09-29&rft_id=https%3A%2F%2Fwww.expresspharma.in%2Flatest-updates%2Fsanofi-concludes-acquisition-of-principia-biopharma%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-79"><a href="#cite_ref-79">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-offers-to-acquire-kiadis-for-359-million/">"Sanofi Picks Up Kiadis and Its Immuno-Oncology Assets for $359 Million"</a>. BioSpace. 2 November 2020. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+Picks+Up+Kiadis+and+Its+Immuno-Oncology+Assets+for+%24359+Million&rft.date=2020-11-02&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-offers-to-acquire-kiadis-for-359-million%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-80"><a href="#cite_ref-80">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWhite2021" class="citation news cs1">White, Sarah (11 January 2021). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-sanofi-immunotherapy-idUSKBN29G0RT">"Sanofi buys Kymab for up to $1.5 billion to expand in immunotherapy"</a>. Reuters. Retrieved 11 January 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+buys+Kymab+for+up+to+%241.5+billion+to+expand+in+immunotherapy&rft.date=2021-01-11&rft.aulast=White&rft.aufirst=Sarah&rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-sanofi-immunotherapy-idUSKBN29G0RT&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-81"><a href="#cite_ref-81">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.globenewswire.com/news-release/2021/01/11/2155914/0/en/Sanofi-to-acquire-Kymab-adding-KY1005-to-its-pipeline-a-human-monoclonal-antibody-targeting-key-immune-system-regulator-OX40L.html">"Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L"</a> (Press release). 11 January 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+to+acquire+Kymab%2C+adding+KY1005+to+its+pipeline%2C+a+human+monoclonal+antibody+targeting+key+immune+system+regulator+OX40L&rft.date=2021-01-11&rft_id=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2021%2F01%2F11%2F2155914%2F0%2Fen%2FSanofi-to-acquire-Kymab-adding-KY1005-to-its-pipeline-a-human-monoclonal-antibody-targeting-key-immune-system-regulator-OX40L.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-82"><a href="#cite_ref-82">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-boosts-immunology-pipeline-with-1-4-billion-acquisition-of-kymab/?s=79">"Sanofi Ups Immunology Game with $1.4 Billion Acquisition of Kymab"</a>. 11 January 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+Ups+Immunology+Game+with+%241.4+Billion+Acquisition+of+Kymab&rft.date=2021-01-11&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-boosts-immunology-pipeline-with-1-4-billion-acquisition-of-kymab%2F%3Fs%3D79&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-83"><a href="#cite_ref-83">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-snatches-up-tidal-therapeutics-in-470-deal/?s=79">"Sanofi Snatches up Tidal Therapeutics in $470 Million Deal"</a>. 9 April 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+Snatches+up+Tidal+Therapeutics+in+%24470+Million+Deal&rft.date=2021-04-09&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-snatches-up-tidal-therapeutics-in-470-deal%2F%3Fs%3D79&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-84"><a href="#cite_ref-84">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBlamont2021" class="citation news cs1">Blamont, Matthias (3 August 2021). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-health-coronavirus-sanofi-translate-b/sanofi-bets-on-mrna-vaccines-beyond-covid-in-3-2-billion-translate-bio-deal-idUSKBN2F328C">"EXCLUSIVE Sanofi offers to buy U.S. Biotech, mRNA partner Translate Bio -sources"</a>. Reuters.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=EXCLUSIVE+Sanofi+offers+to+buy+U.S.+Biotech%2C+mRNA+partner+Translate+Bio+-sources&rft.date=2021-08-03&rft.aulast=Blamont&rft.aufirst=Matthias&rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-sanofi-translate-b%2Fsanofi-bets-on-mrna-vaccines-beyond-covid-in-3-2-billion-translate-bio-deal-idUSKBN2F328C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-85"><a href="#cite_ref-85">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/business/healthcare-pharmaceuticals/frances-sanofi-buy-us-biopharma-firm-kadmon-19-bln-deal-2021-09-08/">"France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal"</a>. Reuters. 8 September 2021. Retrieved 8 September 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=France%27s+Sanofi+to+buy+U.S.+biopharma+firm+Kadmon+in+%241.9+bln+deal&rft.date=2021-09-08&rft_id=https%3A%2F%2Fwww.reuters.com%2Fbusiness%2Fhealthcare-pharmaceuticals%2Ffrances-sanofi-buy-us-biopharma-firm-kadmon-19-bln-deal-2021-09-08%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-86"><a href="#cite_ref-86">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRosemain2021" class="citation web cs1">Rosemain, Mathieu (18 November 2021). <a rel="nofollow" class="external text" href="https://www.metro.us/drugmaker-sanofi-invests-180/">"Drugmaker Sanofi invests $180 million in French AI startup Owkin - Metro US"</a>. metro.us. Retrieved 18 November 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=metro.us&rft.atitle=Drugmaker+Sanofi+invests+%24180+million+in+French+AI+startup+Owkin+-+Metro+US&rft.date=2021-11-18&rft.aulast=Rosemain&rft.aufirst=Mathieu&rft_id=https%3A%2F%2Fwww.metro.us%2Fdrugmaker-sanofi-invests-180%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-87"><a href="#cite_ref-87">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-to-acquire-origimm-biotechnology-in-first-move-to-treat-acne-with-vaccine-based-immunotherapy-/">"Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy"</a>. BioSpace.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+to+acquire+Origimm+Biotechnology+in+first+move+to+treat+acne+with+vaccine-based+immunotherapy&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-to-acquire-origimm-biotechnology-in-first-move-to-treat-acne-with-vaccine-based-immunotherapy-%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-88"><a href="#cite_ref-88">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-group-sanofi-buy-origimm-biotechnology-boost-vaccines-business-2021-12-01/">"Sanofi to buy Origimm Biotechnology for acne vaccine candidate"</a>. Reuters. 1 December 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+to+buy+Origimm+Biotechnology+for+acne+vaccine+candidate&rft.date=2021-12-01&rft_id=https%3A%2F%2Fwww.reuters.com%2Fbusiness%2Fhealthcare-pharmaceuticals%2Fhealthcare-group-sanofi-buy-origimm-biotechnology-boost-vaccines-business-2021-12-01%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-89"><a href="#cite_ref-89">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/markets/deals/sanofi-1-bln-deal-buy-us-based-amunix-pharma-2021-12-21/">"Sanofi in $1 bln deal to buy U.S.-based Amunix Pharma"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. 21 December 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+in+%241+bln+deal+to+buy+U.S.-based+Amunix+Pharma&rft.date=2021-12-21&rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Fsanofi-1-bln-deal-buy-us-based-amunix-pharma-2021-12-21%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-90"><a href="#cite_ref-90">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTeo2022" class="citation web cs1">Teo, Joyce (20 April 2022). <a rel="nofollow" class="external text" href="https://www.straitstimes.com/singapore/health/pharma-giant-sanofi-breaks-ground-on-638m-vaccine-facility-in-singapore">"Sanofi in $1 bln deal to buy U.S.-based Amunix Pharma"</a>. The Straits Times. Retrieved 30 April 2022.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=The+Straits+Times&rft.atitle=Sanofi+in+%241+bln+deal+to+buy+U.S.-based+Amunix+Pharma&rft.date=2022-04-20&rft.aulast=Teo&rft.aufirst=Joyce&rft_id=https%3A%2F%2Fwww.straitstimes.com%2Fsingapore%2Fhealth%2Fpharma-giant-sanofi-breaks-ground-on-638m-vaccine-facility-in-singapore&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-91"><a href="#cite_ref-91">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBurgerKartit2023" class="citation news cs1">Burger, Ludwig; Kartit, Dina (13 March 2023). <a rel="nofollow" class="external text" href="https://www.reuters.com/markets/deals/frances-sanofi-acquire-us-based-provention-bio-29-bln-2023-03-13/">"Sanofi hones in on type 1 diabetes in $2.9 BLN Provention Bio deal"</a>. Reuters.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reuters&rft.atitle=Sanofi+hones+in+on+type+1+diabetes+in+%242.9+BLN+Provention+Bio+deal&rft.date=2023-03-13&rft.aulast=Burger&rft.aufirst=Ludwig&rft.au=Kartit%2C+Dina&rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Ffrances-sanofi-acquire-us-based-provention-bio-29-bln-2023-03-13%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-92"><a href="#cite_ref-92">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20240221163740/https://www.fiercepharma.com/pharma/sanofis-planned-consumer-health-spinout-picks-interest-top-firms-bloomberg">"Sanofi's planned consumer health spinoff picks up interest from multiple firms: Bloomberg"</a>. Fierce Pharma. Archived from <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/sanofis-planned-consumer-health-spinout-picks-interest-top-firms-bloomberg">the original</a> on 21 February 2024. Retrieved 27 February 2024.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Fierce+Pharma&rft.atitle=Sanofi%27s+planned+consumer+health+spinoff+picks+up+interest+from+multiple+firms%3A+Bloomberg&rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofis-planned-consumer-health-spinout-picks-interest-top-firms-bloomberg&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-93"><a href="#cite_ref-93">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMollaret" class="citation news cs1">Mollaret, Guillaume. <a rel="nofollow" class="external text" href="https://www.lefigaro.fr/secteur/high-tech/aqemia-cette-pepite-de-l-intelligence-artificielle-qui-a-seduit-sanofi-20231205">"Aqemia, cette pépite de l'intelligence artificielle qui a séduit Sanofi"</a>. Le Figaro. Le Figaro. Retrieved 6 December 2023.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aqemia%2C+cette+p%C3%A9pite+de+l%27intelligence+artificielle+qui+a+s%C3%A9duit+Sanofi&rft.aulast=Mollaret&rft.aufirst=Guillaume&rft_id=https%3A%2F%2Fwww.lefigaro.fr%2Fsecteur%2Fhigh-tech%2Faqemia-cette-pepite-de-l-intelligence-artificielle-qui-a-seduit-sanofi-20231205&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-94"><a href="#cite_ref-94">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-buys-inhibrx-for-up-to-2-2b-to-bolster-inflammation-drug-pipeline/">"Sanofi Buys Inhibrx for Up to $2.2B to Bolster Inflammation Drug Pipeline"</a>. BioSpace. 23 January 2024. Retrieved 24 January 2024.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+Buys+Inhibrx+for+Up+to+%242.2B+to+Bolster+Inflammation+Drug+Pipeline&rft.date=2024-01-23&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-buys-inhibrx-for-up-to-2-2b-to-bolster-inflammation-drug-pipeline%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-95"><a href="#cite_ref-95">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://go.zageno.com/blog/sanofi-optimized-lab-supply-procurement-zageno">"How Sanofi Optimized Lab Supply Procurement Using the ZAGENO Marketplace"</a>. ZAGENO. 10 July 2024. Retrieved 17 March 2025.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=ZAGENO&rft.atitle=How+Sanofi+Optimized+Lab+Supply+Procurement+Using+the+ZAGENO+Marketplace&rft.date=2024-07-10&rft_id=https%3A%2F%2Fgo.zageno.com%2Fblog%2Fsanofi-optimized-lab-supply-procurement-zageno&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-96"><a href="#cite_ref-96">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/sanofi-exclusive-negotiations-sell-50-stake-eu16b-consumer-health-unit-opella">"Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella"</a>. Fiercepharma.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Fiercepharma&rft.atitle=Sanofi+in+%27exclusive+negotiations%27+to+sell+50%25+stake+in+%E2%82%AC16B+consumer+health+unit+Opella&rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofi-exclusive-negotiations-sell-50-stake-eu16b-consumer-health-unit-opella&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-97"><a href="#cite_ref-97">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000119312506069546/d20f.htm">"Annual Report 2005 on SEC Filing Form 20-F"</a>. Sanofi. 31 March 2006. Retrieved 22 February 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Annual+Report+2005+on+SEC+Filing+Form+20-F&rft.pub=Sanofi&rft.date=2006-03-31&rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1121404%2F000119312506069546%2Fd20f.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-98"><a href="#cite_ref-98">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000119312511050947/d20f.htm">"Annual Report 2010 on SEC Filing Form 20-F"</a>. Sanofi. 1 March 2011. Retrieved 22 February 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Annual+Report+2010+on+SEC+Filing+Form+20-F&rft.pub=Sanofi&rft.date=2011-03-01&rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1121404%2F000119312511050947%2Fd20f.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-99"><a href="#cite_ref-99">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000119312516493072/d246196d20f.htm">"Annual Report 2015 on SEC Filing Form 20-F"</a>. Sanofi. 4 March 2016. Retrieved 22 February 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Annual+Report+2015+on+SEC+Filing+Form+20-F&rft.pub=Sanofi&rft.date=2016-03-04&rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1121404%2F000119312516493072%2Fd246196d20f.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-100"><a href="#cite_ref-100">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000119312517069257/d245496d20f.htm">"Form 20-F 2016"</a>. <a href="/wiki/EDGAR" class="mw-redirect" title="EDGAR">EDGAR</a>. 8 March 2019. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Form+20-F+2016&rft.pub=EDGAR&rft.date=2019-03-08&rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1121404%2F000119312517069257%2Fd245496d20f.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-101"><a href="#cite_ref-101">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000119312518073307/d466787d20f.htm">"Form 20-F 2017"</a>. <a href="/wiki/EDGAR" class="mw-redirect" title="EDGAR">EDGAR</a>. 2 March 2018. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Form+20-F+2017&rft.pub=EDGAR&rft.date=2018-03-02&rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1121404%2F000119312518073307%2Fd466787d20f.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-Form_20-F_2018-102"><a href="#cite_ref-Form_20-F_2018_102-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/1121404/000119312519068926/d614161d20f.htm">"Form 20-F 2018"</a>. <a href="/wiki/EDGAR" class="mw-redirect" title="EDGAR">EDGAR</a>. 8 March 2019. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Form+20-F+2018&rft.pub=EDGAR&rft.date=2019-03-08&rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F1121404%2F000119312519068926%2Fd614161d20f.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-103"><a href="#cite_ref-103">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1121404/000112140420000006/sanofi20-f2019.htm">"Inline XBRL Viewer"</a>. sec.gov. Retrieved 3 June 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=sec.gov&rft.atitle=Inline+XBRL+Viewer&rft_id=https%3A%2F%2Fwww.sec.gov%2Fix%3Fdoc%3D%2FArchives%2Fedgar%2Fdata%2F1121404%2F000112140420000006%2Fsanofi20-f2019.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-104"><a href="#cite_ref-104">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/sanofi-buys-inhibrx-for-up-to-2-2b-to-bolster-inflammation-drug-pipeline/">"Sanofi Buys Inhibrx for Up to $2.2B to Bolster Inflammation Drug Pipeline"</a>. BioSpace. 23 January 2024. Retrieved 24 January 2024.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BioSpace&rft.atitle=Sanofi+Buys+Inhibrx+for+Up+to+%242.2B+to+Bolster+Inflammation+Drug+Pipeline&rft.date=2024-01-23&rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fsanofi-buys-inhibrx-for-up-to-2-2b-to-bolster-inflammation-drug-pipeline%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-105"><a href="#cite_ref-105">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120913084145/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm319277.htm">"FDA approves new multiple sclerosis treatment Aubagio"</a> (Press release). U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). 12 September 2012. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm319277.htm">the original</a> on 13 September 2012. Retrieved 14 September 2012.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=FDA+approves+new+multiple+sclerosis+treatment+Aubagio&rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&rft.date=2012-09-12&rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm319277.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-106"><a href="#cite_ref-106">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.kaleopharma.com/intelliject-inc-receives-fda-approval-for-auvi-qtm-epinephrine-injection-usp/">"kaléo"</a>. kaléo.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=kal%C3%A9o&rft.atitle=kal%C3%A9o&rft_id=http%3A%2F%2Fwww.kaleopharma.com%2Fintelliject-inc-receives-fda-approval-for-auvi-qtm-epinephrine-injection-usp%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-107"><a href="#cite_ref-107">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFThomas2013" class="citation news cs1">Thomas, Katie (1 February 2013). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2013/02/02/business/auvi-q-challenges-epipen-with-a-new-shape-and-size.html">"Brothers Develop New Device to Halt Allergy Attacks"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Brothers+Develop+New+Device+to+Halt+Allergy+Attacks&rft.date=2013-02-01&rft.aulast=Thomas&rft.aufirst=Katie&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F02%2F02%2Fbusiness%2Fauvi-q-challenges-epipen-with-a-new-shape-and-size.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-108"><a href="#cite_ref-108">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.cbc.ca/news/health/allerject-epinephrine-auto-injectors-recalled-by-drugmaker-sanofi-1.3293765">"All Allerject epinephrine auto-injectors recalled"</a>. Cbc.ca.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Cbc.ca&rft.atitle=All+Allerject+epinephrine+auto-injectors+recalled&rft_id=http%3A%2F%2Fwww.cbc.ca%2Fnews%2Fhealth%2Fallerject-epinephrine-auto-injectors-recalled-by-drugmaker-sanofi-1.3293765&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-109"><a href="#cite_ref-109">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.allerject.ca/Common/docs/en/Sanofi-Canada-Issues-Voluntary-Recall-of-Allerject.pdf">"Sanofi Canada Issues Voluntary Nationwide Recall of Allerject Due to Potential Inaccurate Dosage Delivery"</a> (PDF). Allerject.ca. Retrieved 22 September 2018.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Allerject.ca&rft.atitle=Sanofi+Canada+Issues+Voluntary+Nationwide+Recall+of+Allerject+Due+to+Potential+Inaccurate+Dosage+Delivery&rft_id=http%3A%2F%2Fwww.allerject.ca%2FCommon%2Fdocs%2Fen%2FSanofi-Canada-Issues-Voluntary-Recall-of-Allerject.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-auvi-q.com-110">^ <a href="#cite_ref-auvi-q.com_110-0">a</a> <a href="#cite_ref-auvi-q.com_110-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.auvi-q.com/">"Auvi-Q® (epinephrine injection, USP)"</a>. Auvi-q.com.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Auvi-q.com&rft.atitle=Auvi-Q%C2%AE+%28epinephrine+injection%2C+USP%29&rft_id=https%3A%2F%2Fwww.auvi-q.com%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-fda.gov-111">^ <a href="#cite_ref-fda.gov_111-0">a</a> <a href="#cite_ref-fda.gov_111-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20170203141137/https://www.fda.gov/Safety/Recalls/ucm469980.htm">"UPDATED: Sanofi US Issues Voluntary Nationwide Recall of All Auvi-Q Due to Potential Inaccurate Dosage Delivery"</a>. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). 30 October 2015. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/Safety/Recalls/ucm469980.htm">the original</a> on 3 February 2017. Retrieved 23 May 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=UPDATED%3A+Sanofi+US+Issues+Voluntary+Nationwide+Recall+of+All+Auvi-Q+Due+to+Potential+Inaccurate+Dosage+Delivery&rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&rft.date=2015-10-30&rft_id=https%3A%2F%2Fwww.fda.gov%2FSafety%2FRecalls%2Fucm469980.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-112"><a href="#cite_ref-112">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.newswire.ca/news-releases/sanofi-canada-issues-voluntary-nationwide-recall-of-allerject-due-to-potential-inaccurate-dosage-delivery-538090301.html">"Sanofi Canada Issues Voluntary Nationwide Recall of Allerject® Due to Potential Inaccurate Dosage"</a>. Newswire.ca.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Newswire.ca&rft.atitle=Sanofi+Canada+Issues+Voluntary+Nationwide+Recall+of+Allerject%C2%AE+Due+to+Potential+Inaccurate+Dosage&rft_id=http%3A%2F%2Fwww.newswire.ca%2Fnews-releases%2Fsanofi-canada-issues-voluntary-nationwide-recall-of-allerject-due-to-potential-inaccurate-dosage-delivery-538090301.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-113"><a href="#cite_ref-113">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://cmcpediatrics.com/2015/10/sanofi-us-issues-voluntary-nationwide-recall-of-all-auvi%e2%80%91q-epi-pens/">"Sanofi US Issues Voluntary Nationwide Recall of ALL Auvi‑Q Epi Pens - Children's Medical Center"</a>. 29 October 2015. Retrieved 8 August 2024.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+US+Issues+Voluntary+Nationwide+Recall+of+ALL+Auvi%E2%80%91Q+Epi+Pens+-+Children%27s+Medical+Center&rft.date=2015-10-29&rft_id=https%3A%2F%2Fcmcpediatrics.com%2F2015%2F10%2Fsanofi-us-issues-voluntary-nationwide-recall-of-all-auvi%25e2%2580%2591q-epi-pens%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-114"><a href="#cite_ref-114">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.epipen101.ca/en/welcome">"Welcome to EpiPen® 101"</a>. Epipen101.ca. 19 March 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Epipen101.ca&rft.atitle=Welcome+to+EpiPen%C2%AE+101&rft.date=2015-03-19&rft_id=https%3A%2F%2Fwww.epipen101.ca%2Fen%2Fwelcome&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-115"><a href="#cite_ref-115">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFReprints2015" class="citation news cs1">Reprints, Cynthia Koons CynthiaLKoons Robert Langreth RobertLangreth (23 September 2015). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/articles/2015-09-23/how-marketing-turned-the-epipen-into-a-billion-dollar-business">"How Marketing Turned the EpiPen into a Billion-Dollar Business"</a>. Bloomberg.com.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Bloomberg.com&rft.atitle=How+Marketing+Turned+the+EpiPen+into+a+Billion-Dollar+Business&rft.date=2015-09-23&rft.aulast=Reprints&rft.aufirst=Cynthia+Koons+CynthiaLKoons+Robert+Langreth+RobertLangreth&rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-09-23%2Fhow-marketing-turned-the-epipen-into-a-billion-dollar-business&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-116"><a href="#cite_ref-116">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.fiercepharmamarketing.com/story/sanofis-auvi-q-recall-puts-mylans-rival-epipen-full-control-blockbuster-mar/2015-11-02">"Sanofi's Auvi-Q recall puts Mylan's rival EpiPen in full control of blockbuster market – FiercePharma"</a>. Fiercepharmamarketing.com.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Fiercepharmamarketing.com&rft.atitle=Sanofi%27s+Auvi-Q+recall+puts+Mylan%27s+rival+EpiPen+in+full+control+of+blockbuster+market+%E2%80%93+FiercePharma&rft_id=http%3A%2F%2Fwww.fiercepharmamarketing.com%2Fstory%2Fsanofis-auvi-q-recall-puts-mylans-rival-epipen-full-control-blockbuster-mar%2F2015-11-02&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-117"><a href="#cite_ref-117">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/story/its-open-season-mylans-epipen-sanofi-teva-stumble/2015-11-02">"It's open season for Mylan's EpiPen as Sanofi, Teva stumble – FiercePharma"</a>. Fiercepharma.com. 2 November 2015.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Fiercepharma.com&rft.atitle=It%27s+open+season+for+Mylan%27s+EpiPen+as+Sanofi%2C+Teva+stumble+%E2%80%93+FiercePharma&rft.date=2015-11-02&rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fstory%2Fits-open-season-mylans-epipen-sanofi-teva-stumble%2F2015-11-02&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-118"><a href="#cite_ref-118">^</a> Lisa M. Jarvis for Chemical and Engineering News. 14 January 2008 <a rel="nofollow" class="external text" href="http://cen.acs.org/articles/86/i2/Isis-Genzyme-Heart-Drug-Deal.html">Isis, Genzyme In Heart Drug Deal</a> </li> <li id="cite_note-119"><a href="#cite_ref-119">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2013/01/30/business/fda-approves-genetic-drug-to-treat-rare-disease.html">"F.D.A. Approves Genetic Drug to Treat Rare Disease"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. 29 January 2013. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=F.D.A.+Approves+Genetic+Drug+to+Treat+Rare+Disease&rft.date=2013-01-29&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F01%2F30%2Fbusiness%2Ffda-approves-genetic-drug-to-treat-rare-disease.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-120"><a href="#cite_ref-120">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://en.sanofi-aventis.com/binaries/Sanofi_RA_EN_tcm28-24842.pdf">"Annual Review 2008"</a> (PDF). Sanofi-Aventis. Retrieved 19 April 2009.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Annual+Review+2008&rft.pub=Sanofi-Aventis&rft_id=http%3A%2F%2Fen.sanofi-aventis.com%2Fbinaries%2FSanofi_RA_EN_tcm28-24842.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-121"><a href="#cite_ref-121">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="http://www.prescribingreference.com/news/showNews/which/MozobilApprovedForNonHodgkinsLymphomaAndMultipleMyeloma121801">"Mozobil approved for non-hodgkin's lymphoma and multiple myeloma"</a> (Press release). Monthly Prescribing Reference. 18 December 2008. Retrieved 3 January 2009.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Mozobil+approved+for+non-hodgkin%27s+lymphoma+and+multiple+myeloma&rft.pub=Monthly+Prescribing+Reference&rft.date=2008-12-18&rft_id=http%3A%2F%2Fwww.prescribingreference.com%2Fnews%2FshowNews%2Fwhich%2FMozobilApprovedForNonHodgkinsLymphomaAndMultipleMyeloma121801&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-122"><a href="#cite_ref-122">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="http://www.prescribingreference.com/news/showNews/which/MozobilApprovedForNonHodgkinsLymphomaAndMultipleMyeloma121801">"Mozobil approved for non-Hodgkin's lymphoma and multiple myeloma"</a> (Press release). Monthly Prescribing Reference. 18 December 2008. Retrieved 3 January 2009.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Mozobil+approved+for+non-Hodgkin%27s+lymphoma+and+multiple+myeloma&rft.pub=Monthly+Prescribing+Reference&rft.date=2008-12-18&rft_id=http%3A%2F%2Fwww.prescribingreference.com%2Fnews%2FshowNews%2Fwhich%2FMozobilApprovedForNonHodgkinsLymphomaAndMultipleMyeloma121801&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-123"><a href="#cite_ref-123">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.telfast-arabia.com/">"Recommended Allergy Medicine in the UAE | Telfast"</a>. Recommended Allergy Medicine in the UAE | Telfast.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Recommended+Allergy+Medicine+in+the+UAE+%26%23124%3B+Telfast&rft.atitle=Recommended+Allergy+Medicine+in+the+UAE+%26%23124%3B+Telfast&rft_id=https%3A%2F%2Fwww.telfast-arabia.com%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-124"><a href="#cite_ref-124">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.enterogermina.ae/">"Enterogermina – Probiotic Medicine for Diarrhea in UAE"</a>. Enterogermina Oral Suspension - Medicine For Diarrhea in the UAE.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Enterogermina+Oral+Suspension+-+Medicine+For+Diarrhea+in+the+UAE&rft.atitle=Enterogermina+%E2%80%93+Probiotic+Medicine+for+Diarrhea+in+UAE&rft_id=https%3A%2F%2Fwww.enterogermina.ae%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-125"><a href="#cite_ref-125">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mucosolvan-arabia.com/">"Cough Medicine UAE - Eliminate Excess Mucus & Phlegm | Mucosolvan"</a>. Cough And Cold Medicine To Eliminate Mucus | Mucosolvan®.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Cough+And+Cold+Medicine+To+Eliminate+Mucus+%26%23124%3B+Mucosolvan%C2%AE&rft.atitle=Cough+Medicine+UAE+-+Eliminate+Excess+Mucus+%26+Phlegm+%26%23124%3B+Mucosolvan&rft_id=https%3A%2F%2Fwww.mucosolvan-arabia.com%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-126"><a href="#cite_ref-126">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKolata2013" class="citation news cs1">Kolata, Gina (9 July 2013). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2013/07/10/health/rare-mutation-prompts-race-for-cholesterol-drug.html">"Rare Mutation Ignites Race for Cholesterol Drug"</a>. <a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>. Retrieved 27 November 2019.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Rare+Mutation+Ignites+Race+for+Cholesterol+Drug&rft.date=2013-07-09&rft.aulast=Kolata&rft.aufirst=Gina&rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F07%2F10%2Fhealth%2Frare-mutation-prompts-race-for-cholesterol-drug.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-127"><a href="#cite_ref-127">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120416102019/http://www.regeneron.com/regn727">"Alirocumab on Regeneron's website"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.regeneron.com/regn727">the original</a> on 16 April 2012. Retrieved 11 December 2020.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Alirocumab+on+Regeneron%27s+website&rft_id=http%3A%2F%2Fwww.regeneron.com%2Fregn727&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-128"><a href="#cite_ref-128">^</a> John Carroll for FierceBiotech 7 March 2014 <a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/story/regeneron-sanofi-and-amgen-shares-suffer-fdas-frets-about-pcsk9-drug/2014-03-07">UPDATED: Regeneron, Sanofi and Amgen shares suffer on FDA's frets about PCSK9 class</a> </li> <li id="cite_note-129"><a href="#cite_ref-129">^</a> John Carroll for FierceBiotech 22 November 2013 <a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/story/regeneron-sanofi-hit-trio-goals-first-phiii-test-rheumatoid-arthritis-drug/2013-11-22#ixzz2yojrEVlP">Regeneron, Sanofi hit a trio of goals in first PhIII test of rheumatoid arthritis drug</a> </li> <li id="cite_note-130"><a href="#cite_ref-130">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sanofi.com/about-us/governance/board-of-directors">"board-of-directors"</a>. sanofi.com. Retrieved 23 January 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=sanofi.com&rft.atitle=board-of-directors&rft_id=https%3A%2F%2Fwww.sanofi.com%2Fabout-us%2Fgovernance%2Fboard-of-directors&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-131"><a href="#cite_ref-131">^</a> PharmaLive. 4 September 2019 <a rel="nofollow" class="external text" href="https://www.pharmalive.com/sanofi-picks-ceo-successor/">Sanofi picks CEO successor</a> </li> <li id="cite_note-132"><a href="#cite_ref-132">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sanofi.com/about-us/governance/executive-committee">"Executive Committee Sanofi - Sanofi"</a>. sanofi.com. Retrieved 23 January 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=sanofi.com&rft.atitle=Executive+Committee+Sanofi+-+Sanofi&rft_id=https%3A%2F%2Fwww.sanofi.com%2Fabout-us%2Fgovernance%2Fexecutive-committee&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-133"><a href="#cite_ref-133">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.daf-mag.fr/Thematique/fonction-finance-1242/mouvements-2126/Breves/Fran-ois-Xavier-Roger-devient-directeur-financier-de-Sanofi-400274.htm">"Sanofi recruits François-Xavier Roger"</a>. 2 February 2024.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+recruits+Fran%C3%A7ois-Xavier+Roger&rft.date=2024-02-02&rft_id=https%3A%2F%2Fwww.daf-mag.fr%2FThematique%2Ffonction-finance-1242%2Fmouvements-2126%2FBreves%2FFran-ois-Xavier-Roger-devient-directeur-financier-de-Sanofi-400274.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-AR2013-134"><a href="#cite_ref-AR2013_134-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140326200214/http://en.sanofi.com/Images/35795_20-F_2013.pdf">"Annual Report 2013"</a> (PDF). Sanofi-Aventis. Archived from <a rel="nofollow" class="external text" href="http://en.sanofi.com/Images/35795_20-F_2013.pdf">the original</a> (PDF) on 26 March 2014. Retrieved 13 April 2014.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Annual+Report+2013&rft.pub=Sanofi-Aventis&rft_id=http%3A%2F%2Fen.sanofi.com%2FImages%2F35795_20-F_2013.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-135"><a href="#cite_ref-135">^</a> MarketWatch 29 April 2011 <a rel="nofollow" class="external text" href="http://www.marketwatch.com/story/total-cfo-says-firm-cut-sanofi-stake-to-under-5-2011-04-29">Total CFO says firm cut Sanofi stake to under 5%</a> </li> <li id="cite_note-137"><a href="#cite_ref-137">^</a> "<a rel="nofollow" class="external text" href="http://www.journaldunet.com/economie/reportage/les-sieges-sociaux-des-entreprises-du-cac-40/sanofi-aventis-regroupement-a-paris.shtml">Sanofi-Aventis : regroupement à Paris</a>." Le Journal du Net. Retrieved on 28 September 2010. </li> <li id="cite_note-138"><a href="#cite_ref-138">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKansteiner2022" class="citation web cs1">Kansteiner, Fraiser (28 November 2022). <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/sanofi-moves-swanky-new-paris-hq-built-around-hybrid-work-and-sustainability">"Sanofi moves into swanky new Paris HQ designed around hybrid work and sustainability"</a>. Fierce Pharma. Retrieved 29 November 2022.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Fierce+Pharma&rft.atitle=Sanofi+moves+into+swanky+new+Paris+HQ+designed+around+hybrid+work+and+sustainability&rft.date=2022-11-28&rft.aulast=Kansteiner&rft.aufirst=Fraiser&rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofi-moves-swanky-new-paris-hq-built-around-hybrid-work-and-sustainability&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-139"><a href="#cite_ref-139">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sanofi.com/en/media-room/press-releases/2022/2022-11-28-09-00-00-2562820">"Press Release: Sanofi moves into its new Paris global headquarters - Sanofi"</a>. www.sanofi.com. Retrieved 29 November 2022.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=www.sanofi.com&rft.atitle=Press+Release%3A+Sanofi+moves+into+its+new+Paris+global+headquarters+-+Sanofi&rft_id=https%3A%2F%2Fwww.sanofi.com%2Fen%2Fmedia-room%2Fpress-releases%2F2022%2F2022-11-28-09-00-00-2562820&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-140"><a href="#cite_ref-140">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMattes2008" class="citation book cs1">Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". In Mendrick, Donna L.; Mattes, William B. (eds.). Essential Concepts in Toxicogenomics. <a href="/wiki/Methods_in_Molecular_Biology" title="Methods in Molecular Biology">Methods in Molecular Biology</a>. Vol. 460. pp. 221–238. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-1-60327-048-9_11">10.1007/978-1-60327-048-9_11</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-58829-638-2" title="Special:BookSources/978-1-58829-638-2"><bdi>978-1-58829-638-2</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18449490">18449490</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Public+Consortium+Efforts+in+Toxicogenomics&rft.btitle=Essential+Concepts+in+Toxicogenomics&rft.series=Methods+in+Molecular+Biology&rft.pages=%3Cspan+class%3D%22nowrap%22%3E221-%3C%2Fspan%3E238&rft.date=2008&rft_id=info%3Apmid%2F18449490&rft_id=info%3Adoi%2F10.1007%2F978-1-60327-048-9_11&rft.isbn=978-1-58829-638-2&rft.aulast=Mattes&rft.aufirst=William+B.&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-InnoMed_PredTox_official_project_website-141"><a href="#cite_ref-InnoMed_PredTox_official_project_website_141-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20080926214522/http://www.innomed-predtox.com/consortium/members/">"InnoMed PredTox Member Organizations"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.innomed-predtox.com/consortium/members/">the original</a> on 26 September 2008. Retrieved 25 August 2008.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=InnoMed+PredTox+Member+Organizations&rft_id=http%3A%2F%2Fwww.innomed-predtox.com%2Fconsortium%2Fmembers%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-IMI_Call_Topics_2008-142"><a href="#cite_ref-IMI_Call_Topics_2008_142-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFInnovative_Medicines_Initiative" class="citation web cs1">Innovative Medicines Initiative. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20091015122459/http://imi.europa.eu/docs/calls01_en.zip">"IMI Call Topics 2008"</a>. IMI-GB-018v2-24042008-CallTopics.pdf. European Commission. Archived from <a rel="nofollow" class="external text" href="http://imi.europa.eu/docs/calls01_en.zip">the original</a> on 15 October 2009. Retrieved 25 August 2008.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=IMI-GB-018v2-24042008-CallTopics.pdf&rft.atitle=IMI+Call+Topics+2008&rft.au=Innovative+Medicines+Initiative&rft_id=http%3A%2F%2Fimi.europa.eu%2Fdocs%2Fcalls01_en.zip&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-143"><a href="#cite_ref-143">^</a> <a rel="nofollow" class="external text" href="http://www.infogrok.com/index.php/pharma-companies/sanofi-aventis-charite-sign-research-cooperation-agreement.html">Sanofi-aventis, Charite University Sign Cooperation Agreement</a> News article from InfoGrok. </li> <li id="cite_note-144"><a href="#cite_ref-144">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/aponline/2012/10/25/world/europe/ap-eu-france-earns-sanofi.html">"Sanofi Earns Slump in Q3 as Competition Heats Up"</a>. The New York Times. 25 October 2012.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+York+Times&rft.atitle=Sanofi+Earns+Slump+in+Q3+as+Competition+Heats+Up&rft.date=2012-10-25&rft_id=https%3A%2F%2Fwww.nytimes.com%2Faponline%2F2012%2F10%2F25%2Fworld%2Feurope%2Fap-eu-france-earns-sanofi.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> [<a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot">dead link</a>‍] </li> <li id="cite_note-145"><a href="#cite_ref-145">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20050425220406/http://www.presseportal.de/story.htx?nr=664301&ressort=7">"Sanofi pasteur Awarded $97 Million HHS Contract to Accelerate Cell-Culture Pandemic Influenza Vaccine Development"</a>. 4 January 2005. Archived from <a rel="nofollow" class="external text" href="http://www.presseportal.de/story.htx?nr=664301&ressort=7">the original</a> on 25 April 2005. Retrieved 12 June 2013.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Sanofi+pasteur+Awarded+%2497+Million+HHS+Contract+to+Accelerate+Cell-Culture+Pandemic+Influenza+Vaccine+Development&rft.date=2005-01-04&rft_id=http%3A%2F%2Fwww.presseportal.de%2Fstory.htx%3Fnr%3D664301%26ressort%3D7&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-FDA_2012-146">^ <a href="#cite_ref-FDA_2012_146-0">a</a> <a href="#cite_ref-FDA_2012_146-1">b</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm310376.htm">"April 2012 Inspectional Observations (form 483)"</a>, U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA), Vaccines, Blood & Biologics, 12 April 2012, retrieved 29 January 2016</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&rft.atitle=April+2012+Inspectional+Observations+%28form+483%29&rft.date=2012-04-12&rft_id=https%3A%2F%2Fwww.fda.gov%2FBiologicsBloodVaccines%2FCellularGeneTherapyProducts%2FApprovedProducts%2Fucm310376.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-WHO_2004-147"><a href="#cite_ref-WHO_2004_147-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFFine,_P.E.M2004" class="citation book cs1">Fine, P.E.M (2004). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20121021215237/http://www.who.int/vaccines-documents/DocsPDF99/www9943.pdf">Issues relating to the use of BCG in immunization programmes: A discussion document, WHO/V&B/99.23</a> (PDF). Geneva: <a href="/wiki/World_Health_Organization" title="World Health Organization">WHO</a>. Archived from <a rel="nofollow" class="external text" href="https://www.who.int/vaccines-documents/DocsPDF99/www9943.pdf">the original</a> (PDF) on 21 October 2012.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Issues+relating+to+the+use+of+BCG+in+immunization+programmes%3A+A+discussion+document%2C+WHO%2FV%26B%2F99.23&rft.place=Geneva&rft.pub=WHO&rft.date=2004&rft.au=Fine%2C+P.E.M&rft_id=https%3A%2F%2Fwww.who.int%2Fvaccines-documents%2FDocsPDF99%2Fwww9943.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-Sanofi_2014_BCG_vaccine-148"><a href="#cite_ref-Sanofi_2014_BCG_vaccine_148-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPalmer2014" class="citation cs2">Palmer, Eric (10 September 2014), "Merck again shipping BCG cancer treatment but Sanofi still is not: Shortages of bladder cancer and tuberculosis treatment have persisted for two years", FiercePharma</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=FiercePharma&rft.atitle=Merck+again+shipping+BCG+cancer+treatment+but+Sanofi+still+is+not%3A+Shortages+of+bladder+cancer+and+tuberculosis+treatment+have+persisted+for+two+years&rft.date=2014-09-10&rft.aulast=Palmer&rft.aufirst=Eric&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-FiercePharma_mar_2015-149"><a href="#cite_ref-FiercePharma_mar_2015_149-0">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPalmer2015" class="citation cs2">Palmer, Eric (31 March 2015), <a rel="nofollow" class="external text" href="http://www.fiercepharmamanufacturing.com/story/sanofi-vaccine-plant-canada-again-producing-immucyst-bladder-drug/2015-03-31">"Sanofi Canada vax plant again producing ImmuCyst bladder cancer drug"</a>, FiercePharma, retrieved 29 January 2016</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=FiercePharma&rft.atitle=Sanofi+Canada+vax+plant+again+producing+ImmuCyst+bladder+cancer+drug&rft.date=2015-03-31&rft.aulast=Palmer&rft.aufirst=Eric&rft_id=http%3A%2F%2Fwww.fiercepharmamanufacturing.com%2Fstory%2Fsanofi-vaccine-plant-canada-again-producing-immucyst-bladder-drug%2F2015-03-31&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-150"><a href="#cite_ref-150">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://www.gsk.com/en-gb/media/press-releases/sanofi-and-gsk-selected-for-operation-warp-speed-to-supply-united-states-government-with-100-million-doses-of-covid-19-vaccine/">Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine</a>, 31 July 2020, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Sanofi+and+GSK+selected+for+Operation+Warp+Speed+to+supply+United+States+Government+with+100+million+doses+of+COVID-19+vaccine&rft.date=2020-07-31&rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fsanofi-and-gsk-selected-for-operation-warp-speed-to-supply-united-states-government-with-100-million-doses-of-covid-19-vaccine%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-151"><a href="#cite_ref-151">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://www.statnews.com/2020/07/31/operation-warp-speed-sanofi-gsk-covid19-vaccine/">Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and 100 million doses</a>, 31 July 2020, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Sanofi+and+GSK+land+%242.1+billion+deal+with+U.S.+for+Covid-19+vaccine+development+and+100+million+doses&rft.date=2020-07-31&rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F07%2F31%2Foperation-warp-speed-sanofi-gsk-covid19-vaccine%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-152"><a href="#cite_ref-152">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20210227070318/http://www.pmlive.com/pharma_news/sanofi_accelerates_coronavirus_vaccine_plans_1342841">Sanofi accelerates coronavirus vaccine plans</a>, 24 June 2020, archived from <a rel="nofollow" class="external text" href="http://www.pmlive.com/pharma_news/sanofi_accelerates_coronavirus_vaccine_plans_1342841">the original</a> on 27 February 2021, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Sanofi+accelerates+coronavirus+vaccine+plans&rft.date=2020-06-24&rft_id=http%3A%2F%2Fwww.pmlive.com%2Fpharma_news%2Fsanofi_accelerates_coronavirus_vaccine_plans_1342841&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-153"><a href="#cite_ref-153">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20210613192737/http://ir.novavax.com/news-releases/news-release-details/novavax-announces-positive-phase-1-data-its-covid-19-vaccine">Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate</a>, 4 August 2020, archived from <a rel="nofollow" class="external text" href="https://ir.novavax.com/news-releases/news-release-details/novavax-announces-positive-phase-1-data-its-covid-19-vaccine">the original</a> on 13 June 2021, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Novavax+Announces+Positive+Phase+1+Data+for+its+COVID-19+Vaccine+Candidate&rft.date=2020-08-04&rft_id=https%3A%2F%2Fir.novavax.com%2Fnews-releases%2Fnews-release-details%2Fnovavax-announces-positive-phase-1-data-its-covid-19-vaccine&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-154"><a href="#cite_ref-154">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins">Phase 3 clinical trial of investigational vaccine for COVID-19 begins</a>, 27 July 2020, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Phase+3+clinical+trial+of+investigational+vaccine+for+COVID-19+begins&rft.date=2020-07-27&rft_id=https%3A%2F%2Fwww.nih.gov%2Fnews-events%2Fnews-releases%2Fphase-3-clinical-trial-investigational-vaccine-covid-19-begins&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-155"><a href="#cite_ref-155">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://www.cnbc.com/2020/07/31/us-agrees-to-pay-sanofi-and-gsk-2point1-billion-for-100-million-doses-of-coronavirus-vaccine.html">U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine</a>, 31 July 2020, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=U.S.+agrees+to+pay+Sanofi+and+GSK+%242.1+billion+for+100+million+doses+of+coronavirus+vaccine&rft.date=2020-07-31&rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F07%2F31%2Fus-agrees-to-pay-sanofi-and-gsk-2point1-billion-for-100-million-doses-of-coronavirus-vaccine.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-156"><a href="#cite_ref-156">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://www.statnews.com/2020/06/23/sanofi-a-straggler-in-the-covid-19-vaccine-race-accelerates-its-plans/">Sanofi, a straggler in the Covid-19 vaccine race, accelerates its plans</a>, 23 June 2020, retrieved 7 August 2020</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Sanofi%2C+a+straggler+in+the+Covid-19+vaccine+race%2C+accelerates+its+plans&rft.date=2020-06-23&rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F06%2F23%2Fsanofi-a-straggler-in-the-covid-19-vaccine-race-accelerates-its-plans%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-157"><a href="#cite_ref-157">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.france24.com/en/france/20210928-france-s-sanofi-halts-work-on-mrna-covid-vaccine-amid-rivals-success">"France's Sanofi halts work on mRNA Covid vaccine amid success of Pfizer, Moderna"</a>. France 24. 28 September 2021. Retrieved 29 September 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=France+24&rft.atitle=France%27s+Sanofi+halts+work+on+mRNA+Covid+vaccine+amid+success+of+Pfizer%2C+Moderna&rft.date=2021-09-28&rft_id=https%3A%2F%2Fwww.france24.com%2Fen%2Ffrance%2F20210928-france-s-sanofi-halts-work-on-mrna-covid-vaccine-amid-rivals-success&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-158"><a href="#cite_ref-158">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.euronews.com/2021/09/28/covid-vaccine-french-drugmaker-sanofi-halts-development-of-its-mrna-jab">"French drugmaker Sanofi halts development of its mRNA COVID vaccine"</a>. euronews. 28 September 2021. Retrieved 29 September 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=euronews&rft.atitle=French+drugmaker+Sanofi+halts+development+of+its+mRNA+COVID+vaccine&rft.date=2021-09-28&rft_id=https%3A%2F%2Fwww.euronews.com%2F2021%2F09%2F28%2Fcovid-vaccine-french-drugmaker-sanofi-halts-development-of-its-mrna-jab&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-159"><a href="#cite_ref-159">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://archive.today/20080916100937/http://www.efpia.eu/content/default.asp?PageID=559&DocID=4883">"The Pharmaceutical Industry in Figures – 2008 Edition"</a>. European Federation of Pharmaceutical Industries and Associations (EFPIA). p. 49. Archived from <a rel="nofollow" class="external text" href="http://www.efpia.eu/content/default.asp?PageID=559&DocID=4883">the original</a> on 16 September 2008. Retrieved 25 August 2008.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Pharmaceutical+Industry+in+Figures+%E2%80%93+2008+Edition&rft.pages=49&rft_id=http%3A%2F%2Fwww.efpia.eu%2Fcontent%2Fdefault.asp%3FPageID%3D559%26DocID%3D4883&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-160"><a href="#cite_ref-160">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.bio.org/articles/bio-members-web-site-links">"BIO Member Directory – BIO"</a>. BIO. Retrieved 22 September 2018.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=BIO&rft.atitle=BIO+Member+Directory+%E2%80%93+BIO&rft_id=http%3A%2F%2Fwww.bio.org%2Farticles%2Fbio-members-web-site-links&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-161"><a href="#cite_ref-161">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.phrma.org/about/member-companies">"Members – PhRMA"</a>. Phrma.org. Retrieved 22 September 2018.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Phrma.org&rft.atitle=Members+%E2%80%93+PhRMA&rft_id=http%3A%2F%2Fwww.phrma.org%2Fabout%2Fmember-companies&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-162"><a href="#cite_ref-162">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140427151456/http://www.europabio.org/members">"Members | Europabio"</a>. Archived from <a rel="nofollow" class="external text" href="https://www.europabio.org/members">the original</a> on 27 April 2014. Retrieved 19 April 2014.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Members+%26%23124%3B+Europabio&rft_id=http%3A%2F%2Fwww.europabio.org%2Fmembers&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-163"><a href="#cite_ref-163">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTazrout2021" class="citation web cs1 cs1-prop-foreign-lang-source">Tazrout, Zacharie (11 June 2021). <a rel="nofollow" class="external text" href="https://www.actuia.com/english/orange-generali-sanofi-and-capgemini-launch-future4care-a-start-up-accelerator/">"Orange, Generali, Sanofi and Capgemini launch Future4care, a start-up accelerator"</a>. Actu IA (in French). Retrieved 7 July 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Actu+IA&rft.atitle=Orange%2C+Generali%2C+Sanofi+and+Capgemini+launch+Future4care%2C+a+start-up+accelerator&rft.date=2021-06-11&rft.aulast=Tazrout&rft.aufirst=Zacharie&rft_id=https%3A%2F%2Fwww.actuia.com%2Fenglish%2Forange-generali-sanofi-and-capgemini-launch-future4care-a-start-up-accelerator%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-164"><a href="#cite_ref-164">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSchenker2021" class="citation web cs1">Schenker, Jennifer L. (11 June 2021). <a rel="nofollow" class="external text" href="https://theinnovator.news/future4care-four-corporates-team-to-make-europe-a-global-leader-in-e-health/">"Future4Care: Four Corporates Team To Make Europe A Global Leader in E-Health"</a>. The Innovator. Retrieved 7 July 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=The+Innovator&rft.atitle=Future4Care%3A+Four+Corporates+Team+To+Make+Europe+A+Global+Leader+in+E-Health&rft.date=2021-06-11&rft.aulast=Schenker&rft.aufirst=Jennifer+L.&rft_id=https%3A%2F%2Ftheinnovator.news%2Ffuture4care-four-corporates-team-to-make-europe-a-global-leader-in-e-health%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> <li id="cite_note-165"><a href="#cite_ref-165">^</a> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1 cs1-prop-foreign-lang-source"><a rel="nofollow" class="external text" href="https://www.aventis-foundation.org/englisch/">"Englisch | Aventis Foundation"</a> (in German). Retrieved 14 September 2021.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Englisch+%7C+Aventis+Foundation&rft_id=https%3A%2F%2Fwww.aventis-foundation.org%2Fenglisch%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASanofi" class="Z3988"> </li> </ol></div></div> <div class="mw-heading mw-heading2"><h2 id="External_links">External links</h2>[<a href="/w/index.php?title=Sanofi&action=edit&section=23" title="Edit section: External links">edit</a>]</div> <style data-mw-deduplicate="TemplateStyles:r1235681985">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:var(--background-color-interactive-subtle,#f8f9fa);display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1;min-width:0}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><style data-mw-deduplicate="TemplateStyles:r1237033735">@media print{body.ns-0 .mw-parser-output .sistersitebox{display:none!important}}@media screen{html.skin-theme-clientpref-night .mw-parser-output .sistersitebox img[src*="Wiktionary-logo-en-v2.svg"]{background-color:white}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .sistersitebox img[src*="Wiktionary-logo-en-v2.svg"]{background-color:white}}</style><div class="side-box side-box-right plainlinks sistersitebox"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" /> <div class="side-box-flex"> <div class="side-box-image"><a href="/wiki/File:Commons-logo.svg" class="mw-file-description"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png" decoding="async" width="30" height="40" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/60px-Commons-logo.svg.png 1.5x" data-file-width="1024" data-file-height="1376" /></a></div> <div class="side-box-text plainlist">Wikimedia Commons has media related to <a href="https://commons.wikimedia.org/wiki/Category:Sanofi" class="extiw" title="commons:Category:Sanofi">Sanofi</a>.</div></div> </div> <ul><li><a rel="nofollow" class="external text" href="https://www.sanofi.com/">Official website</a></li> <li><a rel="nofollow" class="external text" href="https://www.opensecrets.org/orgs/summary?id=D000000215">Sanofi</a> on <a href="/wiki/OpenSecrets" title="OpenSecrets">OpenSecrets</a>, a website that tracks and publishes data on campaign finance and lobbying <a href="https://www.wikidata.org/wiki/Q158205#P4691" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></li></ul> <div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style></div><div role="navigation" class="navbox" aria-labelledby="Sanofi51" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Sanofi" title="Template:Sanofi"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Sanofi" title="Template talk:Sanofi"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Sanofi" title="Special:EditPage/Template:Sanofi"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Sanofi51" style="font-size:114%;margin:0 4em"><a class="mw-selflink selflink">Sanofi</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Predecessors</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Sanofi-Synth%C3%A9labo" class="mw-redirect" title="Sanofi-Synthélabo">Sanofi-Synthélabo</a></li> <li><a href="/wiki/Aventis" class="mw-redirect" title="Aventis">Aventis</a></li> <li><a href="/wiki/Hoechst_AG" title="Hoechst AG">Hoechst</a></li> <li><a href="/wiki/Rh%C3%B4ne-Poulenc" title="Rhône-Poulenc">Rhône-Poulenc</a></li> <li><a href="/wiki/Cassella" title="Cassella">Cassella</a></li> <li><a href="/wiki/Roussel_Uclaf" title="Roussel Uclaf">Roussel Uclaf</a></li> <li><a href="/wiki/Marion_Merrell_Dow" title="Marion Merrell Dow">Marion Merrell Dow</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CEOs</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Chris_Viehbacher" title="Chris Viehbacher">Chris Viehbacher</a></li> <li><a href="/wiki/Olivier_Brandicourt" title="Olivier Brandicourt">Olivier Brandicourt</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Main products</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Cardiovascular</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Aprovel" class="mw-redirect" title="Aprovel">Aprovel</a></li> <li><a href="/wiki/CoAprovel" class="mw-redirect" title="CoAprovel">CoAprovel</a></li> <li><a href="/wiki/Tritace" class="mw-redirect" title="Tritace">Tritace</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Thrombosis</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Plavix" class="mw-redirect" title="Plavix">Plavix</a></li> <li><a href="/wiki/Clexane" class="mw-redirect" title="Clexane">Clexane</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oncology</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Taxotere" class="mw-redirect" title="Taxotere">Taxotere</a></li> <li><a href="/wiki/Eloxatin" class="mw-redirect" title="Eloxatin">Eloxatin</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Diabetes</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Amaryl" class="mw-redirect" title="Amaryl">Amaryl</a></li> <li><a href="/wiki/Apidra" class="mw-redirect" title="Apidra">Apidra</a></li> <li><a href="/wiki/Lantus" class="mw-redirect" title="Lantus">Lantus</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Central nervous system</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/w/index.php?title=Depakine_Chrono&action=edit&redlink=1" class="new" title="Depakine Chrono (page does not exist)">Depakine Chrono</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Internal medicine</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Actonel" class="mw-redirect" title="Actonel">Actonel</a></li> <li><a href="/wiki/Arava_(drug)" class="mw-redirect" title="Arava (drug)">Arava</a></li> <li><a href="/wiki/Avil" title="Avil">Avil</a></li> <li><a href="/w/index.php?title=Avipect&action=edit&redlink=1" class="new" title="Avipect (page does not exist)">Avipect</a></li> <li><a href="/w/index.php?title=Bi-Profenid&action=edit&redlink=1" class="new" title="Bi-Profenid (page does not exist)">Bi-Profenid</a></li> <li><a href="/w/index.php?title=Bronchicum&action=edit&redlink=1" class="new" title="Bronchicum (page does not exist)">Bronchicum</a></li> <li><a href="/wiki/Claforan" class="mw-redirect" title="Claforan">Claforan</a></li> <li><a href="/wiki/Daonil" class="mw-redirect" title="Daonil">Daonil</a></li> <li><a href="/wiki/Flagyl" class="mw-redirect" title="Flagyl">Flagyl</a></li> <li><a href="/w/index.php?title=Hemoclar&action=edit&redlink=1" class="new" title="Hemoclar (page does not exist)">Hemoclar</a></li> <li><a href="/wiki/Lanzor" class="mw-redirect" title="Lanzor">Lanzor</a></li> <li><a href="/wiki/Lasix" class="mw-redirect" title="Lasix">Lasix</a></li> <li><a href="/wiki/Maalox" title="Maalox">Maalox</a></li> <li><a href="/w/index.php?title=Maalox_Plus&action=edit&redlink=1" class="new" title="Maalox Plus (page does not exist)">Maalox Plus</a></li> <li><a href="/wiki/Proctosedyl" title="Proctosedyl">Proctosedyl</a></li> <li><a href="/wiki/Targocid" class="mw-redirect" title="Targocid">Targocid</a></li> <li><a href="/wiki/Tavanic" class="mw-redirect" title="Tavanic">Tavanic</a></li> <li><a href="/wiki/Telfast" class="mw-redirect" title="Telfast">Telfast</a></li> <li><a href="/wiki/Trental" class="mw-redirect" title="Trental">Trental</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Subsidiaries</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Chattem" title="Chattem">Chattem Inc.</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks hlist navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Brands6" scope="row" class="navbox-group" style="width:1%">Brands</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Fexofenadine" title="Fexofenadine">Allegra</a></li> <li><a href="/wiki/Fexofenadine/pseudoephedrine" title="Fexofenadine/pseudoephedrine">Allegra-D</a></li> <li><a href="/wiki/Gold_Bond" title="Gold Bond">Gold Bond</a></li> <li>ACT Mouthwash</li> <li>Balmex Diaper Rash Ointment</li> <li><a href="/wiki/Rolaids" title="Rolaids">Rolaids</a></li> <li>Cortizone-10</li> <li>Flexall</li> <li><a href="/wiki/IcyHot" class="mw-redirect" title="IcyHot">IcyHot</a></li> <li>Sun-In</li> <li>Ultra Swim</li> <li>Pamprin</li> <li>Premsyn</li> <li><a href="/wiki/Kaopectate" title="Kaopectate">Kaopectate</a></li> <li><a href="/wiki/Dexatrim" title="Dexatrim">Dexatrim</a></li> <li><a href="/wiki/Aspercreme" class="mw-redirect" title="Aspercreme">Aspercreme</a></li> <li><a href="/wiki/Selsun_Blue" title="Selsun Blue">Selsun Blue</a></li> <li><a href="/wiki/Nasacort" class="mw-redirect" title="Nasacort">Nasacort</a></li> <li><a href="/wiki/Unisom" class="mw-redirect" title="Unisom">Unisom</a></li> <li><a href="/wiki/Capzasin" class="mw-redirect" title="Capzasin">Capzasin</a></li> <li>Benzodent</li> <li>Herpecin-L</li> <li>Garlique</li> <li>New Phase</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Ablynx" title="Ablynx">Ablynx</a></li> <li><a href="/wiki/Bioverativ" title="Bioverativ">Bioverativ</a></li> <li><a href="/wiki/Genzyme" title="Genzyme">Genzyme</a></li> <li><a href="/wiki/Kadmon_Corporation" title="Kadmon Corporation">Kadmon Corporation</a></li> <li><a href="/wiki/Sanofi_Pasteur" title="Sanofi Pasteur">Sanofi Pasteur</a></li> <li><a href="/wiki/Shantha_Biotechnics" title="Shantha Biotechnics">Shantha Biotechnics</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /></div><div role="navigation" class="navbox" aria-labelledby="23x15px&#124;border_&#124;alt=European_Union&#124;link=European_Union_EURO_STOXX_50_companies_of_the_Euro_Area201" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231" /><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Euro_Stoxx_50_Companies" title="Template:Euro Stoxx 50 Companies"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Euro_Stoxx_50_Companies" title="Template talk:Euro Stoxx 50 Companies"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Euro_Stoxx_50_Companies" title="Special:EditPage/Template:Euro Stoxx 50 Companies"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="23x15px&#124;border_&#124;alt=European_Union&#124;link=European_Union_EURO_STOXX_50_companies_of_the_Euro_Area201" style="font-size:114%;margin:0 4em"><a href="/wiki/European_Union" title="European Union"><img alt="European Union" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Flag_of_Europe.svg/23px-Flag_of_Europe.svg.png" decoding="async" width="23" height="15" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Flag_of_Europe.svg/35px-Flag_of_Europe.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Flag_of_Europe.svg/45px-Flag_of_Europe.svg.png 2x" data-file-width="810" data-file-height="540" /></a> <a href="/wiki/EURO_STOXX_50" title="EURO STOXX 50">EURO STOXX 50</a> companies of the <a href="/wiki/Eurozone" title="Eurozone">Euro Area</a></div></th></tr><tr><td class="navbox-abovebelow" colspan="2"><div>Last updated: 18 September 2023</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Adidas" title="Adidas">Adidas</a></li> <li><a href="/wiki/Adyen" title="Adyen">Adyen</a></li> <li><a href="/wiki/Ahold_Delhaize" title="Ahold Delhaize">Ahold Delhaize</a></li> <li><a href="/wiki/Air_Liquide" title="Air Liquide">Air Liquide</a></li> <li><a href="/wiki/Airbus" title="Airbus">Airbus</a></li> <li><a href="/wiki/Allianz" title="Allianz">Allianz</a></li> <li><a href="/wiki/AB_InBev" title="AB InBev">Anheuser-Busch InBev</a></li> <li><a href="/wiki/ASML_Holding" title="ASML Holding">ASML</a></li> <li><a href="/wiki/Axa" title="Axa">Axa</a></li> <li><a href="/wiki/Banco_Bilbao_Vizcaya_Argentaria" title="Banco Bilbao Vizcaya Argentaria">BBVA</a></li> <li><a href="/wiki/BASF" title="BASF">BASF</a></li> <li><a href="/wiki/Bayer" title="Bayer">Bayer</a></li> <li><a href="/wiki/BMW" title="BMW">BMW</a></li> <li><a href="/wiki/BNP_Paribas" title="BNP Paribas">BNP Paribas</a></li> <li><a href="/wiki/Danone" title="Danone">Danone</a></li> <li><a href="/wiki/Deutsche_B%C3%B6rse" title="Deutsche Börse">Deutsche Börse</a></li> <li><a href="/wiki/Deutsche_Telekom" title="Deutsche Telekom">Deutsche Telekom</a></li> <li><a href="/wiki/DHL_Group" title="DHL Group">DHL Group</a></li> <li><a href="/wiki/Enel" title="Enel">Enel</a></li> <li><a href="/wiki/Eni" title="Eni">Eni</a></li> <li><a href="/wiki/EssilorLuxottica" title="EssilorLuxottica">EssilorLuxottica</a></li> <li><a href="/wiki/Ferrari" title="Ferrari">Ferrari</a></li> <li><a href="/wiki/Flutter_Entertainment" title="Flutter Entertainment">Flutter Entertainment</a></li> <li><a href="/wiki/Herm%C3%A8s" title="Hermès">Hermès</a></li> <li><a href="/wiki/Iberdrola" title="Iberdrola">Iberdrola</a></li> <li><a href="/wiki/Inditex" title="Inditex">Inditex</a></li> <li><a href="/wiki/Infineon_Technologies" title="Infineon Technologies">Infineon Technologies</a></li> <li><a href="/wiki/ING_Group" title="ING Group">ING Group</a></li> <li><a href="/wiki/Intesa_Sanpaolo" title="Intesa Sanpaolo">Intesa Sanpaolo</a></li> <li><a href="/wiki/Kering" title="Kering">Kering</a></li> <li><a href="/wiki/L%27Or%C3%A9al" title="L'Oréal">L'Oréal</a></li> <li><a href="/wiki/LVMH" title="LVMH">LVMH</a></li> <li><a href="/wiki/Mercedes-Benz_Group" title="Mercedes-Benz Group">Mercedes-Benz</a></li> <li><a href="/wiki/Munich_Re" title="Munich Re">Munich Re</a></li> <li><a href="/wiki/Nokia" title="Nokia">Nokia</a></li> <li><a href="/wiki/Nordea" title="Nordea">Nordea</a></li> <li><a href="/wiki/Pernod_Ricard" title="Pernod Ricard">Pernod Ricard</a></li> <li><a href="/wiki/Prosus" title="Prosus">Prosus</a></li> <li><a href="/wiki/Safran" title="Safran">Safran</a></li> <li><a href="/wiki/Saint-Gobain" title="Saint-Gobain">Saint-Gobain</a></li> <li><a class="mw-selflink selflink">Sanofi</a></li> <li><a href="/wiki/Banco_Santander" title="Banco Santander">Santander</a></li> <li><a href="/wiki/SAP" title="SAP">SAP</a></li> <li><a href="/wiki/Schneider_Electric" title="Schneider Electric">Schneider Electric</a></li> <li><a href="/wiki/Siemens" title="Siemens">Siemens</a></li> <li><a href="/wiki/Stellantis" title="Stellantis">Stellantis</a></li> <li><a href="/wiki/TotalEnergies" title="TotalEnergies">TotalEnergies</a></li> <li><a href="/wiki/Vinci_SA" title="Vinci SA">Vinci</a></li> <li><a href="/wiki/UniCredit" title="UniCredit">UniCredit</a></li> <li><a href="/wiki/Volkswagen_Group" title="Volkswagen Group">Volkswagen</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /></div><div role="navigation" class="navbox" aria-labelledby="23x15px&#124;border_&#124;alt=France&#124;link=France_CAC_40_companies_of_France158" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231" /><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:CAC_40_companies" title="Template:CAC 40 companies"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:CAC_40_companies" title="Template talk:CAC 40 companies"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:CAC_40_companies" title="Special:EditPage/Template:CAC 40 companies"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="23x15px&#124;border_&#124;alt=France&#124;link=France_CAC_40_companies_of_France158" style="font-size:114%;margin:0 4em"><a href="/wiki/France" title="France"><img alt="France" src="//upload.wikimedia.org/wikipedia/en/thumb/c/c3/Flag_of_France.svg/40px-Flag_of_France.svg.png" decoding="async" width="23" height="15" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/c/c3/Flag_of_France.svg/60px-Flag_of_France.svg.png 2x" data-file-width="900" data-file-height="600" /></a> <a href="/wiki/CAC_40" title="CAC 40">CAC 40</a> companies of France</div></th></tr><tr><td class="navbox-abovebelow" colspan="2"><div>Last updated: 30 September 2023</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Air_Liquide" title="Air Liquide">Air Liquide</a></li> <li><a href="/wiki/Airbus" title="Airbus">Airbus</a></li> <li><a href="/wiki/Alstom" title="Alstom">Alstom</a></li> <li><a href="/wiki/ArcelorMittal" title="ArcelorMittal">ArcelorMittal</a></li> <li><a href="/wiki/Axa" title="Axa">Axa</a></li> <li><a href="/wiki/BNP_Paribas" title="BNP Paribas">BNP Paribas</a></li> <li><a href="/wiki/Bouygues" title="Bouygues">Bouygues</a></li> <li><a href="/wiki/Capgemini" title="Capgemini">Capgemini</a></li> <li><a href="/wiki/Carrefour" title="Carrefour">Carrefour</a></li> <li><a href="/wiki/Cr%C3%A9dit_Agricole" title="Crédit Agricole">Crédit Agricole</a></li> <li><a href="/wiki/Danone" title="Danone">Danone</a></li> <li><a href="/wiki/Dassault_Syst%C3%A8mes" title="Dassault Systèmes">Dassault Systèmes</a></li> <li><a href="/wiki/Edenred" title="Edenred">Edenred</a></li> <li><a href="/wiki/Engie" title="Engie">Engie</a></li> <li><a href="/wiki/EssilorLuxottica" title="EssilorLuxottica">EssilorLuxottica</a></li> <li><a href="/wiki/Eurofins_Scientific" title="Eurofins Scientific">Eurofins Scientific</a></li> <li><a href="/wiki/Herm%C3%A8s" title="Hermès">Hermès</a></li> <li><a href="/wiki/Kering" title="Kering">Kering</a></li> <li><a href="/wiki/L%27Or%C3%A9al" title="L'Oréal">L'Oréal</a></li> <li><a href="/wiki/Legrand_(company)" title="Legrand (company)">Legrand</a></li> <li><a href="/wiki/LVMH" title="LVMH">LVMH</a></li> <li><a href="/wiki/Michelin" title="Michelin">Michelin</a></li> <li><a href="/wiki/Orange_S.A." class="mw-redirect" title="Orange S.A.">Orange</a></li> <li><a href="/wiki/Pernod_Ricard" title="Pernod Ricard">Pernod Ricard</a></li> <li><a href="/wiki/Publicis" title="Publicis">Publicis</a></li> <li><a href="/wiki/Renault" title="Renault">Renault</a></li> <li><a href="/wiki/Safran" title="Safran">Safran</a></li> <li><a href="/wiki/Saint-Gobain" title="Saint-Gobain">Saint-Gobain</a></li> <li><a class="mw-selflink selflink">Sanofi</a></li> <li><a href="/wiki/Schneider_Electric" title="Schneider Electric">Schneider Electric</a></li> <li><a href="/wiki/Soci%C3%A9t%C3%A9_G%C3%A9n%C3%A9rale" title="Société Générale">Société Générale</a></li> <li><a href="/wiki/Stellantis" title="Stellantis">Stellantis</a></li> <li><a href="/wiki/STMicroelectronics" title="STMicroelectronics">STMicroelectronics</a></li> <li><a href="/wiki/Teleperformance" title="Teleperformance">Teleperformance</a></li> <li><a href="/wiki/Thales_Group" title="Thales Group">Thales</a></li> <li><a href="/wiki/TotalEnergies" title="TotalEnergies">TotalEnergies</a></li> <li><a href="/wiki/Unibail-Rodamco-Westfield" title="Unibail-Rodamco-Westfield">Unibail-Rodamco-Westfield</a></li> <li><a href="/wiki/Veolia" title="Veolia">Veolia</a></li> <li><a href="/wiki/Vinci_SA" title="Vinci SA">Vinci</a></li> <li><a href="/wiki/Worldline_(company)" class="mw-redirect" title="Worldline (company)">Worldline</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /></div><div role="navigation" class="navbox authority-control" aria-labelledby="Authority_control_databases_frameless&#124;text-top&#124;10px&#124;alt=Edit_this_at_Wikidata&#124;link=https&#58;//www.wikidata.org/wiki/Q158205#identifiers&#124;class=noprint&#124;Edit_this_at_Wikidata822" style="padding:3px"><table class="nowraplinks hlist mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Authority_control_databases_frameless&#124;text-top&#124;10px&#124;alt=Edit_this_at_Wikidata&#124;link=https&#58;//www.wikidata.org/wiki/Q158205#identifiers&#124;class=noprint&#124;Edit_this_at_Wikidata822" style="font-size:114%;margin:0 4em"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control databases</a> <a href="https://www.wikidata.org/wiki/Q158205#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">International</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><a rel="nofollow" class="external text" href="https://viaf.org/viaf/264497535">VIAF</a></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">National</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><a rel="nofollow" class="external text" href="https://d-nb.info/gnd/5151108-3">Germany</a></li><li><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb11883894f">France</a></li><li><a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb11883894f">BnF data</a></li><li><a rel="nofollow" class="external text" href="https://datos.bne.es/resource/XX5425271">Spain</a></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><a rel="nofollow" class="external text" href="https://www.idref.fr/027563022">IdRef</a></li></ul></div></td></tr></tbody></table></div>    </div><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?useformat=desktop&type=1x1&usesul3=0" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Sanofi&oldid=1281041578">https://en.wikipedia.org/w/index.php?title=Sanofi&oldid=1281041578</a>"</div></div> <div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:CAC_40" title="Category:CAC 40">CAC 40</a></li><li><a href="/wiki/Category:Sanofi" title="Category:Sanofi">Sanofi</a></li><li><a href="/wiki/Category:Biotechnology_companies_of_France" title="Category:Biotechnology companies of France">Biotechnology companies of France</a></li><li><a href="/wiki/Category:Companies_in_the_Euro_Stoxx_50" title="Category:Companies in the Euro Stoxx 50">Companies in the Euro Stoxx 50</a></li><li><a href="/wiki/Category:Companies_in_the_Dow_Jones_Global_Titans_50" title="Category:Companies in the Dow Jones Global Titans 50">Companies in the Dow Jones Global Titans 50</a></li><li><a href="/wiki/Category:Companies_listed_on_Euronext_Paris" title="Category:Companies listed on Euronext Paris">Companies listed on Euronext Paris</a></li><li><a href="/wiki/Category:French_brands" title="Category:French brands">French brands</a></li><li><a href="/wiki/Category:French_companies_established_in_1973" title="Category:French companies established in 1973">French companies established in 1973</a></li><li><a href="/wiki/Category:Healthcare_companies_of_France" title="Category:Healthcare companies of France">Healthcare companies of France</a></li><li><a href="/wiki/Category:Health_care_companies_established_in_1973" title="Category:Health care companies established in 1973">Health care companies established in 1973</a></li><li><a href="/wiki/Category:Multinational_companies_headquartered_in_France" title="Category:Multinational companies headquartered in France">Multinational companies headquartered in France</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_established_in_1973" title="Category:Pharmaceutical companies established in 1973">Pharmaceutical companies established in 1973</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_of_France" title="Category:Pharmaceutical companies of France">Pharmaceutical companies of France</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_January_2022" title="Category:Articles with dead external links from January 2022">Articles with dead external links from January 2022</a></li><li><a href="/wiki/Category:Webarchive_template_wayback_links" title="Category:Webarchive template wayback links">Webarchive template wayback links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_November_2019" title="Category:Articles with dead external links from November 2019">Articles with dead external links from November 2019</a></li><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_April_2022" title="Category:Use dmy dates from April 2022">Use dmy dates from April 2022</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2009" title="Category:Articles containing potentially dated statements from 2009">Articles containing potentially dated statements from 2009</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2013" title="Category:Articles containing potentially dated statements from 2013">Articles containing potentially dated statements from 2013</a></li><li><a href="/wiki/Category:Commons_category_link_is_on_Wikidata" title="Category:Commons category link is on Wikidata">Commons category link is on Wikidata</a></li></ul></div></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> <li id="footer-info-lastmod"> This page was last edited on 17 March 2025, at 23:08 (UTC).</li> <li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>; additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Sanofi&mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://www.wikimedia.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><picture><source media="(min-width: 500px)" srcset="/static/images/footer/wikimedia-button.svg" width="84" height="29"><img src="/static/images/footer/wikimedia.svg" width="25" height="25" alt="Wikimedia Foundation" lang="en" loading="lazy"></picture></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><picture><source media="(min-width: 500px)" srcset="/w/resources/assets/poweredby_mediawiki.svg" width="88" height="31"><img src="/w/resources/assets/mediawiki_compact.svg" alt="Powered by MediaWiki" lang="en" width="25" height="25" loading="lazy"></picture></a></li> </ul> </footer> </div> </div> </div> <div class="vector-header-container vector-sticky-header-container"> <div id="vector-sticky-header" class="vector-sticky-header"> <div class="vector-sticky-header-start"> <div class="vector-sticky-header-icon-start vector-button-flush-left vector-button-flush-right" aria-hidden="true"> <button class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-sticky-header-search-toggle" tabindex="-1" data-event-name="ui.vector-sticky-search-form.icon"> Search </button> </div> <div role="search" class="vector-search-box-vue vector-search-box-show-thumbnail vector-search-box"> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail"> <form action="/w/index.php" id="vector-sticky-search-form" class="cdx-search-input cdx-search-input--has-end-button"> <div class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia"> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <div class="vector-sticky-header-context-bar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-sticky-header-toc" class="vector-dropdown mw-portlet mw-portlet-sticky-header-toc vector-sticky-header-toc vector-button-flush-left" > <input type="checkbox" id="vector-sticky-header-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-sticky-header-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-sticky-header-toc-label" for="vector-sticky-header-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" > Toggle the table of contents </label> <div class="vector-dropdown-content"> <div id="vector-sticky-header-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div class="vector-sticky-header-context-bar-primary" aria-hidden="true" >Sanofi</div> </div> </div> <div class="vector-sticky-header-end" aria-hidden="true"> <div class="vector-sticky-header-icons"> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-talk-sticky-header" tabindex="-1" data-event-name="talk-sticky-header"> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-subject-sticky-header" tabindex="-1" data-event-name="subject-sticky-header"> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-history-sticky-header" tabindex="-1" data-event-name="history-sticky-header"> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only mw-watchlink" id="ca-watchstar-sticky-header" tabindex="-1" data-event-name="watch-sticky-header"> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-edit-sticky-header" tabindex="-1" data-event-name="wikitext-edit-sticky-header"> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-ve-edit-sticky-header" tabindex="-1" data-event-name="ve-edit-sticky-header"> </a> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-viewsource-sticky-header" tabindex="-1" data-event-name="ve-edit-protected-sticky-header"> </a> </div> <div class="vector-sticky-header-buttons"> <button class="cdx-button cdx-button--weight-quiet mw-interlanguage-selector" id="p-lang-btn-sticky-header" tabindex="-1" data-event-name="ui.dropdown-p-lang-btn-sticky-header"> 50 languages </button> <a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive" id="ca-addsection-sticky-header" tabindex="-1" data-event-name="addsection-sticky-header"> Add topic </a> </div> <div class="vector-sticky-header-icon-end"> <div class="vector-user-links"> </div> </div> </div> </div> </div> <div class="mw-portlet mw-portlet-dock-bottom emptyPortlet" id="p-dock-bottom"> <ul> </ul> </div> <script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-585dc88b6-4jrz7","wgBackendResponseTime":212,"wgPageParseReport":{"limitreport":{"cputime":"1.476","walltime":"1.722","ppvisitednodes":{"value":12750,"limit":1000000},"postexpandincludesize":{"value":300823,"limit":2097152},"templateargumentsize":{"value":9064,"limit":2097152},"expansiondepth":{"value":20,"limit":100},"expensivefunctioncount":{"value":11,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":518078,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 1451.951 1 -total"," 50.39% 731.633 2 Template:Reflist"," 23.85% 346.344 73 Template:Cite_web"," 11.38% 165.229 1 Template:Infobox_company"," 10.76% 156.237 1 Template:Infobox"," 10.03% 145.572 38 Template:Cite_news"," 7.42% 107.704 6 Template:Navbox"," 5.55% 80.559 1 Template:Sanofi"," 5.32% 77.305 11 Template:Rp"," 5.19% 75.325 1 Template:Short_description"]},"scribunto":{"limitreport-timeusage":{"value":"0.843","limit":"10.000"},"limitreport-memusage":{"value":9235347,"limit":52428800}},"cachereport":{"origin":"mw-web.codfw.main-6fd9bbc867-rgnxt","timestamp":"20250326221148","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Sanofi","url":"https:\/\/en.wikipedia.org\/wiki\/Sanofi","sameAs":"http:\/\/www.wikidata.org\/entity\/Q158205","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q158205","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-03-31T16:54:46Z","dateModified":"2025-03-17T23:08:16Z","headline":"French pharmaceutical company"}</script> </body> </html>